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Lipotoxicity (LTx) is involved in mostly every process of neuronal injury. Using 
NGFDPC12 cells we show that palmitic acid (PA) induces the expression of stress 
response genes HIF-1α and BNIP3, increases the accumulation of reactive oxygen 
species, and decreases cell viability by apoptosis.  Inhibition of cathepsins does not 
rescue neurons from PA-LTx but inhibition of necroptosis and promotion of autophagy 
do.  DHA decreases the expression of HIF-1α and BNIP3 and rescues PA-induced cell 
death by inhibiting apoptosis and necroptosis. Besides DHA stimulates the mRNA 
expression, phosphorylation and conjugation of autophagy controlling proteins.  
Inhibiting autophagy during DHA treatment decreases its capacity to rescue cells form 
PA-LTx.  PA-induced ROS also stimulate the expression of EFABP that could be 
prevented by co-treating the cells with the antioxidant N-Acetyl-Cystein during PA-LTx.  
Conversely lowering EFABP expression by siRNA increases the accumulation of ROS 
and decreases cell viability but stimulating PPARβ and PPARγ with direct agonists 
increases the expression of EFABP and increases cell viability during PA-LTx.  
As a parallel study .5% [O2] hypoxia induces the expression of the same stress 
response genes and triggered apoptosis in NGFDPC12 cells just like PA-LTx. Hypoxia 
 
xiv 
disrupts the architecture of NGFDPC12 cells microscopically by diminishing the body 
size, reducing the confluency, thinning the neurites and producing apoptotic bodies. The 
decrease in cell viability can be prevented with an array of different concentration of 
DHA and the autophagy promoter rapamycin just like in PA-LTx.  Pre-treatment of 
NGFDPC12 cells with DHA and EPA (another PUFA) increases cell viability under 
hypoxia. As in PA-LTx hypoxia also induces ROS and can be prevented with antioxidant 
MCI-186. The mRNA and protein level of FABP5 are also increased under hypoxia and 
can be prevented by co-treatment with antioxidant.  Lastly the hypoxia-induced 








Lipids are major and important components of the brain and the central nervous 
system (CNS).  Due to the complex shape and prominent extension of the plasma 
membranes neurons and glial cells have a high cell membrane to cytoplasmic ratio 
(Bourre et al. 1992).  The cell membrane is a linear mosaic of a fluid lipid bilayer having 
as main components saturated and unsaturated fatty acids, cholesterols and others 
hydrophobic molecules (Zerouga et al. 1991).  Lipids are also important nutrients to the 
brain because of its availability during hypoglycemia and because of its high caloric 
value (Choi et al. 2003). Lipids are also important as biologically active substances either 
by direct participation in signal transduction or modulation of metabolic functions by 
lipids metabolites. Free fatty acids (FA) are classified according to the amount of double 
bonds in their chain. Saturated fatty acids by definition are fatty acid saturated of 
hydrogen atoms in their chain and by definition devoid of carbon-carbon double bonds 
(e.g. stearic acid).  Monounsaturated fatty acids have one carbon-carbon double bond in 
their chain (e.g. oleic acid).  And those fatty acid that have two or more carbon-carbon 
double bonds are called polyunsaturated fatty acids (e.g. DHA).  Not all fatty acids can be 
synthesized endogenously and for this reason some of them have to be acquired from the 
diet.  More important for the present study polyunsaturated fatty acids with double bonds 
at the n3 and n6 position are essential fatty acids and need to be supplied because 
mammals lack the enzymes Δ3-desaturase and Δ6-desaturase respectively.   The most 
well studied polyunsaturated fatty acids, n-3 and n-6, are represented by 
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Docosahexaenoic acid and Arachidonic acid respectively.  They are major component in 
the brain (Sastry 1985).  It’s well established the role of ARA through the body during 
time of injury and stress when it is released from the cell membrane by phospholipase A2 
and metabolized into other bioactive substances such as prostaglandins by enzymes like 
cyclooxygenases, leading to various physiological functions (Bazan et al. 1993, Stella et 
al. 1995, Oomagari et al. 1991).  In general FA are essential nutrients used in a myriad 
array of cellular processes.  They are the building blocks of glycerophospholipids and 
sphingolipids to build all biological membranes.  As the more caloric dense nutrient of 
our diet lipids are used as storehouse for triacylglycerol to be broken down during 
starvation. They are used to modify proteins for signal transduction and immune 
recognition (Afshordel et al. 2015).  During neurogenesis and nerve regeneration 
increased amount of fatty acids are needed to synthesize and expand the neurite network 
which is the hallmark of the nervous system.  Thus, we can conclude that the normal 
function of the nervous system is dependent on the healthy metabolism of fatty acids. 
 
FABP 
Given that the blood is an aqueous media FAs cannot be solubilized easily and 
need the assistance of albumin to be carried in the blood to its destination (Richieri et al. 
1993).  In the blood lipids form complexes with lipoprotein to signal their fate and 
modulate fat metabolism or the metabolism of the tissue where they are taken to (Jacome-
Sosa & Parks 2014, Picq et al. 2010, Voshol et al. 2009). Once inside the cell fatty acids 
and fatty acids binding proteins complexes signal for nuclear hormone receptors like 
peroxisome proliferator-activated receptor (PPAR) for gene expression and protein 
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regulation (Atshaves et al. 2010, Schroeder et al. 2008).   
The interactions of FABPs and their ligands are quite complex. FABPs show a 
variety of ligand specificity, but many FABPs have a general tendency to bind to long-
chain PUFAs more strongly than to short-chain saturated fatty acids (Zimmerman et al. 
2001).  For example, FABP7 shows higher predilection for long PUFAs such as 
eicosapentanoic acid (EPA; 20:5), DHA (22:6), and ARA (24:4), but low binding affinity 
to the saturated fatty acids like lauric acid (12:0), palmitic acid (16:0), and stearic acid 
(18:2), while FABP3 has higher affinity to shorter PUFAs, like oleic acid (18:1), and 
linolenic acid (18:2) than long PUFAs, like EPA and DHA (Balendiran et al. 2000).  
FABP5 binds not only to long PUFAs but also to eicosanoids such as 5 (S)- and 15 (S)- 
hydroperoxyeicosatetraenoic acid (HPETE), which are ARA metabolites, with moderate 
binding affinities (Kane et al. 1996).   
FABP5 (or epidermal fatty acid binding protein, EFABP) in particular, is the one 
expressed the most in the developing brain (Liu et al. 2000, Owada et al. 1996b).  In the 
adult brain, FABP5 expression is observed in both neurons and glia in a region specific 
manner with various intensities (Owada 2008).  FABP5 is induced by peripheral nerve 
injury, indicating its potential role on neuroregeneration (Owada et al. 1996a, De Leon et 
al. 1996).  Although significant expression of FABP5 is observed in the developing brain, 
FABP5-knockout mice are viable and show no significant deficit in the brain at neither 
macro- nor microscopic level (Owada et al. 2002).  But it’s been reported that FABP5 
knockout mice have reduced neurogenesis in the hippocampus (Matsumata et al. 2012). 
FABP5 have been observed to regulate cognitive function such as learning and memory 
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through the degradation of endocannabinoid anandamide and the PPARβ/δ activation (Yu 
et al. 2014).  
Our group has published important observations about FABP5 in neurogenesis, 
differentiation and neuroprotection.  De Leon et al published the findings that fatty acid 
binding protein 5 is induced in neurons of the dorsal root ganglia after peripheral nerve 
injury in the sciatic nerve (De Leon et al. 1996). Liu, et al reported that FABP5 (DA11) 
expression coincides with axon growth and neuronal differentiation during central 
nervous tissue development. There was a correlation in time and space evidenced by 
Northern blots, Western blots and immune- cytochemistry. (Liu et al. 1997).  Allen et al. 
reported that depletion of a fatty acid binding protein impairs neurite outgrowth in PC12 
cells during differentiation with nerve growth factor (Allen et al. 2000).  Along these 
lines, Allen et al. described the same phenomenon in retinal ganglion cells by showing 
induction and axonal localization of FABP5 during differentiation and axon growth 
(Allen et al. 2001).  More recently Liu et al. showed that DHA increases FABP5 
expression and FABP5 mediates DHA/EPA enhanced neurite outgrowth in PC12 cells 
(Liu et al. 2008).  Further,  Liu et al. reported that FABP5 protects nerve growth factor 
differentiated PC12 cells from lipotoxic injury when PPARβ and PPARγ are stimulated 
resulting in decrease ROS and increased cell viability (Liu et al. 2015). 
 
DHA 
DHA is a highly polyunsaturated fatty acid of the ω-3 series with 22 carbon atoms 
and six cis double bonds.  This chemical arrangement gives DHA the curved (kinked or 
bent) structure that is key to its capacity to increase the fluidity of membranes (Stillwell 
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& Wassall 2003, Hashimoto et al. 1999). In a diverse array of experiments increasing 
membrane fluidity resulted in increased drug permeability (Roach et al. 2004), carrier 
mediated transport (Wu & Robinson 1999), activities of membrane-bound enzymes 
(Keeffe et al. 1980), and enhanced neurotransmission (Clarke et al. 1999). The common 
biochemical event to all these processes is the microaggregation and conformational 
change of receptors and enzymes at the membrane surface. The strongest inducer of 
membrane fluidity is ω-3 polyunsaturated fatty acid specially DHA (Hashimoto et al. 
1999, Onuki et al. 2006).  Yehuda et al. (Yehuda et al. 1997) showed that 
polyunsaturated fatty acids affect brain functions by modifying membrane fluidity, 
activity of membrane-bound enzymes, number and affinity of receptors, functions of ion 
channels, production and activity of neurotransmitter, and signal transduction.  Moreover, 
an increased incorporation of DHA into synaptic membranes reportedly improves signal 
transduction involving phospholipase A2 and/or C (Jones et al. 1997), enhances 
glutaminergic (Kim et al. 2011) and dopaminergic (Zimmer et al. 1998) synaptic 
activities, and enhances [
3
H]-noradrenaline release in SH-SY5Y cultured cells (Mathieu 
et al. 2010).  Lastly Hashimoto et al. (Hashimoto et al. 2006) has reported that 
neurobehavioral effects, particularly avoidance-related memory function, are associated 
with neuronal plasma membrane fluidity. 
DHA has antioxidant properties.  This might sound counterintuitive because DHA 
is highly polyunsaturated and an increase in the number of double bonds renders cells 
more susceptible to damage by oxidation (Saito & Nakatsugawa 1994).  It is published 
that the concentration of Arachidonic acid (ω-6 polyunsaturated fatty acid) is positively 
correlated with the levels of lipid peroxidation; however, the concentration of DHA was 
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negatively correlated with levels of lipid peroxidation. Based on these findings the 
authors concluded that the molar ratio of DHA/AA acted as an indicator of antioxidant 
defense (Bondy & Orozco 1994).  Also working as an indirect antioxidant oral 
administration of DHA increase the enzyme activity of catalase, glutathione peroxidase 
(GPx) and glutathione reductase (GR) (Hossain et al. 1999).    
Dietary supplementation with DHA restores neurotransmitter release and 
impairment in expression of long term potentiation (Fujita et al. 2001).  N-Methyl-D-
Aspartate (NMDA) receptor is key for the induction of long term potentiation. Inhibitors 
of NMDAR such as AP5 (Morris 1989) stop the induction of long term potentiation in 
the hippocampus.  Transgenic mice with increased NMDAR expression, showed 
increased memory (Tang et al. 2001).  DHA increased the mRNA expression of the 
NMDA receptor in the hippocampus of DHA fed rats compared to control (Hashimoto et 
al. 2017).  Therefore DHA seems to be important for memory consolidation because it 
increases the expression and/or activation of mostly every key protein involved in long 
term potentiation like BDNF (brain derived neurotrophic factor) (Bhatia et al. 2011), 
NR2B (a subcomponent of the NMDA receptor) (Dyall et al. 2007), and TrKB (tyrosine 
protein kinase B) involved in differentiation and survival of specific neuronal population 
(Bhatia et al. 2011).   Taken together DHA directly or indirectly regulates the expression 
of various genes and may exert increasing effects on learning and memory.  
Moreover DHA elevated the number of Tuj-1-positive neurons (marker of neural 
stem cells) taken from the dentate gyrus of the hippocampus  when compared with that of 
control after 4 or 7 days of cultures from 15 day old rat embryos (Kawakita et al. 2006). 
The DHA treated cells were morphologically more mature and numerous than that of 
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control.   This observation is worth noting because the dentate gyrus is critical for 
forming and storing spatial memories. It is one of the regions of the brain where neuronal 
progenitor cells constantly produced new neurons (neurogenesis), which then integrate 
into the new neuronal network and form new synapses with other neurons (Gross 2000). 
The proposed mechanism is that DHA stimulated the differentiation of neuronal stem 
cells into neurons by inducing the exit from cell cycle and suppressing cell death.  
Another mechanism by which DHA exerts its effect is by modifying lipid-raft 
domain in the cell membrane.  Lipid rafts or caveolae are specialized membrane 
structures composed of saturated fatty acids and cholesterol-rich membrane-invaginated 
floating microdomains.  The enrichment of DHA in these lipid-raft domains induces the 
expulsion of cholesterol and saturated fatty acids, and renders it more fluid for better 
protein-protein and lipid-protein interaction that facilitates specific signal transduction 
(Eckert PE. Manipulation of lipid rafts in neuronal cells. Open Biol J. 2010;3:32-38).  
Lipid rafts are involved in intracellular trafficking of proteins and lipids, secretory-
endocytic pathways, signal transduction, inflammatory and proteolytic signals (Tsui-
Pierchala et al. 2002).  
DHA is now recognized as an important signaling molecule, particularly in brain 
function.  EPA, (20:5, n-3) the precursor of DHA, can act as a substrate for the AA-
cascade enzyme, producing alternatives eicosanoids such as 3-series prostanoids and 5-
series leukotrienes, which are considered to be anti-inflammatory and/or less pro-
inflammatory than AA-derived metabolites (Moreno 2009).  Recently DHA-derived 
mediators (docosanoids) have been reported in brain circuity.  The best well known is 
neuroprotective D-1 (NPD1), formed from free DHA through 15-lipoxygenase-1 (15-
 
8 
LOX-1) (Bazan et al. 2011). NPD1 has been reported to decrease Aβ42 release in 
Alzheimer’s disease (Lukiw et al. 2005), and to downregulate inflammatory signaling, 
amyloidogenic APP cleavage and apoptosis (Chen et al. 2012). It’s been described that 
NPD1 interacts with peroxisome-proliferator activated receptor-γ (PPARγ), and induces 
the expression of genes which control lipoprotein metabolism, adipogenesis and insulin 
sensitivity (Tontonoz & Spiegelman 2008, Zhao et al. 2011).  The induction of these 
proteins enhances survival of neurons under circumstances of chronic ischemia and 
Alzheimer’s disease.  Many other DHA-derived docosanoids metabolites like oxylipines, 
neuroprostanes, protectines, maresines and resolvines have already been identified but 
their specific function remains unknown (Galano et al. 2018).  
Our group has reported diverse effect of DHA on neurons during differentiation, 
lipotoxicity and spinal cord injury.  Almaguel et al reported that NGFDPC12 cells co-
treated with PA and DHA (PA+DHA) from the start exhibited increased cell viability.  
Interestingly, NGFDPC12 cells pre-incubated in DHA for 12 hours before PA treatment 
(there was no DHA during PA treatment) showed a moderate decrease in viability when 
compared to control cells and cells undergoing lipotoxicity without previous DHA 
treatment. DHA decreased the morphological features of apoptosis as well as apoptotic 
nuclei during lipotoxicity. Also, DHA co-treatment inhibited the PA-induced apoptotic 
cleavage of PARP and Lamin-B.  More over DHA stabilized mitochondrial membrane 
potential.  The PA-LTx induced apoptosis and reversal with DHA was also tested in 
primary rat cortical cells (Almaguel et al. 2009).  In another series of experiment 
Almaguel et al. published again that DHA keeps the integrity of lysosomal membranes 
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during PA-LTx and prevents cathepsin-L over spilling from the lysosomes (Almaguel et 
al. 2010).    
Using Sprague-Dawley rats Figueroa et al. (Figueroa et al. 2012) showed that 
injection of DHA through the tail vein before spinal cord injury ameliorates functional 
locomotor deficits and inhibits the apoptotic pathway but not necessarily the 
inflammatory pathway.  In 2013 Figueroa et al. also published that spinal cord injury 
triggers a robust alteration in the cord PUFA neurolipidome, which was characterized by 
a marked docosahexaenoic acid (DHA) deficiency.  Pre-treated animals with DHA 
exhibited lower sensory deficits, better autonomic bladder recovery, and early 
improvements in locomotion that persisted for at least 8 weeks after trauma (Figueroa et 
al. 2013a).  In another work done the same year Figueroa et al. showed that ω-3 PUFAs 
provides significant antinociceptive benefits and attenuated the development of below-
level thermal hyperalgesia.  Also, metabolomic profiling revealed that DHA led to 
accumulation of novel N-acyl ethanolamines precursors including the glycerophospho-
containing docosahexaenoyl ethanolamine (DHEA), docosapentaenoyl ethanolamine 
(DPEA), and eicosapentaenoyl ethanolamine (EPEA) (Figueroa et al. 2013b).  And lastly 
in 2014 Figueroa et al. used Sprague-Dawley rats to identify and define the dominant 
metabolic pathways targeted by dietary long chain ω-3 poly unsaturated fatty acids. They 
reported that the spinal cord metabolome of animals fed with long chain ω-3 PUFA 
exhibited increases in the level of antioxidant/ anti-inflammatory amino acids and 






Autophagy is the degradative mechanism with higher capacity in the cell. 
Contrary to ubiquitin-proteasome degradation, autophagy is a lysosomal degradation 
pathway that is able to target large protein aggregates and even entire organelles.  It is not 
restricted to protein degradation but breaks down lipids, DNA and RNA so that they can 
be recycled for energy or building materials (Wirawan et al. 2012).  Autophagy is 
generally considered to be a pro-survival pathway protecting cells under stress or poor 
nutrient conditions.  In this way autophagy provides new pools of amino acids, fatty acids 
and nucleosides for anabolic process and drives a continuous flow of materials in the cell 
(Rabinowitz & White 2010). Autophagy preserves the health of cells and tissues by 
replacing old, outdated and damaged cellular components and even whole organelles with 
new ones. During starvation, hypoxia or high oxidative stress it provides an internal 
source of nutrients for energy generation and survival. Autophagy is particularly 
important in neurons because they are non-dividing cells and are more sensitive to 
accumulation of toxic components (Hara et al. 2006). Second, the brain needs a constant 
supply of energy even under conditions of stress like ischemia, starvation or infection. 
It’s well known that inhibition of autophagy causes neurodegeneration in mature neurons 
indicating that autophagy may regulate neuronal homeostasis (Komatsu et al. 2006).  
Many stress signals stimulate both autophagy and apoptosis and at the same time 
autophagy and apoptosis are regulating each other. The Bcl-2-binding factor Beclin-1 
(ATG6) is the central protein controlling this process (Glick et al. 2010). Beclin-1 
associates with VPS34 (vacuolar protein sorting 34) and initiates the isolation of double 
membrane to start autophagy. This Beclin-1/VPS34 complex is inhibited when bound by 
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Bcl-2 mainly or Bcl-X.  In the situation that c-Jun N-terminal kinases (JNK) is activated, 
which causes Bcl-2 phosphorylation, frees Beclin-1 to form active Beclin-1/VPS34 
complex and initiate autophagy. Another control of autophagy is the activation of DAPK 
(death associated protein kinase), which causes the phosphorylation of Beclin-1 and also 
frees Beclin-1 to form active Beclin-1/VPS34 complex to initiate autophagy (Todde et al. 
2009). Autophagy is able to inhibit apoptosis, by means of reducing damaged 
mitochondria (mitophagy) or pro-apoptotic proteins (Green & Levine 2014).  When the 
intensity of stress overcome the capability of autophagy, the apoptosis-stimulated 
caspases may digest essential autophagy proteins and disable autophagy pathway (Long 
& Ryan 2012) or Bcl-2 is inactivated and not able to inhibit Bak and Bax leading to 
apoptosis (Mizushima & Levine 2010).  There is a line of thought regarding autophagy as 
a cell death mechanism. This rational comes from the fact that autophagy inhibitors 
sometimes stimulate cell survival (Zhang et al. 2009b). The main reason is that the 
regulation of autophagy is context dependent. Autophagy inhibitor Bafilomaycin-1 works 
by neutralizing (inhibiting the acidification) lysosomal pH and 3-methyladenine (3-MA), 
a PI3K inhibitor, by modulating mTOR activity. When a stress is severe or ATP 
deficiency is prolonged, the integrity of lysosomes or autophagolysosomes will be 
impaired and the vesicle contents of autolysome may be spilled into the cytoplasm, i.e. 
hyperautophagy. At this point, reducing hydrolazes/cathepsins activity by increasing pH 
(in the case of Bafilomaycin-1) or decreasing additional autolysome formation (in the 
case of 3-MA) may provide cells temporary protective effect.   
Additionally, the nutrient environment may affect the effect of 3-MA. It is shown 
that 3-MA promotes autophagy under nutrient-rich conditions, whereas 3-MA inhibits 
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starvation-induced autophagy. These results are attributed to differential effects on class I 
versus class III PI3K (Wu et al. 2010). Therefore, the mere accumulation of autophagic 
vesicles when cells were dying cannot be interpreted as an evidence of autophagic cell 
death (ACD), this may actually reflect death accompanied by the block of autophagic 
flux with its concomitant accumulation of vacuoles rather than death mediated by 
autophagy itself (Marino et al. 2014).  Under stress, the cell will ramp up the autophagic 
flux to get rid of harmful products in an effort to cope with the challenge. But if the 
damaged products cannot be degraded, the apoptotic or necroptotic machinery (that has 
some autophagic features like cathepsins activation) will prevail. 
Moreover, most of the research done where autophagy was described as a cell 
death process mechanism is either using cancer cells or tumor models where the specific 
microenvironment of starvation and hypoxia inside of the tumor promote the increase in 
survival genes, proteins and autophagy (Xie & Klionsky 2007).  However, in mammals 
ACD is one mechanism of cell death through a non-apoptotic or necrotic pathway that is 
documented in pathological or drug-induced conditions (Zhu et al. 2007). 
Autophagy morphology is often evident in cells going through programed cell 
death because it shares some of the machinery with apoptosis and necroptosis (Lu et al. 
2011). This tightly controlled interaction within the death-inducing signaling complex 
comprises FADD, RIP1, caspase 8 and some of the catalytic proteins for autophagy, 
ATG5:ATG12 and ATG16 (Bell et al. 2008). The constant inhibition of necroptosis by 
basal caspase 8 maintains a basal level of autophagy and the constant basal level of 
autophagy will digest caspase 8 to inhibit the apoptotic cascade.  By inhibiting Beclin-1 
by Bcl-2 the cell secures that neither necroptosis nor enhanced autophagy take place (Luo 
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& Rubinsztein 2010, Maiuri et al. 2007). In a T-cell model lacking caspase 8 and FADD 
the cell develops a hyperautophagic morphology and dies from necroptosis, which could 
be prevented with necroptosis inhibitor and deletion of RIP3K, (Lu et al. 2011). 
 
Lipotoxicity 
Overweight and obesity are rampant in United States of America. According to 
the CDC 34% of the population are obese and over two thirds are overweight and/or 
obese in the United States (https://www.cdc.gov/obesity/data/adult.html, accessed May 
2018).  Consumption of a diet rich in fats increases the levels of saturated fatty acids in 
serum (Gambino et al. 2016) and brain particularly the hypothalamus (Posey et al. 2009).  
The most abundant saturated fatty acid in the diet is Palmitic Acid and the one most 
elevated after an oral fat load (Gambino et al. 2016).  When the storing capacity of 
adipocytes has reached its maximum, lipids are distributed to other organs triggering 
lipotoxicity. This over spilling of lipid to the peripheral tissue promotes visceral obesity 
and the onset of type 2 diabetes mellitus among other diseases (Guilherme et al. 2008, 
Unger & Scherer 2010).   
The accumulation of Palmitic Acid and its metabolites in the hypothalamus 
induces inflammation in the tissue and cell stress at endoplasmic reticulum level with a 
decrease in insulin signaling, metabolic derangement and more weight gain and obesity 
(Benoit et al. 2009) (Posey et al. 2009).  In cultured hypothalamic neuropeptide Y cells 
exposed to palmitic acid a decreased in insulin signaling could be observed as evidenced 
by reduced insulin-stimulated phosphor Akt and increased caspase-3 protein levels 
(Mayer & Belsham 2010).  It’s been also reported that this 16 carbon free fatty acid in 
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hypothalamic neurons in vitro increases the mRNA expression of pro-inflammatory 
cytokines IL-6, TNF-α, and IL-1β, the classical endoplasmic reticulum markers Chop, 
Bax/Bax, increased Bax/Bcl-2 ratio, and Grp78 among others protein involved in the 
unfolded protein response. (Dalvi et al. 2017, McFadden et al. 2014, Ye et al. 2016). The 
palmitic acid metabolite ceramide is associated with insulin resistance and apoptosis in 
hypothalamic neurons in Zucker diabetic rats (Chavez et al. 2003, Contreras et al. 2014).   
The detrimental effects of FFA and PA in particular are not only observed in 
neuronal tissue.  Gao et al (Gao et al. 2014) described that palmitate impairs endothelial 
function through COX-2 up-regulation and COX-2-dependent ROS over-production in 
mouse aortic endothelial cells. Palmitic acid triggers inflammation through activation of 
toll-like receptor-dependent IKKα-NF-κB signaling in human endothelial cells (Maloney 
et al. 2009), increases endoplasmic reticulum stress and apoptosis in mouse endothelial 
cells (Li et al. 2013), and promotes ROS formation from mitochondrial electron transport 
chain and NADPH oxidase in rat skeletal muscle (Lambertucci et al. 2008). In diabetic 
and obese individuals, increased saturated fatty acids stimulate prostaglandin production 
(Hellmann et al. 2013). FFAs activate protein kinase C and reduces endothelium-
dependent relaxations in rat aortas (Li et al. 2011) while inhibition of protein kinase C or 
adenosine monophosphate-activated kinase attenuates the stimulatory effect of PA on 
ROS production in human endothelial cells (Mugabo et al. 2011). In addition, PA lowers 
nitric oxide (NO) bioavailability through reducing the phosphorylation of Akt and eNOS 
(Tian et al. 2012). 
Palmitic acid also induces reactive oxygen species (ROS) production with lose of 
mitochondrial membrane potential (Δψm) and mitochondrial induced cell death 
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(Lambertucci et al. 2008, Koshkin et al. 2008).  In pancreatic β-cell lines lipotoxicity 
induces the Ca-dependent assembly of the mitochondrial permeability transition pore 
(MTP).  Palmitate was significantly a more efficient inducer of MPT than the unsaturated 
FA oleate, although upon acute application both caused similar MPT activation. 
Treatment with antioxidants, inhibitors of the ceramide pathway, or modifiers of 
membrane fluidity did not protect β-cell mitochondria from FA exposure. However, 
significant protection was provided by co-application of the unsaturated FA oleate in a 
phosphatidylinositol 3-kinase-dependent manner (Koshkin et al. 2008).   
According to the center for disease control (https://www.cdc.gov/stroke/facts.htm 
accessed April 2018) every year more than 795,000 people have a stroke. About 610,000 
of these are first or new strokes and 140,000 will die of stroke each year.  The cost to the 
United States is estimated at $34 billion each year and is a leading cause of serious long-
term disability and immobility in more than half of the stroke survivors.  The cardinal 
features observed during stroke or traumatic brain injury are glutamate release, increased 
intracellular Ca
2+
 levels, phospholipids degradation, local accumulation of free fatty 
acids, free radical formation and lipid peroxidation (White et al. 2000).  FFAs play an 
important role in what is called the delayed phase of neuronal injury.  FFAs accumulate 
in response to ischemia-hypoxia as a consequence of lecithinases and phospholipases 
activation with concomitant membrane degradation (Bazan et al. 1971) (Belayev et al. 
2004).  After injury the fatty acids with the higher concentration expressed in the CSF are 
C16:0˃C18:0˃C18:1˃C20:4˃C22:6 (Sun et al. 1994).  This accumulation is central to 
the delayed phase that induces apoptosis in the area of the penumbra days later after the 
original insult (Sun & Gilboe 1994). 
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Our group has published that palmitic acid at concentrations comparable to those 
found following traumatic brain injury, trigger cell death. NGFDPC12 cells exposed to 
oleic and arachidonic acids display normal cell survival. However, when cells are 
exposed to stearic and palmitic acids, there is a dramatic loss of cell viability that is 
apoptotic as assessed by morphological analysis, and activation of caspase-8 and caspase-
3-like activities (Ulloth et al. 2003).  We also have published that in NGFDPC12 cells 
PA induces reactive oxygen species, alteration of the mitochondrial transmembrane 
potential, and increase in the mRNA levels cell death-associated proteins BNIP3 and 
FAS receptor (Almaguel et al. 2009).  A year later Almaguel et al. published that PA 
induces lysosomal membrane permeabilization before mitochondrial membrane 
permeabilization and cathepsin L activation in NGFDPC12 cells (Almaguel et al. 2010). 
In 2011 Padilla et al. reported that in Schwann cells hyperglycemia magnifies cell 
dysfunction during PA-LTx as measured by a decrease in Ca
2+
 and an increase in 
endoplasmic reticulum stress signature genes CHOP, XBP1 and GRP78 with cell death 
measured by Annexin V/7AAD (Padilla et al. 2011).   
 
Apoptosis 
Apoptosis is one of several types of programmed cell death and is described by its 
microscopical morphological characteristics like nuclear condensation and fragmentation 
(pyknosis and karyorrhexis respectively), blebbing of the plasma membrane and at the 
end apoptotic bodies (Marino et al. 2014).  Besides morphological changes there are 
some biochemical events that execute apoptosis.  Mitochondrial outer membrane 
permeabilization (MOMP), activation of the effector caspases like caspase 3, caspase 6, 
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and caspase 7 and the activation of catabolic hydrolases that degrades the DNA in the 
nucleus (Galluzzi et al. 2009).  In physiological terms the whole events of apoptosis are 
rarely seen because apoptotic cells are engulfed and degraded by phagocytic cells before 
the full apoptotic phenotype can be displayed (Galluzzi et al. 2009).  
Depending on the kind of trigger apoptosis is described in two categories albeit 
the final outcome is the same.  Extrinsic apoptotic pathway occurs in response to 
stimulation of the death receptors, which are CD95 (also known as FAS), tumor necrosis 
factor receptor 1 or TNF-related apoptosis-inducing ligand receptor (TRAILR). This 
results in the recruitment of several proteins, including FAS-associated death domain 
(FADD), TNFR1-associated death domain (TRADD) and caspase 8. Activated caspase 8 
then proteolytically activates downstream effector caspases or truncates the BH3 (BCL-2 
homology 3)-only protein BID (BH3-interacting domain death agonist), which co-
activates the intrinsic pathway of apoptosis by translocating to mitochondria. 
On the other hand, the intrinsic apoptosis pathway is mainly a mitochondrial 
triggered event.  Any stimulus that destabilizes the mitochondria membrane potential 
induces the mitochondrial membrane permeabilization pore with its concomitant 
cytochrome C release from the intermembrane space.  Once cytochrome C is in the 
cytosol it triggers the assembly of a caspase-activating complex between caspase 9 and 
apoptotic protease-activating factor 1 (APAF1; the apoptosome).  Mitochondrial outer 
membrane permeabilization (MOMP) can be triggered by the activation of BH3-only 
proteins following their mobilization from other subcellular compartments and their post-
translational modification (such as phosphorylation or proteolysis) or transcriptional 
upregulation (for instance in response to p53 activation) (Vousden & Lane 2007).  BH3-
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only proteins generally stimulate MOMP by inducing the oligomerization of Bcl-2-
associated X protein (BAX) and/or Bcl-2 antagonist or killer (BAK) in the outer 
mitochondrial membrane, an in this way forming channels that mediate the liberation of 
soluble proteins from the mitochondrial intermembrane space (Adams & Cory 2007, 
Galonek & Hardwick 2006).  Another intrinsic trigger for apoptosis is DNA damage that 
stimulates the transactivation of genes encoding pro-apoptotic proteins such as NOXA 
and PUMA (p53 upregulated modulator of apoptosis) by p53, or activated caspase 2 in a 
p53-dependent manner. Caspase 2 may then induce MOMP and activate other caspases, 
such as caspase 3, directly. It is worth noting that some of the protein released from the 
mitochondria can also induced caspase independent cell death. Proteins like apoptosis-
inducing factor (AIF) and endonuclease G (EndoG) can promote caspase-independent 
cell death (Kroemer & Martin 2005) that can be due to lysosomal membrane 
permeabilization (LMP) and release of cathepsin proteases into the cytosol (Boya & 
Kroemer 2008). In turn cathepsins can also trigger MOMP, thereby stimulating the 
intrinsic apoptotic pathway (Boya & Kroemer 2008). 
 
Necrosis / Necroptosis 
Distinct from apoptosis, the morphology of necrosis is characterized by cell 
swelling, plasma membrane permeabilization and finally rupture with spilling of 
intracellular products inducing inflammation (Vandenabeele et al. 2010b).  Some have 
described necrosis with features of lysosomal degradation, release of lysosomal 
hydrolases and increased breakdown of the cell membrane and organelles (Boya & 
Kroemer 2008).  Different from apoptosis, the nuclei of necrotic cells remains largely 
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intact (Vandenabeele et al. 2010b).  As a surprised to the field of cell death Vercammen 
et al. (Vercammen et al. 1998)  showed that classical death receptors could induce 
necrosis upon inhibition of apoptosis by the caspase inhibitor, zVAD-fmk.  Later on, 
others reported that this kind of cell death involved the activation of kinases of the 
receptor interacting protein (RIP) family, RIP1 and RIP3 (Holler et al. 2000, He et al. 
2009, Zhang et al. 2009a).  In 2005 Degterev et al. (Degterev et al. 2005) discovered that 
necrostatin-1 was a potent inhibitor of this kind of programmed necrosis cell death and it 
was given the name necroptosis.   
The best characterized signal for necroptosis is the tumor necrosis factor receptor 
1 (TNFR1), which induces the assembly of a cytoplasmic complex (TNFR1 complex1) 
composed of TNFR-associated death domain (TRADD), cellular inhibitor of apoptosis 1 
(cIAP1), cIAP2 and as we mentioned before receptor interacting protein kinase 1 (RIP1 
or RIPK1) (Chan et al. 2003).  Once the complex I is formed, RIP1 might be targeted for 
ubiquitylation by cIAP and for deubiquitylation by cylindromatosis (CYLD) and A20 
(another name TNFAIP3) (Csomos et al. 2009, Rothe et al. 1995).  The two possible 
outcomes are ubiquitylated RIP1 promoting the activation of nuclear factor-κB (NF-κB 
system) that activates cytoprotective genes and facilitates cell survival or deubiquitylated 
RIP1 functioning as a cell death-inducing kinase.  If the TNFR1 is internalized, it 
combines with TRADD, FAS-associated protein with a death domain (FADD) and 
caspase 8 forming what is called complex II (Micheau & Tschopp 2003, Christofferson & 
Yuan 2010).  In a normal physiological situation once the complex II is formed, caspase 
8 becomes activated triggering the pro-apoptotic caspase. Caspase 8 inactivates RIP1 and 
RIP3 by proteolytic cleavage and initiates the pro-apoptotic caspase cascade (Feng et al. 
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2007).  If caspase 8 is deleted, depleted or inhibited, complex II cannot enter the 
apoptotic mode and TNFR1 ligation results in RIP1 physically and functionally 
interacting with RIP3 forming the necrosome complex and inducing  (at least in some cell 
types) programmed necrosis or necroptosis (Vercammen et al. 1998).  
Necrostatin 1 abolishes the assembly of the RIP1–RIP3 complex, suggesting that 
the kinase activity of RIP1 is required for necrosome formation.  Necroptosis depends on 
a tightly regulated mutual relationship between RIP1 and RIP3 kinase activities, 
involving the autophosphorylation of RIP1 on Ser161 and direct or indirect RIP3-
mediated phosphorylation of RIP1 (He et al. 2009).  The inhibition of RIP1 by 
necrostatin 1 truncates (in most systems) the RIP1-RIP3 interaction and abolishes 
necroptosis.  There are some examples where RIP1 was not required for the execution of 
necroptosis.  In a murine model cytomegalovirus infection was shown to induce RIP3-
dependent but RIP1 independent necroptosis (Upton et al. 2010).  Overexpression of 
catalytically active RIP3 can trigger necroptosis irrespective of the presence of RIP1 
(Zhang et al. 2009a).  According to Vandenabeele ((Vandenabeele et al. 2010b) the RIP1 
independent necroptosis is always induced in a virus infected model in vivo or in vitro.  
We infer that because (as we will show in chapter 2)  the type of necroptosis we induced 
with the PA and zVAD combination is the classical necrosome dependent cascade, 
necrostatin 1 is able to block it and increase cell survival.  
ROS also seem to play a role in necroptosis cell death.  Although ROS production 
is not necessary for all cases of TNF-induced necrosis, the kinase activity of RIP3 might 
link TNFR1, mitochondria functional status and ROS production.  RIP3 interacts with 
several metabolic enzymes like glycogen phophorylase (PYGL), glutamate-ammonia 
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ligase (GLUL) and glutamate dehydrogenase (GLUD1) (Vandenabeele et al. 2010a). 
These enzymes are directly involved in the metabolism of energy substrates and 
indirectly induce the production of ROS resulting in unbalance redox status.  Knock 
down of any of these enzymes attenuates TNF plus zVAD.fmk-mediated ROS production 
and necroptosis (Zhang et al. 2009a).  We propose that PA-LTx-dependent ROS induces 
the cellular signaling necessary for complex II formation and as we will see in chapter 2 
the presence of zVAD.fmk will tip the scale for necroptosis.  ROS can react with 
polyunsaturated fatty acids in cellular membranes to generate reactive aldehydes (such as 
4-hydroxynonenal), they in turn can oxidase proteins and lipids in organelles and 
membranes, thereby affecting their structure and function (Benedetti et al. 1980).  In 
mitochondria, the products of lipid peroxidation inhibit oxidative phosphorylation, alters 
the permeability of the inner membrane, disrupts the mitochondrial Δψ and reduce the 
Ca
2+
 buffering capacity, thus contributing to necrosis (Orrenius et al. 2007).  And what 
might be the final outcome, destabilization of cellular membranes due to lipid 
peroxidation (including the plasma, lysosomal and ER membranes) results in a leakage of 
proteases or an elevation of cytosolic Ca
2+
 concentrations, two events that take place in 
necrotic cell death (Benedetti et al. 1980). Taking all of this information into 
consideration we conclude that inhibition of necroptosis (in this present study by the 
RIP1 inhibitor necrostatin-1) can confer consistent neuroprotection, suggesting that 
necroptosis may constitute a promising target for treating nerve injury. 
 
Hypoxia 
The brain utilizes 20-25% of all oxygen consumed by the body (Hoiland et al. 
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2016).  The neurons or the central nervous system in general have no capacity to store 
substrates for ATP production because it doesn’t store glucose nor oxygen to be used on 
demand.  Therefore disruption of cerebral blood flow rapidly results in a hypoxic or 
anoxic state that triggers an array of mechanism leading to cell death (Guo et al. 2011).  
The classical description of CNS injury during hypoxia (Dirnagl et al. 1999) is a sharp 
decrease in pH, glutamate excitotoxicity, production of oxygen free radicals and 
oxidative stress, with acute necrosis with inflammation followed by prolonged periods of 
delayed cell death by apoptosis.  Mitochondria respiratory dysfunction results in 
decreased ATP and the formation of reactive oxygen species. On the other hand, 
excitatory neurotransmitters, such as glutamate, bind to a variety of receptors allowing 
for an influx of calcium ions with depolarization (Nathaniel et al. 2015).  Because 
glutamate reuptake is an energy driven process, the lack of ATP availability during 
hypoxia allows for glutamate to persist more time in the neural cleft and induce more 




 pump fails to 
extrude Ca
2+
 out and the resultant high intracellular Ca
2+
 triggers a series of events that 
end up in mitochondrial dysfunction and cell death (Thushara Vijayakumar et al. 2016).  
This accidental and not-regulated type of cell death cannot be prevented or modulated.  
This type of cell death will induce the release of DAMPs (damage-associated molecular 
patterns) that eventually will have a toxic effects on surrounding cells that survived the 
initial insult and will make the primary injury bigger (van der Kooij et al. 2010).  The 
main forms of delayed or regulated cell death under hypoxia are apoptosis and to a lesser 
extent necroptosis of which we already spoke about in their respective sections of this 
introduction.  The main mediator of hypoxia induced endotoxicity is the activation of 
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HIF-1α (hypoxia inducible factor-1α) that induces the activation of stress response 
protein or cell death pathways.  HIF-1α is part of the heterodimer Hypoxia Inducible 
Factor (HIF). Under normoxia conditions HIF-1α is hydroxylated by proline 
hydroxylases and targeted for proteasome degradation via von Hippel Lindau E3 
ubiquitine ligase complex.  Under hypoxia conditions, proline hydroxylase is not able to 
hydroxylate HIF-1α rendering it stable and able to interact with HIF-β becoming a 
heterodimer that stimulates the expression of hundreds of Hypoxia Response Elements-
containing genes (Bargiela et al. 2018). 
HIF-1α induces the expression and interacts with BNIP3 (Bcl-2 adenovirus E1B 
19-kDa interacting protein 3) (Bellot et al. 2009). This interaction at the early stages of 
the injury hinders the capacity of Bcl-2 to inhibit the master protein controlling 
autophagy, Beclin-1 also known as ATG6 (Kim et al. 2013).  Once Bcl-2 is inhibited 
Beclin-1 could be phosphorylated and the Beclin1-Vps34-ATGs-LC3 complex can be 
assembled (Codogno et al. 2011). This interaction has preference when ATP is available 
and takes place near the ER membrane.  As we will demonstrate in chapter 4 this is the 
route for survival in our model. When the availability of oxygen and energy is low and 
the amount of reactive oxygen species is high the interaction of HIF-1α with BNIP3 
during cell injury and stress will tip the cell machinery into cell death. This other 
mechanism is spatially separated and takes place in the vicinity of the mitochondria.  This 
time HIF-1α+BNIP3 will prevent the interaction of Bcl-2 in another domain with pro-
apoptotic protein Bax (Bcl-2-associated X protein) and Bak (Bcl-2 antagonist/killer 1) 
(Ravagnan et al. 2002).  The activation of these proteins at the mitochondrial membrane 
elicit the formation of the mitochondrial transition pore with cytochrome C release from 
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the mitochondria.  Cytochrome C release will form the complex (apoptosome) with 
deoxy-ATP, apoptotic peptidase-activating factor 1 (APAF-1) and caspase-9 leading to 
the downstream activation of the executioner caspase-3 (Li et al. 1997). 
It’s been well known for many years the benefits of polyunsaturated fatty acids in 
the whole body and nervous system. In the heart eicosapentaenoic acid protects 
cardiomyoblasts from lipotoxicity in an autophagy dependent manner (Hsu et al. 2018).  
In new born piglets DHA reduced oxidative stress and lipid peroxidation following 
hypoxia-ischemia in new born piglets (Huun et al. 2018).  In a model of traumatic brain 
injury in rats DHA provided neuroprotection via activating Nrf2-ARE signaling (Zhu et 
al. 2018).  In this case DHA decreased the expression of Bax and cleavage of caspase-3 
and increased the activity of Bcl-2.  In the section of DHA we discussed more of the 
effect of DHA and what our lab already has published in regard to polyunsaturated fatty 
acids.    
It is our purpose in chapter four to test the effect of DHA in NGFDPC12 cells 
subjected to a subacute 48 hours hypoxia at .5% [O2] concentration.  We hypothesize that 
DHA will stimulate the protective response by inducing LC3 and autophagy. There is 
activation of phospholipases during hypoxia, particularly phospholipase A2 (PLA2).  
PLA2 releases free fatty acids from the membranes and add the effect of lipotoxicity with 
peroxidation of other molecules to the already dire condition of the stressed cell.  By 
stimulating autophagy DHA helps the cell to eliminate damage proteins, organelles and 
even mitochondria and prevent the cascade of cytochrome C release with activation of 
caspases or the induction of necroptosis when oxygen concentration is low and ATP is 
not available.  We believe that the mechanism induced by DHA and the proteins it 
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activates are targets for therapeutic options during CNS injury by hypoxia, trauma or 
degenerative disease.  
 
Hypothesis and Goals 
In light of the implications for neuronal lipotoxicity, understanding the 
mechanisms of PA-induced cell death is key to develop a strategy for neuroprotection. A 
better comprehension of the cell death events taking place during PA-LTx and hypoxia 
gives us an opportunity to tackle key proteins and pathways that can be modulated for a 
better outcome.  DHA inhibiting apoptosis and necroptosis and inducing autophagy is a 
novel finding and gives great significance to our project.  The long term goal of this study 
is to elucidate the mechanisms by which DHA induces its neuroprotective effect, so we 
can identify key players and exploit the manipulation for neuronal cell survival. The 
objective of this research is to understand how DHA divert the cell from apoptosis/ 
necroptosis into autophagy.  The central hypothesis is that the presence of DHA in an 
augmented concentration will make the membranes more fluid, allow the activation of 
pro-autophagy proteins and facilitate the formation of the autophagofore during PA-LTx, 
hypoxia or another ROS producing environment. The rational of the study is that the 
unique chemical properties of polyunsaturated fatty acid gives DHA the capacity to keep 
the autophagic flux in the cell.  We will focus on the capacity of DHA to inhibit or induce 
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Lipotoxicity (LTx) leads to cellular dysfunction and cell death and has been 
proposed to be an underlying process during traumatic and hypoxic injuries and 
neurodegenerative conditions in the nervous system. The objective of this study is to 
identify cellular LTx mechanisms and examine whether autophagy mediates the 
neuroprotective function of docosahexaenoic acid (DHA). Nerve growth factor-
differentiated pheochromocytoma (NGFDPC12) cells exposed to palmitic acid (PA) 
show a significant PA-induced lipotoxicity (PA-LTx), evidenced by induction of 
apoptosis and increased HIF-1α and BNIP3 gene expression. Treating NGFDPC12 cells 
undergoing PA-LTx with the pan-caspase inhibitor ZVAD was not protective, and shifted 
the process from apoptosis to necroptosis confirmed with the appearance of the signature 
necroptotic Topo I protein cleavage fragments and inhibition with necrostatin-1. In 
addition, co-treatment with necrostatin-1 and rapamycin (autophagy promoter), exhibited 
greater protection against PA-LTx compared to necrostatin-1 alone. Treatment with DHA 
showed a full protection against PA-LTx, and reduced levels of HIF-1α and BNIP3 
transcripts. DHA neuroprotection was accompanied with phosphorylation of beclin-1, 
appearance of LC3-II, and upregulation of Atg7 and Atg12 genes, which are associated 
with induction of autophagy. Further, DHA-induced protection was suppressed by the 
lysosomotropic agent chloroquine that has been shown to inhibit the autophagic process. 
Our findings suggest that DHA elicits neuroprotection by stimulating autophagy and 
inhibiting apoptosis and necroptosis. Protection of cells vulnerable to PA-LTx may 





Lipids play essential roles in membrane structure, signal transduction and energy 
usage/storage. However, non-adipose cells exposed to lipids overload exhibit lipotoxicity 
(LTx), with detrimental consequences including cell death in vitro or in vivo (Ulloth et al. 
2003) (Scheff & Dhillon 2004) (Leroy et al. 2008) (Listenberger & Schaffer 2002). The 
mechanisms underlying LTx-induced cell death are not well understood in nerve cells, 
and there are no adequate treatments to block its detrimental cellular effects. This is 
important considering the significant increase in the levels of free fatty acid (FFA) 
following traumatic brain injury (TBI), spinal cord injury (SCI), hypoxic-ischemic insults 
in the central nervous system (CNS) and peripheral nervous system (PNS), and during 
chronic obesity (Dhillon et al. 1997) (Rodriguez de Turco et al. 2002). Our previous 
reports showed that saturated fatty acid overload, palmitic acid (PA) in particular, triggers 
apoptosis in nerve growth factor-differentiated PC12 (NGFDPC12) cells, primary rat 
cortical cells, and Schwann cells (Ulloth et al. 2003) (Almaguel et al. 2009) (Padilla et al. 
2011). We also reported that treatment with DHA suppressed PA-LTx but inhibition of 
caspases with the pan-caspase inhibitor carbobenzoxy – valyl – alanyl – aspartyl - [O-
methyl] -  fluoromethylketone (ZVAD) did not prevent the loss of cell viability resulting 
from PA-LTx (Ulloth et al. 2003). We concluded that PA-LTx involves caspase-
independent cell death and reasoned that a mechanistic understanding of this process 
could provide novel insights into the protective effects of DHA against lipotoxicity 
(Ulloth et al., 2003).  
Recent studies have shown that stressful conditions that prevent caspases 
activation may trigger cells to switch to necroptotic cell death (Galluzzi et al. 2014). 
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Necroptosis is driven by the kinases RIP1 and RIP3 (Receptor Interacting Proteins 1 and 
3) which together with MLKL (mixed lineage kinase domain-like) forms the 
necroptosome. Upon phosphorylation in the necroptosome, MLKL forms pores in the 
plasma membrane, triggering release of intracellular contents and lysosomal membrane 
permeability (LMP), leading to cytoplasmic degradation (Meng et al. 2016) (Su et al. 
2016) (Holler et al. 2000).  
Plasma membrane permeabilization is a biochemical hallmark in which 
necroptosis, primary necrosis and secondary necrosis converge, leading to the release of 
intracellular damaged-associated molecular patterns (DAMPS) into the extracellular 
milieu, resulting in a pro-inflammatory immune response (Vanden Berghe et al. 2010). 
Under normal cell growth conditions, apoptosis and necroptosis are in a mutual inhibitory 
state. During apoptosis, caspase-8 cleaves and inactivates RIP3, preventing necroptosis 
from occurring (Newton et al. 2014) (Feltham et al. 2017). Due to its non-inflammatory 
properties and highly organized and efficient cell demise program, apoptosis is the 
preferred mode of death for the cell, both under normal and pathological states. However, 
in recent years necroptosis has emerged as a key pro-inflammatory mode of cell death in 
the pathogenesis of human disease, from renal ischemic reperfusion injury, cardiac 
hypoxic injury, to hypoxic, traumatic, seizure, and degenerative brain injury (Linkermann 
et al. 2012) (Smith et al. 2007) (Oerlemans et al. 2012) (Northington et al. 2011) (Zhu et 
al. 2011). 
Autophagy is a critical cellular process that eliminates damaged and harmful 
intracellular molecules, even organelles, in order to maintain homeostasis and survival in 
the presence of stress (Wirawan et al. 2012) (Green & Levine 2014). Autophagy is 
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regulated by ATG (autophagy-related) proteins and redistribution of LC3 (microtubule-
associated protein 1 light chain 3). Further, the appearance of lipidated LC3, i.e. LC3-II, 
is considered a biochemical hallmark of autophagy. During hypoxia, nutrient depletion, 
or growth factor deprivation, autophagy is critical for maintaining cellular ATP and 
macromolecular recycling and, therefore, can represent a pro-survival pathway (Bray et 
al. 2012, Degenhardt et al. 2006). This process has been observed in primary mice 
cortical cells where autophagy was correlated with recovery and cell survival after 
hypoxia/reoxygenation injury (Zhang et al. 2013). There is increasing amount of 
evidence supporting an interplay between autophagy, apoptosis, and necroptosis (Long & 
Ryan 2012). Whether the cell survives or dies by a particular cell death modality in the 
presence of an environmental stressor depends on the severity of cellular damage, the 
energy/ATP availability, and the levels of endogenous inhibitors of specific survival/cell 
death pathways. For instance, low ATP levels may stimulate autophagy to decrease 
energy expenditure and avoid necrosis. By contrast, when autophagy is prolonged by 
stress conditions, the essential components for cell survival are suppressed, causing cell 
demise via apoptotic or necrotic/necroptotic cell death (Damme et al. 2014, Long & Ryan 
2012). 
DHA is the major Omega 3 polyunsaturated fatty acid (PUFA) component of 
neuronal membranes in the gray matter of the cerebral cortex and in retinal 
photoreceptors cells (Lauritzen et al. 2000 (Yehuda, 2002). DHA is highly unsaturated 
and thus can increase the fluidity of neuronal membranes, thereby playing an essential 
role in various neurochemical processes of the brain (Bazan et al. 2005) (Nishio et al. 
2004). In a previous report we found that DHA inhibits PA-LTx-induced apoptosis in 
 
45 
NGFDPC12 cells (Almaguel et al. 2009), protects NGFDPC12 cells against PA-induced 
lysosomal and mitochondrial permeabilization (Almaguel et al. 2010), and attenuates 
neuronal dysfunction following experimental spinal cord injury (Figueroa et al. 2012). 
Further, DHA–derived metabolites have been associated with anti-nociceptive responses 
after experimental spinal cord injury (Figueroa et al. 2012) (Figueroa et al. 2013a) 
(Figueroa et al. 2013b). In this study, we report that DHA rescues NGFDPC12 cells from 
PA-LTx-induced cell death by inhibiting apoptosis and necroptosis while enhancing 
autophagy.  
 
Materials and Methods 
Materials 
We purchased the following reagents from the appropriate suppliers: Ham’s F-12 
medium with Kaighn’s modification (F-12K) was purchased from Mediatech, Inc. 
(Manassas, VA); horse serum and fetal bovine serum were from Atlantic Biological 
(Lawrenceville, GA); Nerve growth factor (NGF, Cat# N-100) was from Alomone Labs 
(Jerusalem, Israel); fatty acid-free bovine serum albumin (Cat# 126575-10GM) was from 
EMD Milipore Corp (Billerica, MA); PA (Cat# P0500-25G) and protease inhibitor 
cocktail tablets (Cat# 4693124001) were from Sigma-Aldrich (St. Louis, MO); DHA 
(Cat# 90310) was from Cayman Chemicals (Ann Arbor, MI); ZVAD (Cat# ALX-260-
020-M005) and Staurosporine (Cat# ALX-380-014-M001) were from Enzo Life Science 
(Farmingdale, NY); and rapamycin (Cat# 9904S) was from Cell Signaling Technology 




Cell Culture and Treatments 
PC12 cells (rat pheochromocytoma cells, Cat# CRL-1721, ATCC, Manassas, VA) 
were plated in F-12K medium with 15% horse serum, 2.5% fetal bovine serum (FBS), 
and penicillin/streptomycin. After attaching to the plates, cells were then differentiated 
with F-12K medium containing NGF (50 ng/mL) and 1% FBS and 
penicillin/streptomycin (1% FBS-NGF medium). Medium was changed every 2-3 days 
and cells were differentiated for 7-10 days before experimental treatments. Fully 
differentiated PC12 cells showing long neurites that form an extensive network were used 
in all experimental conditions. 
PA-LTx treatment was performed as previously described (Ulloth et al. 2003) (Almaguel 
et al. 2009). Briefly, a PA stock solution (300 mM in 100% ethanol) was diluted 1,000 
fold in warm 1% FBS-NGF medium containing 0.15 mM fatty acid-free BSA resulting in 
a complex of  PA:BSA at 2:1 (0.3 mM: 0.15 mM) molar ratio. Previous analysis showed 
that PA:BSA at 2:1 ratio leads to unbound free PA at low nM concentration throughout 
the course of the experiment (Almaguel et al. 2009). DHA stock (100 mM or 50 mM) 
was also prepared in 100% ethanol and diluted in 1% FBS-NGF medium containing 0.15 
mM fatty acid-free BSA with or without PA. For control, cells were treated with 1% 
FBS-NGF medium containing 0.15 mM fatty acid-free BSA and 0.1% ethanol. Cell 
morphology after treatment was documented using a phase contrast Olympus microscope 






Quantitative Real Time PCR Analysis 
The procedures for total RNA extraction, cDNA synthesis and quantitative RT-
PCR were described previously (Almaguel et al. 2009, Padilla et al. 2011). The relative 
amount of mRNA was calculated by the 2
-ΔΔCT
 method, using β-actin as reference gene. 
The primer sets used in the current study are as following: 
HIF-1α, 5’-TCCATGTGACCATGAGGAAA-3’and 5’-CTTCCACGTTGCTGACTTGA-3’ 
BNIP3, 5’-CCAGAAAATGTTCCCCCCAAG-3’and 5’-TTGTCAGACGCCTTCCAATGTAG-3’ 
Atg7, 5’-CCCAAAGACATCAAGGGCTA-3’ and 5’-CCTGACTTTATGGCTTCCCA-3’ 
Atg12, 5’-CGTCTTCGGTTGCAGTTTC-3’ and 5’-CCAGTTTACCATCACTGCCA-3’ 
β-actin, 5’-GGGAAATCGTGCGTGACATT-3’ and 5’-GCGGCAGTGGCCATCTC-3’ 
 
Reactive Oxygen Species Analysis 
Cellular ROS levels were measured by flow cytometry using the florescent 
indicator 2’,7’dichlorodihydrofluorescein diacetate (H2DCFDA, Life Technologies). 
After treatment, NGFDPC12 cells were incubated with 10 μM H2DCFDA in F-12K 
medium for 25 min at 37°C. Cells were then detached by HyClone HyQtase (GE 
Healthcare, Pittsburgh, PA), rinsed and analyzed with a Becton-Dickinson FACSCalibur 
as described earlier (Almaguel et al. 2009, Padilla et al. 2011). NGFDPC12 cells treated 
with 10 μM of DL-Buthionine-[S,R]-sulfoximine for 24 hrs. served as positive control. 
 
Apoptosis Detection 
After treatment, NGFDPC12 cells were detached from plates by HyQtase and 
incubated with the apoptosis marker Annexin V-FITC for 20 min.  Annexin V positive 
cells were detected by flow cytometry as described previously (Padilla et al. 2011).  
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Determination of Cell Viability 
Cell viability after PA-LTx treatment was determined by crystal violet assay. 
PC12 cells were seeded in 12- or 6-well plates at a density of 7,500 cells/cm
2 
and 
differentiated with NGF. After treatment, cells were gently rinsed, fixed, and stained with 
crystal violet solution as stated before (Padilla et al. 2011). Bound crystal violet was 
dissolved with 10% acetic acid and the optical density (OD) at 570 nm was determined 
using a Spectra Max i3X spectrophotometer (Molecular Devices, Sunnyvale, CA). Cell 
viability was calculated as percent of the OD reading relative to control group.  
 
Antibodies and Immunoblotting 
DNA topoisomerase I (Topo I) and its cell death-associated cleavage fragments 
were detected by immunoblotting using human scleroderma-associated autoantibodies as 
described previously (Pacheco et al. 2005, Pacheco et al. 2014). LC3 (Cat# 4108S), 
phospho-beclin-1 (Ser93, Cat# 14717S) and beclin-1 (Cat# 3495S) antibodies were 
purchased from Cell Signaling Technology. We used Laemmli Sample Buffer (0.1 M 
Tris-HCl, pH 6.8 containing 4% SDS, 10 % glycerol and protease inhibitors) to extract 
total protein from cells. After quantification, 15-40 μg of cellular proteins were resolved 
on a NuPAGE Bis-Tris Gel (Thermo Scientific) and transferred to nitrocellulose 
membranes. Membranes were blocked and incubated with primary antibodies overnight 
at 4°C. After washes, the membranes were incubated with appropriate horseradish 
peroxidase-conjugated secondary antibodies for subsequent chemiluminescent detection 
or with IRDye secondary antibody for subsequent Odyssey imaging (Li-Cor 




All measurements were done in triplicates in at least three independent 
experiments. Data analysis was done by GraphPad Prism 6.0 (GraphPad Software, San 
Diego, CA, USA). Identification of outliers was done and normality of data was assessed 
with Kolmogorov-Smirnov test. Statistical comparison analysis for multi-group 
experiments was performed by two-way ANOVA followed by Bonferroni multiple 
comparison test. Experiments comparing two groups were analyzed by student’s t test. 
Significance was accepted at p<0.05. 
 
Results 
PA-LTx Generates a Stress Response and Apoptosis in NGFDPC12 Cells 
PA overload stimulates cellular ROS accumulation (Almaguel et al. 2009, Liu et 
al. 2015). This increase in ROS levels leads to the activation of an array of cellular stress 
response proteins, including hypoxia inducible factor 1 (HIF-1α). In the present study, we 
did a time course measurement of HIF-1α mRNA expression following PA-LTx 
treatment. As shown in Figure 1A, there is a significant increase in HIF-1α expression at 
18 (3.2-fold), 24 (3.7-fold) and 48 (3.8-fold) hours after treatment. One of the 
downstream effects of PA overload is the activation and increased expression of pro-
apoptotic proteins like Bax, Bak and BNIP3 (BCL2/adenovirus E1B 19 kDa protein-
interacting protein 3) (Almaguel et al. 2009).  When BNIP3 mRNA was measured in the 
time course experiments, we found a significant induction of BNIP3 at 12 (2-fold), 18 
(3.5-fold), 24 (3.5-fold), and 48 hours (3.9-fold) (Fig. 1B). Our previous reports showed 
that PA induces NGFDPC12 cell death with apoptotic features using DAPI staining 
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which detects early and late apoptosis (Ulloth et al. 2003, Almaguel et al. 2009) (Liu et 
al. 2008). In order to confirm that PA overload triggers significant early apoptosis in our 
experimental conditions, we labeled cells with Annexin V to analyze early apoptotic cells 
after PA treatment. Figure 1C shows that there was a 3-fold increase in Annexin V 





Figure 1. PA-LTx stimulates HIF-1α and BNIP3 mRNA expression and apoptosis in 
NGFDPC12 cells. NGFDPC12 cells were treated with BSA control medium (CTL) or 
PA complexed with fatty acid-free BSA at 2:1 ratio (PA) for 12 to 48 hrs and the levels 
of (A) HIF-1α and (B) BNIP3 mRNA were analyzed by real-time RT-PCR. (C) 
NGFDPC12 cells were treated with PA for 24 hrs and apoptotic cells were identified by 
Annexin V labeling. The percentage of Annexin V-tagged cells in a sample was 
determined by flow cytometry. The results are expressed as fold-change relative to 
control at 24 hrs and the data is shown as Mean±SEM, n=6. Statistical analysis was done 
by two-way ANOVA followed by Bonferroni multiple comparison test for (A) and (B) 




PA-LTx Induces Necroptosis in NGFDPC12 Cells in The Presence of ZVAD 
While PA-LTx induces loss of cell viability through apoptosis, treatment of 
NGFDPC12 cells undergoing lipotoxicity with the pan-caspase inhibitor ZVAD triggers 
caspase-independent cell death (Ulloth et al. 2003).  Further, it has been observed that 
lysosomal cathepsin L, implicated in TNF-induced necroptosis (Pacheco et al. 2014), is 
also involved in PA-LTx-induced cell death (Almaguel et al. 2010). Based on these 
findings we hypothesized that induction of necroptosis was a possible explanation for the 
caspase-independent cell death induced by PA-LTx in the presence of ZVAD. To address 
this hypothesis, we used a highly specific human autoantibody to nuclear protein 
Topoisomerase I (Topo I) that discriminates between apoptosis and necrosis (primary, 
secondary, and necroptosis) using immunoblotting of protein lysates from affected cells 
(Casiano et al. 1996) (Casiano et al. 1998) (Pacheco et al. 2005) (Pacheco et al. 2014) 
(Wu et al. 2001). These antibodies specifically recognize the Topo 1 70 and 45 kDa 
cleavage fragments generated during necrosis or necroptosis, and the single Topo 1 70 
kDA fragment signature of apoptosis. The first series of experiments were done to 
validate these antibodies in our experimental system by treating NGFDPC12 cells 
cultures with staurosporine and HgCl2, which are well established inducers of apoptosis 
and necrosis respectively, and performed immunoblotting analysis using the cell’s lysates 
to verify the distinct Topo I cleavage patterns for each condition. Given that primary 
necrosis, secondary necrosis, and necroptosis converge into downstream cathepsin-
mediated proteolysis and exhibit identical patterns of Topo I cleavage in L929 fibroblasts 
(Pacheco et al. 2005, Pacheco et al. 2014), we predicted to observe a similar pattern of 
Topo I cleavage in NGFDPC12 cells undergoing necrosis or necroptosis. As shown in 
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Figure 2A, the apoptotic 70 kDa fragment was observed after 6 h treatment with 
staurosporine. The faint 45 kDa band was likely due to secondary necrosis (Wu et al. 
2001, Silva 2010). In contrast, HgCl2 induced the necrosis-associated Topo I cleavage 
pattern (70 and 45 kDa fragments) by 6 hrs and this pattern was sustained after 12 and 18 
hrs. The 60 kDa band shown in all treatment groups is likely due to non-specific 
autoantibody binding. Next, the induction of apoptosis in NGFDPC12 cells treated with 
PA-LTx for 24 hours was confirmed by the appearance of the 70 kDa apoptotic cleavage 
fragment of Topo I, with absence of the necrotic 45 kDa fragment (Fig. 2B).  However, 
when the pan-caspase inhibitor ZVAD was added to PA-LTx treatment (ZVAD+PA), 
instead of inhibiting apoptosis-associated Topo I cleavage, we observed induction of the 
necrosis-associated 45 kDa cleavage fragment, similar to the pattern observed during 
treatment with the necrosis inducer HgCl2 (Fig. 2B).  These results suggest that PA-LTx 
primarily causes apoptosis in NGFDPC12 cells, but a necroptotic pathway is induced 






Figure 2. Cleavage pattern of Topo I in PA-LTx-treated NGFDPC12 cells in the 
presence or absence of ZVAD.fmk. (A) The cleavage pattern of Topo I has been shown to 
differentiate between apoptosis and necrosis or necroptosis. For validation of using this 
method in NGFDPC12 cells, we treated cells with control medium (CTL), an apoptosis 
inducer Staurosporin (Stau, 3 μM) or a necrosis inducer HgCl2 (50 μM) for 6, 12, and 18 
hrs. Total cellular protein was extracted and Topo I immunoblot was performed using a 
human serum carrying Topo I autoantibodies (1:250 dilution). (B) NGFDPC12 cells were 
treated with BSA control medium (CTL) and PA-LTx (PA) in the presence or absence of 
ZVAD (40μM) for 24 and 48 hrs.  Cellular proteins were collected followed by Topo I 
immunoblotting. These experiments were repeated at least three times and representative 




Crosstalk between Apoptosis and Necroptosis in NGFDPC12 Cells 
Undergoing PA-LTx 
In order to understand and successfully inhibit lipotoxicity, it is important to 
identify potential crosstalk between the different cell death modalities. The next series of 
experiments proceeded to use ZVAD to inhibit apoptosis, the RIP1 inhibitor Nec-1 to 
inhibit necroptosis, and the mTOR inhibitor rapamycin to promote autophagy. 
NGFDPC12 cells were treated with ZVAD, Nec-1 or Rapa for 48 hours in the presence 
or absence of PA (Fig. 3A-C). NGFDPC12 cells treated with ZVAD alone showed a 
significant 20% reduction in cell viability compared to control untreated cells (Fig. 3A). 
PA treatment decreased the cell viability to 35% as expected. Confirming our previous 
report (Ulloth et al. 2003), treatment with ZVAD did not rescue the cells from PA-LTx 
(Fig. 3A).  Nec-1 didn’t affect cell viability by itself but when cells were co-treated with 
PA and Nec-1 there was a modest 27% increase in cell viability (Fig. 3B). The autophagy 
promoter rapamycin was used in the following experiments. Figure 3C shows that Rapa 
didn’t decrease or increase cell viability by itself and neither rescued cells when co-
treated with PA. Therefore, inhibiting apoptosis or stimulating autophagy alone is not 
enough to rescue NGFDPC12 from PA-LTx.  Only Nec-1 treatment had a modest 
protective effect. 
We then proceeded to combine these inhibitors and inducers to evaluate the 
effects of inhibiting apoptosis and necroptosis or inhibiting necroptosis and inducing 
autophagy at the same time (Fig. 3D-F).  As shown in Figure 3D, combinatory treatment 
with ZVAD and Nec-1 increased the cell viability by 24% compared to control 
suggesting that this treatment might stop the cell loss process which is constantly taking 
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place in the culture. PA treatment decreased cell viability to 37% but the combinatory 
treatment with ZVAD+Nec-1 increased the cell viability to 65%. These results are 
consistent with our hypothesis that while PA-LTx primarily induces apoptotic cell death 
in NGFDPC12 cells, addition of ZVAD, rather than rescuing the cells from PA-induced 
apoptosis, shifts cell death to necroptosis, which can be inhibited with Nec-1. Thus, 
inhibiting necroptosis, but not apoptosis, attenuates PA-LTx in NGFDPC12 cells. Next, 
we examined the inhibition of necroptosis in combination with promoting autophagy.  
Interestingly, the combinatory treatment of Nec-1 and Rapa rendered significant positive 
effects on cell survival in NGFDPC12 cells (Fig. 3E). Co-treatment of Nec-1+Rapa 
increased cell viability over control by 60% in the absence of PA-LTx.  When Nec-
1+Rapa were co-treated with PA cell viability went back to 84%, which is not 
significantly different from the control. This result indicates that the neuroprotection is 
almost complete when necroptosis is inhibited and the autophagic flux is allowed to 
continue. When ZVAD was added to Nec-1+Rapa during PA-LTx (Fig. 3F), the 
protective effect was still significant but reduced to 60% compared to control. These data 
revealed a dynamic interaction between autophagy and necroptosis where the protective 
effects of autophagy seemed to be enhanced when necroptosis is inhibited. As expected, 






Figure 3. The effect of apoptosis and necroptosis inhibitors and autophagy inducer on 
NGFDPC12 cells with or without PA-LTx. NGFDPC12 cells were treated with ZVAD at 
40 μM (A), necrostatin 1 (Nec-1) at 50 µM (B), rapamycin (Rapa) at 100 nM (C), 
ZVAD+Nec-1 (D), Nec-1+Rapa (E), and ZVAD+Nec-1+Rapa (F) in the presence or 
absence of PA-LTx. Cell viability was determined at 48 hrs after treatment using crystal 
violet assay. The results are expressed as percent of control and the data is shown as 
Mean±SEM, n=4-6. Statistical analysis was done by two-way ANOVA followed by 
Bonferroni multiple comparison test. Significance symbols: *=p<0.05.   *** =p<0.001. 




DHA as a Neuroprotective Agent from PA-LTx 
The next series of experiments examined the mechanism(s) by which DHA 
rescues NGFDPC12 cells from PA-LTx. We assessed the effects of moderate 
physiological concentrations of DHA (20-50 μM bound to fatty acid-free BSA, see 
Methods) on rescuing NGFDPC12 cells from PA-LTx. Figure 4A shows that 
NGFDPC12 cells treated with PA-LTx for 24 hours show dismantle morphology with 
small/short neurites, but appear normal when co-treated with DHA. Quantitative cell 
viability data indicated that DHA at 20, 30, 40 or 50 μM has no negative effect on cell 
viability but is able to rescue NGFDPC12 cells from PA-LTx (Fig. 4B). Interestingly, a 
protective effect was also observed if cells were pre-treated with 50 μM DHA ahead of 





                
Figure 4. DHA rescues PA-LTx-treated NGFDPC12 cells from lipotoxicity. (A) 
Microscopic images show 48 hrs after treated with BSA control medium (CTL), DHA 
(50 μM), PA-LTx (PA) and PA+DHA.  (B) NGFDPC12 cells were treated with DHA 
alone at concentrations from 20-50 μM or together with PA-LTx for 48 hrs and cell 
viability was determined by crystal violet assay.  For pre-treatment group, NGFDPC12 
cells were treated with DHA (50 μM) for 24 hrs followed by PA-LTx without DHA for 
another 48 hrs. The results are expressed as percent of control and the data is shown as 
Mean±SEM, n=5-8. Statistical analysis was done by two-way ANOVA followed by 
Bonferroni multiple comparison test. Significance symbols: **=p<0.01.   *** =p<0.001. 




DHA Diminishes PA-LTx-Induced HIF-1α and BNIP3 but Not ROS 
Subsequently, we quantified the expression of HIF-1α and BNIP3, which are up-
regulated during PA-LTx treatment, in the presence or absence of DHA. Figures 5A and 
5B show that DHA alone did not alter HIF-1α and BNIP3 mRNA levels. However, the 
PA-LTx-simulated gene upregulation of HIF-1α and BNIP3 was back to control level in 
the presence of DHA. Intracellular ROS levels in NGFDPC12 cells are increased during 
PA-LTx (Liu et al. 2015). To examine the possibility that high intracellular ROS levels 
are associated with induction of BNIP3 and HIF-1α expression in NGFDPC12 cells, ROS 
accumulation in the cells was measured for up to 18 hours after the appropriate 
treatments using the DCF-flow cytometry method. Figure 5C shows PA-LTx increased 
ROS levels by 3.4 and 2.9-fold at 12 and 18 hours respectively. Interestingly, co-
treatment with PA+DHA showed an accumulation of ROS similar to that caused by PA-
LTx alone (3.4, 3.1, and 4.2-fold at 6, 12, and 18 hours respectively) indicating that 
inhibition of ROS is dispensable for DHA’s ability to rescue NGFDPC12 cells from the 
detrimental effects of PA-LTx. 
 
DHA Protects NGFDPC12 Cells against PA-LTx by Inhibiting Apoptosis and 
Necroptosis and Enhancing Autophagy 
We showed above that the effects of PA-LTx in NGFDPC12 cells are inhibited by 
the necroptosis inhibitor necrostatin-1 and the autophagy promoter rapamycin (Fig. 3E). 
We hypothesized that the neuroprotective effects of DHA in the presence of PA-LTx may 
influence these cellular processes, and that DHA may have the ability to induce 
autophagy as a protective mechanism. Beclin-1 is a master protein that when activated 
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inhibits apoptosis and leads the cell to autophagy (Green & Levine 2014).  As expected, 
there was an increased phosphorylation of beclin-1 in cells treated with Rapa and DHA 
(Fig. 6A). While total beclin-1 was not significantly altered upon PA-LTx treatment, 
phosphobeclin-1 was greatly reduced at 48 hours in PA-treated cells but co-treatment of 
DHA+PA restored its level (Fig. 6A).  Next, we analyzed the conversion of light chain 
protein 3 (LC3-I) to phosphatidyl ethanolamine (PE)-conjugated LC3 (LC3-II), a well-
established biomarker for autophagy. The immunoblots show a significant increase in 
LC3-II levels in DHA-treated but not in PA-treated cells (Fig. 6B).  The lack of visible 
induction of LC3-II levels by rapamycin alone could be attributed to increased 
autophagic turnover that eliminates the accumulation of LC3-II (Marino et al. 2014). 
However, when DHA or rapamycin were added to PA-LTx treated cells, the levels of 
LC3-II were increased.  These data confirmed that DHA is able to increase autophagy in 
untreated or PA treated cells. To further analyze this autophagic process, the levels of 
autophagy related genes Atg7 (Fig. 6C) and Atg12 (Fig. 6D) transcripts were 
determined. Of importance, both Atg12 and Atg7 mRNA levels were reduced in PA-
treated cells, but showed at control levels (Fig. 6C) or higher than control (Fig. 6D) 
during co-treatment with PA and DHA. 
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Figure 5. DHA diminishes PA-LTx-stimulated HIF-1α and BNIP3 but not PA-LTx-
stimulated ROS accumulation. NGFDPC12 cells were treated with BSA control medium 
(CTL), DHA (50 μM), PA-LTx (PA) and PA+DHA. HIF-1α (A) and BNIP3 (B) mRNA 
levels after 24 hrs treatment was determined by real-time RT-PCR. The results are 
expressed as fold-change relative to control and the data is shown as Mean±SEM, n=9.  
(C) ROS levels at 6 hrs (n=3), 12 hrs (n=7) and 18 hrs (n=7) after treatment was 
determined by DCF flow cytometry. The results are expressed as fold- change relative to 
control at 6 hrs and the data is shown as Mean±SEM.  Statistical analysis was done by 
two-way ANOVA followed by Bonferroni multiple comparison test.  Significance 








Figure 6. DHA stimulates autophagy pathway in NGFDPC12 cells. NGFDPC12 cells 
were treated with BSA control medium (CTL), Rapamycin (100 nM), DHA (50 μM), 
PA-LTx (PA) and PA-LTx together with Rapamycin or DHA for 24 hrs and cellular 
protein was extracted. Immunoblotting analysis of (A) phosphorylated and total Beclin I 
and (B) LC3 were performed. These experiments were repeated at least three times and 
representative blots are shown. Meanwhile, NGFDPC12 cells were treated with BSA 
control medium (CTL), DHA (50 μM), PA-LTx and PA+DHA for 24 hrs. Total cellular 
RNA was extracted and mRNA level of Atg 7(C) and Atg 12 (D) was determined by 
real-time RT-PCR. The results are expressed as fold-change relative to CTL and the data 
is shown as Mean±SEM, n=3. Statistical analysis was done by two-way ANOVA 






In order to further determine the effects of DHA on necroptosis and autophagy we 
added chloroquine (an autophagy inhibitor) and ZVAD to NGFDPC12 cells exposed to 
DHA alone or to PA+DHA co-treatment.  Figure 7A shows that cell viability in the 
DHA+ZVAD treatment group was similar to that of control cells, suggesting that DHA is 
able to reverse ZVAD-induced loss of cell viability (see Fig. 3A for comparison). 
However, DHA’s protective effect against PA-LTx was diminished in the presence of 
chloroquine (Fig. 7B), confirming the important role of autophagy in DHA-induced 
protection against PA-LTx (Fig.7B and 7C). In addition, adding ZVAD and PA together 
leads to diminished cell size and loss of neurites compared to treatment with PA alone 
(Fig. 7C), consistent with the previous cell viability results (Fig. 3A).   
Finally, it was previously shown that low concentrations of HgCl2 induce necrotic 
cell death with autophagic features in hepatocytes (Chatterjee et al. 2014), suggesting a 
cellular attempt to survive in the presence of this strong stressor. In order to address this 
possibility in our PA-LTx model, we compared LC3-II expression in NGFDPC12 cells 
under different treatments. Figure 8A shows that staurosporine, a well-established 
apoptosis inducer, did not increase LC3-II expression compared to control cells. On the 
other hand, treatment with HgCl2, a primary necrosis inducer, led to sustained increase in 
the levels of LC3-II for up to 18 hours compared to control and staurosporine-treated 
cells. Interestingly, when the Topo I cleavage pattern in DHA-treated NGFDPC12 cells 
was examined by immunoblotting, the pattern was similar to that of HgCl2-treated cells 
or ZVAD-treated cells (Fig. 8B), even though the cell fate was very different, i.e., 
autophagy induced by DHA, primary necrosis induced by HgCl2, and necroptosis induced 
by ZVAD.  Likewise, cells co-treated with PA+DHA or PA+ZVAD also showed a Topo 
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I cleavage pattern similar to that of HgCl2-treated cells. These results suggested that 
DHA-induced autophagy may activate the lysosomal cathepsins responsible for the 
cleavage of Topo I (Pacheco et al. 2005), consistent with the recent observation that 






Figure 7. The protective effect of DHA in the presence of ZVAD and chloroquine in 
NGFDPC12 cells. NGFDPC12 cells were treated with BSA control medium (CTL), 
DHA (50 μM), PA-LTx (PA) and PA+DHA in the presence or absence of ZVAD at 40 
µM (A) and chloroquine (CQ, autophagy inhibitor, 20 µM) (B) for 48 hrs. Crystal violet 
assay was performed to determine cell viability.  The results are expressed as percent of 
control and the data is shown as Mean±SEM, n=4-5. Statistical analysis was done by 
two-way ANOVA followed by Bonferroni multiple comparison test. Significance 
symbols: *** =p<0.001. **** =p<0.0001. (C) Representative microscopic images show 








Figure 8. Autophagy and necroptosis pathways share common elements. (A) NGFDPC12 
cells were treated with BSA control medium (CTL), staurosporine (Stau, 3 µM), or 
HgCl2 (50 µM) for 6, 12, and 18 hrs. Total cellular protein was extracted and LC3 
immunoblotting was performed. (B) NGFDPC12 cells were treated with BSA control 
medium (CTL), PA, DHA and ZVAD, separately or in combinations. Total cellular 
protein was extracted 24 hrs after treatment followed by Topo I immunoblotting. These 





The present study reports new insights into mechanisms by which lipotoxicity 
induces cell death in differentiated PC12 cells, and shows for the first time that the 
omega-3 fatty acid DHA inhibits this process by attenuating necroptosis and activating 
autophagy. Lipotoxicity occurs in non-adipose cells, which lack the proper cell 
machinery to manage the overload of saturated FFA like palmitic acid (Engin 2017). 
Nerve cells are especially vulnerable to the lipotoxicity injury especially during trauma, 
hypoxia and neurodegenerative pathologies (Lee 2012). Traumatic or ischemic-hypoxic 
brain injury exhibits an elevation of FFAs in the CNS (Bazan 1970) (Dhillon et al. 1994) 
(Dhillon et al. 1997) (Gewirtz et al. 1999). Activation of phospholipase-A2 (PLA-2), due 
to excitatory amino acids and calcium release, acts on the internal leaflet of the plasma 
membrane releasing FFAs to the cytosol (Farooqui & Horrocks 1998). The magnitude of 
FFA accumulation correlates with the severity of the injury (Bazan et al. 1971) (Zhang & 
Sun 1995). The main species of FFAs found elevated after traumatic and hypoxic-
ischemic injury are stearic, palmitic, oleic and arachidonic acids (Dhillon et al. 1994) 
(Dhillon et al. 1997), and NGFDPC12 cells exposed to high levels of stearic acid or PA 
exhibit apoptotic cell death (Ulloth et al. 2003). Along these lines, during spinal cord 
injury the fatty acid monoglycerides and fatty acid glycerophos-phoethanolamines are 
substantially increased, especially for palmitic, steric and arachidonic acids (Figueroa et 
al. 2013b). Supplementation of omega-3 PUFA in the diet promoted locomotion recovery 
and reduced neuropathic pain following spinal cord injury suggest a role for FFA levels 
and type in this process (Figueroa et al. 2013a) (Figueroa et al. 2013b) (Liu et al. 2015) 
(Figueroa et al. 2016). Up-regulation of fatty acid binding protein 5 (FABP5) following 
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nerve injury mitigates the detrimental effects of high levels of saturated FFA in the cell 
(De Leon et al. 1996).  
Treatment of NGFDPC12 cells undergoing PA-LTx with ZVAD lead to the 
activation of caspase-independent cell death (Ulloth et al. 2003).  Our findings in the 
present study show for the first time that the necroptosis inhibitor Nec-1 attenuates cell 
death induced in the presence of ZVAD and PA in these cells, suggesting necroptosis as 
an important mechanism of cell death in this context. Necroptosis is a pro-inflammatory, 
programmed form of cell death associated with loss of plasma membrane integrity, 
mitochondrial dysfunction, and organelle swelling. It can be activated by ligands of death 
receptors and stimuli that induce the expression of death receptor ligands under caspase-8 
deficient conditions, including inhibition by pan-caspase inhibitors such as ZVAD (Khan 
et al. 2014) (Zhou & Yuan 2014) (Galluzzi et al. 2014). In NGFDPC12 cells, both FAS 
receptor and FAS ligand are up-regulated during PA-LTx treatment (Ulloth et al. 2003), 
which could explain the necroptotic death activated in these cells when we attempted to 
attenuate PA-induced apoptosis with ZVAD. It is also established that during necroptosis 
there is ROS accumulation and cellular damage (Lin et al. 2004) (Shindo et al. 2013) 
(Vanlangenakker et al. 2011) (Galluzzi et al. 2014). This is consistent with our finding 
that PA treatment increases ROS levels in NGFDPC12 cells, which could accelerate 
membrane damage and cellular destruction.  
While PA induces primarily an apoptotic type of cell death in NGFDPC12 cells, 
there was a significant increase of cell viability during PA treatment (in the absence of 
ZVAD) when co-treated with Nec-1, a small molecule inhibitor of RIP1 (He et al. 2009) 
(Degterev et al. 2008).  RIP1, through its death domain, complexes with FADD (Fas-
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associated protein with death domain) and TRADD (tumor necrosis factor receptor-
associated death domain) (Stanger et al. 1995) and binds caspase 8 to form the 
ripoptosome which is necessary for the extrinsic apoptotic pathway (Khan et al. 2014). 
Inhibition of RIP1 kinase activity by Nec-1 suppresses apoptosis by preventing the 
formation of RIP1/FADD/caspase-8 cell death complex also known as Complex IIa 
(Abhari et al. 2013) (Feoktistova et al. 2011).  Rats treated with Nec-1 before spinal cord 
injury showed a smaller lesion size, inhibition of cytokine release and decreased ROS 
production (Wang et al. 2014). These outcomes were accompanied by a reduction in 
caspase 3 and Bax and an activation of the anti-apoptotic and pro-autophagy protein Bcl-
2 (Wang et al. 2014). Since both extrinsic (Fas-mediated) and intrinsic (mitochondrial-
mediated) apoptosis pathways are evident in PA-LTx in NGFDPC12 cells (Ulloth et al. 
2003) (Almaguel et al. 2009), we cannot rule out that Nec-1, in the absence of ZVAD, 
increases cell viability under PA-LTx by attenuating Fas-mediated apoptosis, but the 
effect is not enough to rescue cells to the levels of the control, untreated cells because PA 
overload still triggers the intrinsic apoptosis pathway.  
Our data show that co-treatment with Nec-1 and Rapamycin successfully rescued 
NGFDPC12 cells undergoing PA-LTx, suggesting that activation of autophagy is critical 
in neuroprotection against lipotoxicity. Rapamycin is a macrolide that inhibits mTOR, a 
serine/threonine protein kinase that regulates autophagy, cell growth, and cell 
proliferation (Mukherjee & Mukherjee 2009). When mTOR is inhibited by Rapamycin, 
the ULK1 complex (UNC-51-like kinase 1+ATG17+ ATG13+ATG101) is free to 
stimulate the autophagic cascade (Marino et al. 2014). Autophagy is particularly 
important in neurons because they are non-dividing cells and are more sensitive to 
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accumulation of toxic molecules (Hara et al. 2006). Furthermore, the brain needs a 
constant supply of energy even under conditions of stress like ischemia, starvation or 
infection. It is well known that inhibition of autophagy cause neurodegeneration in 
mature neurons, indicating that autophagy may regulate neuronal homeostasis (Komatsu 
et al. 2006).  
There are a multiple stress signals, including PA-LTx, that can  exhibit the 
involvement of both autophagy and apoptosis (Tan et al. 2012) (Tu et al. 2014).  Along 
this line, the Bcl-2-binding factor Beclin-1 (ATG6) is the central protein regulating the 
autophagy process. Beclin-1 associates with VPS34 (vacuolar protein sorting 34) and 
initiates the isolation of double membrane to start autophagy. This Beclin-1/VPS34 
complex is inhibited when bound by Bcl-2 family members (Bcl-2, Bcl-XL) (Green & 
Levine 2014).  Further, inhibition of Beclin-1 by Bcl-2 allows the cell to ensure that 
neither autophagy nor apoptotic or necroptotic cell death take place under non-stress 
conditions (Luo & Rubinsztein 2010) (Maiuri et al. 2007). In a T-cell model lacking 
caspase-8 and FADD cells developed a hyperautophagic morphology but subsequently 
died by necroptosis, which could be prevented with necroptosis inhibitors and deletion of 
RIP3 (Lu et al. 2011). In addition, if the stress is sufficiently strong to overcome the 
cellular capability of activating autophagy, then apoptosis-activated caspases may digest 
essential autophagic proteins and disable the autophagy pathway (Long & Ryan 2012).  
Thus, if the intracellular contents cannot be degraded during autophagy, the apoptotic or 
necroptotic pathways may prevail.  
A novel finding from this study is that the protective effects of DHA against PA-
LTx are mediated by impacting multiple cellular pathways, i.e. inhibition of necroptosis 
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and stimulation of autophagy. This finding is consistent with our previous results 
showing that DHA inhibited mitochondrial membrane depolarization and lysosomal 
membrane permeabilization (Almaguel et al. 2010). While we found that PA-LTx 
induces the mRNA expression of HIF-1α and BNIP-3, treatment with DHA reduced the 
transcript levels for both genes. HIF-1α, executing his role as cellular stress sensor, 
induces the expression of cell survival genes and/or cell death genes (Guo 2017).  While 
HIF-1α can promote autophagy directly through the HIF-1α/BNIP3/Beclin-1 complex, 
which involves the mTOR signaling (Xia et al. 2015), HIF-1α can also induce apoptosis 
(da Rosa et al. 2015). In our cellular model, PA decreased Beclin-1 phosphorylation, 
suggesting that it decreases autophagy and activates apoptosis through the induction of 
HIF1α and BNIP3 gene expression.  In contrast, treatment with DHA in the presence of 
PA inhibited the expression of these two genes, suggesting that by inducing autophagy 
DHA antagonizes cell death processes associated with increased HIF1α and BNIP3 
expression and activity.   
In our experimental model, DHA elicited a small and transient increase of ROS 
accumulation and did not inhibit generation of ROS accumulation observed during PA-
LTx conditions. Interestingly, studies performed in human retinal pigment epithelial cells 
showed that DHA triggers a transient increase in ROS, and an increase in the levels and 
nuclear translocation of NFE2L2, a transcription factor that regulates cellular redox status 
(Johansson et al. 2015). Subsequently, DHA was shown to increase the levels of 
SQSTM1, which selectively targets misfolded, ubiquitinated proteins for lysosomal 
degradation by binding both to ubiquitinated cargos and to LC3 (Atg8) on the growing 
phagophore membrane (Johansson et al. 2015). LC3-II, which is phosphatidyl 
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ethanolamine (PE)-conjugated, is responsible for docking the autophagosome with the 
lysosome vesicles. Thus, DHA-containing PE can facilitate this process as opposed to 
saturated fatty acid-containing PE (Kim et al. 2004) (Garcia et al. 1998).  
It has been well established that DHA increases membrane fluidity (Hashimoto et 
al. 2017)  (Stillwell & Wassall 2003) by selective incorporating into the sn-1 and sn-2 
positions of the anionic phospholipids phosphatidyl serine (PS) and PE (Shaikh et al. 
2009).  The amount of PUFAs in the membrane becomes a determinant of a “DHA non-
raft domain” in which the membrane becomes more fluid and thinner, cholesterol is 
displaced, and there is a “liquid disorganized domain” where proteins can change 
conformation easier than in cholestrerol rich “organized domains” (Grimm et al. 2011) 
(Hou et al. 2016). For instance, treating NGFCPC12 cells in culture with unsaturated 
long chain fatty acids enhances neurite extension during differentiation (Liu et al. 2015). 
Also, supplementation of mitochondrial membranes with DHA increases the content of 
DHA-enriched cardiolipin that is necessary for mitochondrial function and survival 
(Stanley et al. 2012). DHA-induced increase in membrane fluidity has a direct impact in 
both autophagy membrane elongation and more efficient activation of membrane binding 
proteins (Bahrami et al. 2017).  It is here where DHA induction of non-raft membrane 
domains (Wassall & Stillwell 2008) seems to be a key mechanism where autophagy and 
membrane fluidity intersect. Considering that autophagy requires extensive cell 
membrane assembly, nucleation, expansion and docking, membrane fluidity is critical to 
ensure efficient survival under PA-LTx. 
Beclin-1 has a BH3 domain, a coil domain, and an evolutionary conserved 
domain (ECD) that serves as a membrane binding protein (Huang et al. 2012).  The BH3 
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domain gives Beclin-1 the capacity to interact with Bcl-2.  AMP-activated protein kinase 
(AMPK) directly phosphorylates Beclin-1, which renders it able to detach from Bcl-2 and 
interact with VPS34 to induce autophagy. We suggest that DHA is important in this step 
for the following reasons. First, Beclin-1 anchored with its ECD within the mitochondrial 
membrane travels more efficiently through the non-raft domains when membranes are 
more fluid in the presence of DHA enriched phospholipids.  Second, a DHA metabolite, 
docosahexaenoyl ethanolamine (DHEA), has been shown to induce phosphorylation of 
Bcl-2, which results in its dissociation from Beclin-1 and initiates the autophagy process 
(Rovito et al. 2013). Third, once Beclin-1 is freed from Bcl-2 it is easier for the Beclin-
1/VPS34 complex to conjugate LC3 with DHA-enriched PE for a faster and more 
efficient phagophore formation. 
In summary, the findings reported in this study show for the first time that 
autophagy is a key cellular mechanism by which DHA rescues cells undergoing PA-LTx. 
Omega 3 PUFA have been proposed to play various neuroprotective roles during 
traumatic injuries in the nervous system and neurodegenerative diseases. We propose that 
these neuroprotective DHA actions may involve the activation of survival autophagic 
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EPIDERMAL FATTY ACID-BINDING PROTEIN PROTECTS NERVE 





























Epidermal-fatty acid binding protein (E-FABP/ FABP5/DA11) binds and 
transport long-chain fatty acids in the cytoplasm and may play a protecting role during 
neuronal injury. We examined whether E-FABP protects nerve growth factor 
differentiated PC12 cells (NGFDPC12 cells) from lipotoxic injury observed after palmitic 
acid (C16:0; PAM) overload. NGFDPC12 cells cultures treated with PAM/BSA at 0.3 
mM/0.15 mM show PAM-induced lipotoxicity (PAM-LTx) and apoptosis. The apoptosis 
was preceded by a cellular accumulation of reactive oxygen species (ROS) and higher 
levels of E-FABP. Antioxidants MCI-186 and N-acetyl cysteine prevented E-FABP’s 
induction in expression by PAM-LTx while tert-butyl hydroperoxide increased ROS and 
E-FABP expression. Non-metabolized methyl ester of PAM, methyl palmitic acid failed 
to increase cellular ROS, E-FABP gene expression or trigger apoptosis. Treatment of 
NGFDPC12 cultures with siE-FABP showed reduced E-FABP levels correlating with 
higher accumulation of ROS and cell death after exposure to PAM. In contrast, 
increasing E-FABP cellular levels by pre-loading the cells with recombinant E-FABP 
diminished the PAM-induced ROS and cell death. Finally, agonists for PPARβ 
(GW0742) or PPARγ (GW1929) increased E-FABP expression and enhanced the 
resistance of NGFDPC12 cells to PAM-LTx. We conclude that E-FABP protects 





Epidermal-fatty acid binding protein (E-FABP/ FABP5/DA11) belongs to a 
family of low molecular weight (14-15 kDa) cytosolic proteins that bind long chain free 
fatty acids. The members of the FABP family share similar tertiary structure which 
consists of two short α-helical segments and a fatty acid binding cavity surrounded by 
two five-stranded antiparallel β-sheets (Gutierrez-Gonzalez et al. 2002). FABPs are 
thought to play a prominent role in trafficking of long-chain free fatty acids to respective 
final metabolic or regulatory sites within the cell. Compared to other members of FABPs 
in the family, E-FABP has particularly wide tissue distribution, suggesting its diversified 
functions. E-FABP was first isolated from human epidermal cells (Siegenthaler et al. 
1994), and the rat version (DA11) was later cloned from injured dorsal root ganglion 
cells (De Leon et al. 1996). E-FABP is also found expressed in tissues such as 
vasculature endothelial cells (Masouye et al. 1997), mammary tissue (Buhlmann et al. 
1999), adipose tissue (Coe et al. 1999), pancreatic islets (Hyder et al. 2010), 
macrophages (Owada et al. 2001) in addition to all nerve cells studied. An analysis of the 
temporal and spatial expression profiles in the developing brain shows that E-FABP 
exhibits a robust expression during embryonic neurogenesis, axonal growth, neuronal 
migration and terminal differentiation (Liu et al. 1997, Liu et al. 2000). It is highly 
expressed (more than 100-fold compared to adult) as early as E14 in the rat, and the high 
level of expression is sustained during the first three weeks postnatal followed by a lower 
expression in the adult brain and spinal cord (Liu et al. 2000, Owada et al. 1996b). E-
FABP is up-regulated by nerve growth factor (NGF) and is required for NGF-induced 
and polyunsaturated fatty acid-potentiated neurite outgrowth in PC12 cells (Allen et al. 
2000, Liu et al. 2008). E-FABP co-localizes with growth-associated protein 43 in 
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differentiating PC12 cells and in retinal ganglion cells (Allen et al. 2000, Allen et al. 
2001). Furthermore, we and others have reported that E-FABP is induced in motor 
neurons after peripheral nerve axonal injury (De Leon et al. 1996, Owada et al. 1997). 
Similarly, E-FABP expression is up-regulated in the hippocampus in response to kainic 
acid-induced seizure (Owada et al. 1996a) and in the cerebellum and hippocampus after 
experimental brain ischemia (Boneva et al. 2010, Ma et al. 2010). In addition, hypoxia 
causes elevated expression of E-FABP in aortic endothelial cells (Han et al. 2010) and 
PC12 cells (unpublished data). These results suggest a role of E-FABP during stress 
injury in the nerve cells, but its neuroprotective characteristics in the nervous system have 
not been addressed in the literature. 
Neuronal tissue holds a larger amount of membrane lipids compared to other 
tissues and contains a high concentration of polyunsaturated fatty acids that are 
susceptible to lipid peroxidation, leading to oxidative damage. Modulation lipid 
metabolism plays an important role during neuronal injuries and neuronal disorders. 
Several studies have shown that traumatic injury and hypoxic-ischemic brain injury lead 
to activation of phospholipase A2 and sphingomyelinease that release fatty acids and 
ceramide from membrane phospholipids and sphingolipids respectively (Dhillon et al. 
1997, Liu et al. 2006, Yu et al. 2000). The increase of arachidonic acid and ceramide 
initiates the cascade of inflammatory response (Farooqui et al. 2007, Nixon 2009), and 
the accumulation of free fatty acids, especially saturated fatty acids, can cause 
lipotoxicity (Scheff & Dhillon 2004).  All of these events contribute to a great extent to 
the prolonged-phase of secondary degenerative damage by various pathways, including 
generation of free radicals and lipid peroxidation, eventually leading to cell death (Hall & 
 
87 
Braughler 1989, Lok et al. 2011). Further, there is growing evidence suggesting that 
sustained elevation of saturated fatty acids in the circulation due to high calorie intake 
results in lipotoxicity, inflammation and increased oxidative stress, which are believed to 
take part in the development of neurodegenerative diseases such as Alzheimer’s disease 
and Parkinson’s disease (Adibhatla & Hatcher 2008, Gupta et al. 2012, Middleton & 
Yaffe 2009), and metabolic disorders such as type 2 diabetes and nonalcoholic fatty liver 
disease (Unger & Orci 2001, Wang et al. 2006). 
Our laboratory has been investigating the lipotoxic effect of palmitic acid (C16:0; 
PAM) in the nervous system. Pathophysiological concentration of PAM causes caspase-
dependent and caspase-independent apoptotic cell death in NGF-differentiated PC12 
(NGFDPC12) cells and Schwann cells (Padilla et al. 2011, Ulloth et al. 2003). The injury 
cascade starts with increasing intracellular calcium concentration and reactive oxygen 
species (ROS) generation (Almaguel et al. 2009, Padilla et al. 2011). Meanwhile, ER 
stress genes (CHOP, Xbp1 and GRP78) and apoptosis genes (BNIP3, Bax) have been 
shown to be involved in the process (Almaguel et al. 2009, Padilla et al. 2011, Ulloth et 
al. 2003), and Fas receptor and Fas ligand are dramatically increased (Almaguel et al. 
2009, Ulloth et al. 2003). In NGFDPC12 cells, lysosomal membrane permealization 
precedes mitochondrial membrane permealization, and cathepsin L seems to be a key 
player of this lysosomal-mitochondrial crosstalk in PAM-induced lipotoxicity (PAM-
LTx) (Almaguel et al. 2010). The present study uses an NGFDPC12 cell model to 
evaluate whether E-FABP is a stress response protein that plays a protective role 





Materials and Methods 
Materials 
Rat pheochromocytoma (PC12) cells were obtained from American Type Culture 
Collection (Manassas, VA, USA) and all experiments were performed within seven 
passages. Cell culture medium was acquired from Mediatech (Manassas, VA, USA) 
while horse serum and fetal bovine serum (FBS) were purchased from Atlantic Biological 
(Lawrenceville, GA, USA). Nerve growth factor (NGF) is a product from Alomone Labs 
(Jerusalem, Israel). Fatty acid-free bovine serum albumin (BSA) was from EMD 
Millipore Corp. (Billerica, MA, USA) and palmitic acid (PAM), methyl- palmitic acid 
(mPAM), N-acetyl cysteine (NAC), and tert-butyl hydroperoxise (TBHP) were from 
Sigma-Aldrich (St. Louis, MO, USA). Antioxidant MCI-186 was purchased from Biomol 
Research Laboratories (Plymouth Meeting, PA, USA) and NF-ĸB SN50 cell permeable 
inhibitory peptide and control peptide SN50M were from Enzo Life Sciences 
(Farmingdale, NY, USA). All of the PPAR agonists were bought from R&D Systems 
(Minneapolis, MN, USA).  
 
Cell Culture and PAM Treatment 
PC12 cells were propagated with F-12K medium (Ham’s F-12 Nutrient Mixture, 
Kaighn’s Modification with glutamine) containing 15% horse serum, 2.5 % FBS, and 
penicillin (100 units/mL)/streptomycin (100 μg/mL) (Full serum-medium). The cells 
were then reseeded in 6-well plates at the density of 70,000 cells/well and differentiated 
with 50 ng/mL of NGF in F-12K medium with 1% FBS and penicillin/streptomycin (1% 
FBS-NGF medium). The medium was replaced every 3 days and PC12 cells were 
differentiated for 7-10 days before treatments.  
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PAM was delivered to the cell culture in complex with fatty acid-free BSA at 
PAM to BSA molar ratio of 2:1, 1:1 or 0.5:1. Following previously described procedures 
(Almaguel et al. 2009, Ulloth et al. 2003), PAM was first dissolved in 100% ethanol to 
make 300 mM stock solution and then diluted into warm 1% FBS-NGF medium 
containing 150 µM fatty acid-free BSA to make 300 µM (2:1), 150 µM (1:1) and 75 µM 
(0.5:1) working solution.  The final concentration of ethanol was less than 0.1%. With 
this method, the concentration of unbound free PAM in the medium was about 11 nM in 
the 300 µM PAM medium throughout the course of experiment. For control, the cells 
were treated with 1% FBS-NGF medium containing 150 µM fatty acid-free BSA and 
0.1% ethanol, designated as “control medium.” 
 
Cell Morphology Analysis 
Cell morphology changes were monitored by phase contrast microscopy at 
different time points while nuclear morphology of control and PAM-treated NGFDPC12 
cells were assessed by staining with fluorescent dye Hoechst 33342 (Life Technologies, 
Carlsbad, CA, USA). Hoechst dye was added to the culture medium at 1 ng/ml and 
incubated for 10 min at 37°C. Nuclear morphology was visualized under fluorescent 
microscopy. Apoptotic cells were identified by the presence of highly condensed 
chromatin or fragmented nuclei. 
 
Cell Viability Assay 
At the end of experimental treatments, test medium was replaced by one ml/well 
of plain F-12K medium containing 50 μl of cell proliferation/viability reagent WST-1 
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(Roche Applied Science, Indianapolis, IN, USA). After 30 min incubation in the cell 
culture incubator, 100 μl aliquots were transferred to 96-well plate and optical density at 
450 nm was determined by µQuant plate reader (Bio-Teck Instruments, Winooski, VT, 
USA). WST-1 solution without incubating with cells was served as the blank. Cell 
viability was expressed as relative optical density of experimental group opposed to that 
of control group. For comparison, crystal violet cell viability assay was also performed 
using the same procedure described previously (Padilla et al. 2011). 
 
Reactive Oxygen Species (ROS) Analysis 
The ROS levels in NGFDPC12 cells were evaluated by a florescent indicator 2’, 
7’ dichlorodihydrofluorescein diacetate (H2DCFDA, Life Technologies). After 
treatments, the cells were changed to plain F-12K medium with 10 μM H2DCFDA and 
incubated for 25 min in cell culture incubator. Cells were then detached and analyzed 
using a FACSCalibur flow cytometer and Flow-Jo software as described before 
(Almaguel et al. 2009, Padilla et al. 2011).  
 
siRNA Transfection 
To knockdown E-FABP in NGFDPC12 cells, we selected Ambion In Vivo siRNA 
system. Rat FABP5 siRNA (s139047) and negative control siRNA with scrambled 
sequences were acquired (Life Technologies) and introduced into cells by X-tremeGENE 
siRNA transfection reagent (Roche Applied Science). The siRNA transfection, following 
the manufacturer’s instruction, was performed as below:  siE-FABP or siControl stock 
was prepared at 100 μM in water and 2 μl of stock was diluted with 250 μl of Opti-MEM. 
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Transfection reagent (10 μl) was also diluted with 250 μl of Opti-MEM. Diluted siRNA 
and transfection reagent were combined and incubated for 20 min. Three day-
differentiated PC12 cells in 6-well plates were change to antibiotics-free medium 
(1.5ml/well) and then transfection solution (0.5 ml) was added to the well. After 24 hrs, 
the medium was changed to 1% FBS-NGF medium for continual differentiation for 
another 3-5 days. The transfected NGFDPC12 cells were treated with PAM accordingly. 
 
Deliver Recombinant E-FABP to NGFDPC12 Cells 
Recombinant rat E-FABP protein was produced using IMPACT kit (New England 
Biolabs, Beverly, MA, USA) and delipidated by Lipidex 1000 method as reported before 
(Liu et al. 2008). To increase the level of E-FABP in NGFDPC12 cells, recombinant E-
FABP protein was delivered to the cells by BioPORTER Quik Ease kit (Gene Therapy 
Systems, San Diego, CA, USA). Dried BioPORTER reagent in the vials was hydrated 
with PBS and then incubated with recombinant E-FABP at room temperature for 5 min. 
Recombinant E-FABP/BioPORTER complex solution was diluted with plain F-12 
medium before added to NGFDPC12 cells in 6-well plates (10μg protein/well). 
BioPORTER reagent alone and BioPORTER complexed with a non-related protein, β-
galactosidase, were used as controls. After 3-4 hrs incubation, full serum medium was 
added to the wells to let cells recover for 4 hrs and then the medium was changed to 1% 
FBS-NGF medium. The cells were treated with PAM accordingly on the following day. 
 
Real-Time RT-PCR Analysis 
Total cellular RNA was extracted using TRI reagent (Molecular Research Center, 
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Cincinnati, OH) and quantified by measuring the OD at 260 nm. RNA samples (800 ng) 
were first reversed transcribed to cDNA using iSCRIPT cDNA synthesis kit (Bio-Rad 
Laboratories, Hercules, CA, USA). E-FABP gene as well as another five FABP genes: 
intestinal type FABP (I-FABP), heart type FABP (H-FABP), adipocyte FABP (A-
FABP), brain type FABP (B-FABP) and myelin FABP (M-FABP) were quantified by 
real-time PCR using CFX96 system (Bio-Rad). GAPDH was used as the reference gene. 
Table 1 lists primer sequences used in real-time PCR. Reactions were performed in three 
replicates with a 25 µl mixture containing cDNA samples, primers and iQ Sybr Green 
supermix (Bio-Rad). The relative amount of mRNA in experimental cells was calculated 
using 2
−ΔΔCT
 method. In addition, the sizes of final PCR products were verified with a 4% 





Table 1. Primer Sequences for Real Time PCR to amplify selected FABPs 
 
Western Blots 
The polyclonal antibodies against E-FABP were generated in rabbits against 
recombinant E-FABP produced in the laboratory. After treatment, cells were pelleted and 
extracted with lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 5% 
glycerol, 1mM EDTA, 100 µM PMSF, 1mM DTT, and protease inhibitor cocktail from 
Roche Applied Science). Protein extracts of NGFDPC12 cells (10 μg) were resolved on a 
NuPAGE Bis-Tris gel (Life Technologies) and transferred to a nitrocellulose membrane. 
After blocking with 7.5% milk in Tris-buffered saline with 0.05% Tween 20, pH 7.4 
(TTBS), the membrane was incubated with E-FABP antiserum and anti β-actin (clone 
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AC-15, Sigma-Aldrich) in 5% milk TTBS at 4°C overnight. Subsequently, the membrane 
was washed with TTBS, incubated with horseradish peroxidase-goat anti-rabbit IgG and -
goat anti-mouse IgG for 1 hr, and washed again. The signal was then detected by 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL). 
The relative amount of protein was quantified by densitometry analysis of the 
autoradiographs using Alpha Innotech (Protein Simple, Santa Clara, CA). 
 
Immunofluorescent Staining 
 PC12 cells were seeded in collagen-coated 4-well culture slides (BD Biosciences, 
Bedford, MA) and differentiated with NGF. After PA-LTx treatments, cells were fixed 
with 4% paraformaldehyde. After washed with PBS, the cells were incubated with 
blocking solution that consists of 20% normal donkey serum (NDS) in PBST (PBS with 
0.1% Tween 20) for 2 hrs. Primary antibody, anti-E-FABP antiserum, was prepared in 
3% NDS with PBST and incubated with the cells overnight at 4°C. Next day, the slides 
were washed with PBST and incubated with secondary antibody, Alexa Fluor488 anti-
rabbit (Life Technologies), for 2 hrs. Afterward, cells were counter-stained with Texas 
red-phalloidin (Liu et al. 2008) and examined with fluorescent microscopy. 
 
Statistical Analysis 
All the experiments were repeated independently at least 3 times. Statistical 







Lipotoxicity Caused by Palmitic Acid (PAM) Induces Apoptosis in NGFDPC12 Cells 
The first series of experiments confirmed the effect of PAM-induced lipotoxicity 
(PAM-LTx) in NGFDPC12 cells. Figures 1A-1C show the morphological appearances 
of NGFDPC12 cells after PAM treatment for up to 48 hrs. The extensive neurite network 
seen in control non-treated cells started to disintegrate after 24 hrs and was largely absent 
after 36 and 48 hrs of treatment (Fig. 1A). The loss of neurites coincided with round up 
cell bodies (Fig. 1A) and typical apoptotic nuclei in PAM-treated cells (Fig. 1B). 
Immunocytochemistry analysis of E-FABP revealed that there is an accumulation of E-
FABP in the neurite region after PAM treatment in NGFDPC12 cells (Fig. 1C).  
Quantitative cell viability assays indicated a time-dependent decrease loss of NGFDPC12 
cells following PAM treatment as shown in WST-1 assay and crystal violet assay (Fig. 






Figure 1. Palmitic Acid (PAM) induces apoptotic cell death in NGFDPC12 cells. Cells 
were treated with control medium (CTL) or 300 µM PAM for different time period (12-
48 hrs). (A) Representative cellular morphological images were acquired by phase 
contrast microscopy. (B) Representative nuclear morphological images were analyzed 
with Hoechst staining and fluorescent microscopy. Arrows indicate chromatin 
condensation and fragmentation. (C) Representative immunofluorescent images are 
shown to exhibit intracellular E-FABP in green and cytoskeleton in red. (D) Cell viability 
of NGFDPC12 cells was determined by WST-1 assay. (E) Cell viability of NGFDPC12 
cells was determined by crystal violet assay. The data represent mean ± SEM of three 






E-FABP Is Up-Regulated under PAM-LTx in NGFDPC12 Cells 
In the next series of experiments, we determined the E-FABP mRNA levels in 
NGFDPC12 cells at various time points after cells were treated with 75 µM, 150 µM and 
300 µM PAM (Fig. 2A). When near physiological concentration of PAM was used (75 
µM), mRNA level of E-FABP did not change for up to 48 hrs. However, at 
pathophysiological concentration (150 µM), E-FABP mRNA showed a maximum 
increase of 2.5 fold at 18 hrs and dropped back to control level at 24 and 48 hrs.  When 
NGFDPC12 cells were cultured with even higher PAM concentration of 300 µM, an 
earlier and a stronger response of E-FABP mRNA up-regulation was observed. Under 
such conditions, E-FABP mRNA level reached a maximum 3.5 fold at 12 hrs, followed 
by a lower stimulation at 18 hrs (3 fold) and 24 hrs (2 fold). Western blot analysis 
showed that E-FABP protein level in NGFDPC12 cells was increased continuously up to 
24 hrs by 300 µM PAM while there are no significant changes observed up to 24 hrs 
when treated with 150 µM PAM (Fig. 2B and 2C). In addition to E-FABP, mRNA levels 
of the other five FABPs (I-FABP, H-FABP, A-FABP, B-FABP and M-FABP) in 
NGFDPC12 cells were also analyzed and the results are summarized in Table 2. The data 
show that E-FABP is the most abundant FABP in NGFDPC12 cells by two to three 
orders of magnitude higher and it was significantly increased by PAM exposure. PAM 






Figure 2. E-FABP is up-regulated under PAM-induced lipotoxicity (PAM-LTx) in 
NGFDPC12 cells. (A) Cells were treated with control medium (CTL) or PAM at the 
concentration of 75 µM, 150 µM or 300 µM for 6 to 48 hrs. Quantification of E-FABP 
mRNA levels was performed by real-time RT-PCR. (B) Cells were treated with CTL or 
300 µM PAM for 6 to 24 hrs. Quantification of E-FABP protein levels was done by 
Western blots followed by densitometry analysis, using β-actin as the loading control. 
(C) A representative Western blot for E-FABP (15kDa) and β-actin (42kDa) of 
NGFDPC12 cells treated with 300 µM or 150 µM PAM for 6 to 24 hrs. The data 
represent mean ± SEM of three independent experiments. Significance symbols: 




Table 2. Relative expression of FABPs and their relative changes in response to PA-LTx 




E-FABP Up-Regulation by PAM-LTx in NGFDPC12 Cells Is Mediated through 
Reactive Oxygen Species (ROS) Accumulation 
The accumulation of ROS in NGFDPC12 cells after PAM treatment was analyzed 
using H2DCFDA assay. The results indicate that PAM caused a dose- and time-
dependent increase of ROS levels in NGFDPC12 cells (Fig. 3A). The increase of ROS by 
300 µM and 150 µM PAM occurred as early as 6 hrs after treatment, which precedes the 
up-regulation of E-FABP mRNA seen in the same conditions (18 hrs, Fig. 2A). Their 
ROS accumulation reached the highest level at 12 hrs and returned to control level at 24 
hrs. Furthermore, ROS levels were not increased when NGFDPC12 cells were treated 
with 75 µM PAM, which condition did not affect E-FABP mRNA levels (Fig. 2A). 
Therefore, we hypothesized that the stimulation of E-FABP could be mediated through 
ROS generation. To test this hypothesis, antioxidants MCI-186 (100 µM) or N-acetyl 
cysteine (NAC, 100 µM) were added to NGFDPC12 cultures during PAM-LTx 
treatment. The results are shown in Figure 3B. MCI-186 and NAC by themselves did not 
affect E-FABP expression but were able to partially (MCI-186) or completely (NAC) 
abolish the up-regulation of E-FABP caused by PAM. In addition, NGFDPC12 cells were 
treated with free radical tert-butyl hydroperoxise (TBHP, 100 µM), and the result showed 




after 12-24 hrs (Fig. 3C), which is comparable to the stimulation seen by 300 µM PAM 
(Fig. 2A). These results confirmed that E-FABP is induced via ROS generated by PAM-
LTx. 
ROS have been shown to activate a number of cellular signal transduction 
pathways that could mediate the increase of E-FABP gene expression observed during 
lipotoxic injury. Considering that E-FABP gene has two putative NF-ĸB binding sites in 
the promoter region (Fig. 4A) that mediate the up-regulation of E-FABP in MCF-7 cells 
(Kannan-Thulasiraman et al. 2010), we proceeded to further explore the interactions of 
ROS and E-FABP regulation in cultures treated with SN50, which blocks nucleus 
translocation of NF-ĸB. Figure 4B shows that the increase of E-FABP mRNA by PAM 
was significantly lower in cells co-treated with SN50. Determination of cellular ROS 
levels at a later time showed that cells co-treated with SN50 and PAM exhibited higher 
ROS level than cells treated with PAM alone while the control peptide, SN50M, did not 
affect the ROS levels in NGFDPC12 cells (Fig. 4C). In an additional experiment we also 
examined if MAP kinase mediates the up-regulation of E-FABP by PAM-LTx. Figure 
4D indicates that in the presence or absence of the MAP kinase inhibitor, U0126, E-





Figure 3. Cellular accumulation of Reactive Oxygen Species (ROS) mediates PAM-LTx-
triggered E-FABP up-regulation in NGFDPC12 cells. (A) Cells were treated with control 
medium (CTL) or PAM at the concentration of 75 µM, 150 µM or 300 µM for 3, 6, 12, 
and 24 hrs and cellular ROS level was measured with H2DCFDA method. (B) Cells were 
pretreated with antioxidants MCI-186 (100 µM in control medium) or N-acetyl-cysteine 
(NAC, 100 µM in control medium) for 12 hrs and then incubated with 300 µM PAM in 
the presence of the same antioxidant for another12 hrs. For comparison, cells were 
treated with CTL, 300 µM PAM or antioxidants alone for 12 hrs. Relative E-FABP 
mRNA levels were determined by real-time RT-PCR. (C) Cells were treated with CTL or 
tert-butyl hydroperoxide (TBHP, 100 µM in control medium) for 6, 12, 18 and 24 hrs and 
relative E-FABP mRNA levels were determined. The data represent mean ± SEM of 
three independent experiments. Significance symbols: *=p < 0.05, **=p<0.01 and 
***=p<0.001 (compared to control group). 
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Figure 4. NF-ĸB inhibitor affects PAM-LTx-induced E-FABP expression and ROS accumulation 
in NGFDPC12 cells. (A) The putative binding sites of NF-kB on regulatory region of mouse E-
FABP predicted by PROMO program (Farre et al. 2003). (B) Cells were treated with control 
medium (CTL), NF-kB inhibitor SN50 at 50µg/ml in control medium (SN50), 300 µM PAM 
(PAM) or PAM together with SN50 (PAM+SN50) for 12 hrs and E-FABP mRNA levels were 
determined by real-time RT-PCR. (C) Cells were treated with control medium, SN50 or control 
peptide SN50M with or without 300 µM PAM for 18 hrs and ROS level was measured with 
H2DCFDA method. (D) Cells were treated with 20 µM of U0126 or control medium with 0.1% 
DMSO with or without 300 µM PAM for 12 hrs and E-FABP mRNA levels were determined by 
real-time RT-PCR. The data represent mean ± SEM of three independent experiments. 
Significance symbols: *=p < 0.05, **=p<0.01 and ***=p<0.001. Significance symbols are shown 
above bars when compared to control group and are shown above lines when compared between 
two linked groups. 
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E-FABP Up-Regulation by PAM-LTx in NGFDPC12 Cells May Involve PAM 
Metabolism 
In order to determine whether metabolized PAM is essential for producing 
lipotoxicity, a non-metabolized methyl ester of PAM, methyl palmitic acid (mPAM), was 
tested (Parker et al. 2003). Our results revealed that mPAM does not alter either the E-
FABP mRNA (Fig. 5A) or ROS level (Fig. 5B) and NGFDPC12 cells did not lose their 
morphological integrity as they did with PAM treatment (Fig. 5C). Hence, PAM 







Figure 5. Non-metabolized PAM, methyl palmitic acid (mPAM), does not cause 
lipotoxicity in NGFDPC12 cells. (A) Cells were treated with control medium (CTL), 300 
µM PAM or mPAM at the concentration of 75 µM, 150 µM or 300 µM for 12 hrs. 
Relative E-FABP mRNA levels were determined by real-time RT-PCR. (B) Cells were 
treated with control medium (CTL),  300 µM PAM for 12 hrs or 300 µM mPAM for  6, 
12, and 24 hrs and ROS level was measured with H2DCFDA method. The data represent 
mean ± SEM of three independent experiments. Significance symbols: ***=p<0.001 
(compared to control group). (C) Representative morphological photographs of 





Cellular Levels of E-FABP Affect ROS Concentration and NGFDPC12 Cells Viability 
during PAM-LTx 
To investigate the significance of E-FABP up-regulation during lipotoxicity, we 
tested lipotoxicity effects on NGFDPC12 cells having decreased or increased intracellular 
E-FABP protein levels.  
By transfecting siRNA, both the E-FABP protein level and mRNA level in 
NGFDPC12 cells was significantly reduced when compared to siControl-treated cells 
(Fig. 6A). PAM treatment resulted in elevated E-FABP mRNA in siE-FABP cells and 
siConrol cells, but E-FABP in siE-FABP cells were significant lower than that in 
siControl cells 12 hr and 18 hr after PAM-LTx (Fig. 6A). The effect of decreased E-
FABP in NGFDPC12 cells on intracellular ROS is shown on Figure 6B. In the absence 
of PAM, siE-FABP cells showed higher basal level of ROS than siControl cells, 
presumably due to lacking ROS-buffering effect from E-FABP.  PAM-LTx caused time-
dependent increase of ROS accumulation at 12 and 18 hrs. As expected, siE-FABP cells 
exhibited higher ROS than siControl did (Fig. 6B).  Cell viability assay showed no 
difference between siControl and siE-FABP cells without PAM (Fig. 6C). However, a 
significant higher loss of cell viability in siE-FABP transfected cells during lipotoxicity 
was found when compared to that of siControl (Fig. 6C). These results suggest that the 
E-FABP can reduce ROS accumulation and protect NGFDPC12 cells from apoptosis 





Figure 6. Lowering E-FABP levels in NGFDPC12 cells by siRNA increases ROS 
accumulation and PAM-LTx-induced cell death. (A) Left: Three-day-differentiated PC12 
cells were transfected with siControl or siE-FABP for 5 days.  A representative E-FABP 
Western blot is shown. Right: siControl and siE-FABP transfected cells were treated with 
control medium or 300 µM PAM for 12 and 18 hrs. Relative E-FABP mRNA levels were 
determined by real-time RT-PCR. (B) Cellular ROS levels of transfection reagent 
(vehicle), siControl and siE-FABP treated cells were measured by H2DCFDA method at 
12 and 18 hrs after PAM (or control medium) treatment. (C) Cell viability of siControl 
and siE-FABP cells were measured by WST-1 assay at 24 and 48 hrs after PAM 
treatment. CTL: control medium at 48 hrs.  The data represent mean ± SEM of three 
independent experiments. Significance symbols: *=p < 0.05, **=p<0.01 and 
***=p<0.001. Significance symbols are shown above bars when compared to control 
group and are shown above lines when compared between two linked groups. 
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In a previous report we showed that increasing cellular levels of E-FABP 
significantly potentiated neurite extension in differentiating PC12 cells (Liu et al. 2008). 
Using a similar approach, we delivered recombinant E-FABP protein to NGFDPC12 cells 
before exposure to PAM overload. Figure 7A indicates that NGFDPC12 cells receiving 
recombinant E-FABP protein showed higher E-FABP levels at both basal and lipotoxic 
condition.  Upon PAM treatment, the cells loaded with recombinant E-FABP protein did 
not show significant elevation of ROS as seen in vehicle-treated cells (Fig. 7B). Further, 
this ROS-reducing effect appears to be specific to E-FABP because cells loaded with 
vehicle (BioPORTER) or unrelated protein (β-galactosidase) still displayed increased 
ROS level after PAM treatment (Fig. 7B). Figure 7C shows that the PAM+E-FABP 
group, which exhibits lower ROS levels, had more viable cells than the other three groups 
at the end of PAM treatment.  
E-FABP has been shown to be regulated by peroxisome proliferator-activated 
receptors (PPARs) (Hyder et al. 2010). We used specific PPAR agonists WY14643 (for 
PPARα), GW0742 (for PPARβ/δ) and GW1929 (for PPARγ) to further examine the 
effect of increased levels of E-FAPB during PAM-LTx. Among the PPAR agonists tested 
(Fig. 8A), PPARβ/δ agonist, GW0742, elicited 6-fold stimulation, and PPARγ agonist, 
GW1929, produced 2-fold stimulation of E-FABP expression at 24 hrs but not at 12 hrs. 
Based on this result, we pretreated NGFDPC12 cells with PPAR β/δ agonist and PPARγ 
agonist to increase E-FABP levels before PAM-LTx experiment. Consistent with our 
hypothesis, elevated cellular levels of E-FABP in NGFDPC12 culture resulting from 
treatment with PPARβ/δ and PPARγ agonists increased cell resistance to lipotoxic insult 
(Fig. 8B).  Furthermore, the protecting effect provided by PPARβ/δ and PPARγ agonists 
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was abolished in siE-FABP-transfected cells (Fig. 8C), confirming the important role of 




Figure 7. Preloading NGFDPC12 cells with recombinant E-FABP decreases PAM-LTx-
induced cellular ROS accumulation and cell death. Recombinant proteins were delivered 
to NGFDPC12 cells one day before the addition of 300 µM PAM to the cell culture. (A) 
E-FABP Western blot was performed 24 hrs after treatment and a representative blot is 
shown. Veh: control medium added to vehicle-loaded cells; PAM+Veh: PAM added to 
vehicle-loaded cells; E-FABP: control medium added to E-FABP-loaded cells; PAM+E-
FABP: PAM added to E-FABP-loaded cells. (B) Cellular ROS level was evaluated by 
DCF method at 12 hrs after PAM treatment. CTL: control medium added to vehicle-
loaded cells, PAM: PAM added to untreated cells, PAM+Veh: PAM added to vehicle-
loaded cells, PAM+β-gal: PAM added to β-galactosidase-loaded cells and PAM+E-
FABP: PAM added to E-FABP loaded cells. (C) Cell viability was determined by WST-1 
assay at 48 hrs after PAM treatment. Significance symbols: *=p < 0.05, **=p<0.01 and 
***=p<0.001. Significance symbols are shown above bars when compared to control 




Figure 8. PPAR agonists stimulate E-FABP expression and protect NGFDPC12 cells from 
PAM-LTx. (A) Cells were treated with 10 µM of PPARα agonist (WY14643), PPARβ agonist 
(GW0742) and PPARγ agonist (GW1929) in control medium for 12 and 24 hrs. Relative E-
FABP mRNA levels of cells upon treatments were determined at 12 and 24 hrs. (B) 
NGFDPC12 cells were treated with 300 µM PAM without PPAR agonists pretreatment 
(PAM), with GW0742 pretreatment (PAM+ PPAR-β), or with GW1929 pretreatment (PAM+ 
PPAR-γ) for 2 days. Each group was also treated with control medium without PAM. Cell 
viability was determined by WST-1 assay at 48 hrs. (C) siControl and siE-FABP transfected 
cells were treated with 10 µM GW0742 or GW0742 for 2 days before PAM-LTx experiment.  
Cell viability was determined by WST-1 assay at 48 hrs. The data represent mean ± SEM of 
three independent experiments. Significance symbols: *=p<0.05 and ***=p<0.001. 
Significance symbols are shown above bars when compared to control group and are shown 





The present study provides new experimental evidence that E-FABP is an 
oxidative stress response protein that plays a protective role as an antioxidant in 
NGFDPC12 cells exposed to PAM-LTx injury. We demonstrate that experimental 
conditions that increase cellular levels of E-FABP (administration of E-FABP 
recombinant protein and treatment with PPAR agonists) lower ROS levels and improve 
cell survival in PAM-injured NGFDPC12 cells. Inhibition of E-FABP gene expression 
using E-FABP siRNA magnifies the detrimental effects of PAM-LTx by increasing ROS 
accumulation and cell death. Thus, E-FABP levels in the cell can regulate the outcome of 
PAM-LTx. 
Previous work from our laboratory showed that the detrimental effects of PAM-
LTx can be inhibited by antioxidant treatment (Almaguel et al. 2009, Padilla et al. 2011), 
suggesting that cellular ROS accumulation is an integral part of this PAM-LTx process. 
The mitochondrial electron transport chain (ETC) has been recognized as one of the 
major sites to generate ROS in the cell, mainly from enzyme complexes Complex I and 
Complex III. Long-chain nonesterified fatty acids modulate mitochondrial ROS 
production by interacting or uncoupling of the ETC (Schonfeld & Wojtczak 2008). For 
PAM, in particular, has been shown to increase mitochondrial superoxide generation in 
cardiomyocytes and INS-1 beta cells (Fauconnier et al. 2007, Lin et al. 2012). Palmitoyl-
carnitine that serves as the substrate for β-oxidation releases significant amount of H2O2 
(St-Pierre et al. 2002). Further, the mitochondrial H2O2 emission rates in permeabilized 
muscle fibers are higher during respiration by palmitoyl-carnitine oxidation (fatty acid 
metabolism) than by pyruvate oxidation (glucose metabolism) (Anderson et al. 2007). 
Palmitoyl-CoA was shown to inhibit directly (without β-oxidation) adenine nucleotide 
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translocator and results in reduction in the extramitochondrial ATP/ADP ratio and 
increased ROS production in liver mitochondria (Ciapaite et al. 2006). On the other hand, 
succinate-dependent ROS release from Complex I is decreased by palmitoyl-CoA in 
heart mitochondria (Bortolami et al. 2008). PAM can also be metabolized in peroxisome 
and the balance between H2O2 production (by acyl-CoA oxidases) and H2O2 reduction 
(by catalase) controls the net H2O2 output from peroxisome. Recently, peroxisomal ROS 
generation has also been suggested to mediate the PAM-LTx in insulin-producing cells 
(Elsner et al. 2011). While the present study demonstrates that PAM activation is 
required for generating ROS and producing lipotoxicity, further studies are required to 
assess the respective contributions of metabolic oxidation and the generation of lipid-
derived signals in the cytosol.   
 ROS can be toxic to the cells, due to their strong reactivity with proteins, lipids 
and nucleic acids that causes deleterious modification of these macromolecules (Aruoma 
et al. 1991, Kramer et al. 1994; Radi et al. 1991). High intracellular accumulation of 
ROS can also regulate gene expression as seen in the redox-sensitive NF-ĸB signaling 
pathway (Morgan & Liu 2011). NF-ĸB proteins regulate expression of many genes 
involved in inflammation, immune response, cell growth/differentiation and apoptosis. 
Our findings showing SN50 reduces the increase of E-FABP gene expression in 
NGFDPC12 cells during lipotoxicity points to a potential contribution of the NF-ĸB 
pathway in this process, which leads to future studies to examine the role of this 
important signaling pathway. The NF-ĸB proteins  are composed of dimers of the Rel 
family that bind 10-base pair ĸB sites. NF-ĸB dimers are sequestered in the cytosol by 
inhibitor proteins IĸBs. The activity of IĸBs is controlled through phosphorylation by IĸB 
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kinases (IKKs). Upon phosphorylation, IĸBs become ubiquitinated and degraded in 
proteosomes that allow NF-ĸB dimers to translocate to the nucleus, bind to ĸB motif and 
activate gene transcription. ROS have both stimulatory and inhibitory effects in NF-ĸB 
signaling pathway (Byun et al. 2002). Mitochondrial ROS generated during 
hypoxia/reoxygenation activate NF-ĸB through phosphorylation of IĸBα at alternative 
phosphorylation site tyrosine 42 (Fan et al. 2003). Tyrosine 42-phosphorylated IĸBα is 
bound by regulatory subunit of PI3-kinase, which consequently unmasks NF-ĸB and 
allows it to translocate to the nucleus (Beraud et al. 1999). On the other hand, H2O2 
reduces NF-ĸB signaling by inhibiting inflammatory-stimulated IKK (Reynaert et al. 
2006). Further, IKK is known to be phosphorylated and activated by upstream kinase 
NIK (NF-ĸB-inducing kinase), and this activity is also modulated by H2O2 (Li & 
Engelhardt 2006). Along these lines, PAM can regulate genes such as interleukin 6 in the 
skeletal muscle (Weigert et al. 2004) and adipocytes (Ajuwon & Spurlock 2005) through 
NF-ĸB activation.  PAM has been shown to stimulate DNA binding of NF-ĸB, decrease 
cytosolic IĸBα, and increase nuclear levels of p65/RalA in L6 myotubes, which is the 
pathway implicated in fatty acid-induced insulin resistance in skeletal muscle (Sinha et 
al. 2004).  
The fact that treating NGFDPC12 cultures with PPAR agonists is followed by 
induction of E-FABP suggests an important role of these proteins in protecting cells 
during PAM-LTx. PPARs, comprising three isotypes PPARα, PPARβ/δ and PPARγ, are 
transcription factors activated by a wide range of naturally occurring or metabolized 
lipids derived from the diet or from intracellular signaling pathways and subsequently 
modulate lipid-related gene expression (Feige et al. 2006). PPARs serve as a lipid signal 
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sensor in the cell and play a crucial role to integrate various pathways involved in lipid 
metabolism, inflammation, cellular proliferation and differentiation (Feige et al. 2006). 
Elevated plasma saturated fatty acid due to over nutrition as well as traumatic/ischemic 
CNS injury lead to activation of inflammatory cascades, as NF-ĸB the key regulator of 
inflammation (Cai 2013, Fleming et al. 2006). PPARs are shown to suppress NF-ĸB 
through various mechanisms (Wahli & Michalik 2012) and PPARγ is considered a 
promising neuroprotective strategy mainly through its anti-neuroinflammatory activity 
(Heneka et al. 2011, Munhoz et al. 2008).  FABPs are able to facilitate this 
neuroprotective pathway through channeling lipid ligands to respective PPAR ligand 
binding domain (Velkov 2013).  Members of the FABP family are regulated by PPARs. 
Adipocyte-FABP and liver-FABP are among the best characterized PPAR target genes 
(Mochizuki et al. 2001, Poirier et al. 1997, Tontonoz et al. 1994). The impressive up-
regulation of E-FABP by PPARβ/δ agonist observed in the present study is similar to the 
effect of PPARβ/δ in prostate cancer (Morgan et al. 2010). In addition, the neuronal 
differentiating activity of PPARβ/δ can occur through modulating MAP kinase pathway 
(D'Angelo et al. 2011), which is consistent with our previous study showing that MAP 
kinase mediates the NGF-induced up-regulation of E-FABP gene in PC12 cells (Liu et al. 
2008). However, data presented in current study suggest that PAM-stimulated E-FABP 
gene expression is dependent on NF-ĸB but not MAP kinase. Our data agree with the 
notion that the expression of E-FABP may be at the center of neuronal differentiating and 
injury processes (De Leon et al. 1996, Liu et al. 1997, Liu et al. 2000, Liu et al. 2008). 
 Multiple lines of evidence support an antioxidant role of FABPs as function of 
their demonstrated fatty acid/lipid binding properties (Terrasa et al. 1998, Wang et al. 
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2005, Wang et al. 2007). For instance, Ek et al. (1997) showed that FABPs can serve as 
an intracellular fatty acids buffer that can alter their availability for cell metabolic 
functions. Therefore, the increase in the level of E-FABP by PAM-LTx observed in our 
study may reduce the effective amount of PAM to generate additional ROS. Further, 
FABPs can also bind to long-chain fatty acid oxidation derivatives (Raza et al. 1989) and, 
thus, may neutralize their potential toxic effect.  In addition, FABPs are known to directly 
involve PPAR-mediated gene control by transporting PPAR ligands to the nucleus 
(Kaczocha et al. 2009, Wolfrum et al. 2001), and PPARs regulate the balance between 
cell survival and apoptosis (Feige et al. 2006). Along these lines, Tan et al. (2002) 
reported that E-FABP and adipocyte FABP can transport selective ligands to PPARβ/δ 
and PPARγ, respectively, to enhance their transcriptional activity. For instance, in breast 
cancer, retinoic acid either inhibits or promotes cell growth depending on how FABPs, 
i.e. CRABP-II and E-FABP, channel it to either the nuclear retinoic acid receptor or 
PPARβ/δ, respectively (Schug et al. 2008). In another series of studies, FABPs have been 
shown to serve as antioxidant proteins through modification of their amino acid residues 
not through their ligand binding. For example, E-FABP protein has the highest number of 
cysteine residue among all FABPs (Odani et al. 2000). Disulfide bonds may be formed 
between spatially close cysteine pairs: Cys-120/Cys-127 and Cys-67/Cys-87 in the case 
of rat E-FABP, and they seem not to be directly involved in fatty acid binding. That the 
cysteine pairs form disulfide bonds or remain free thiols is affected by the cellular redox 
state suggests that E-FABP can serve as an intracellular free radical scavenger (Odani et 
al. 2000). The protective role of E-FABP was also evident in the study by Bennaars-
Edien et al. (2002) showing that Cys-120 and Cys-127, to a lesser extent, are covalently 
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modified by 4-hydroxynonenal (4-HNE), a toxic lipid peroxidation product, and the 4-
HNE modification is potentiated by fatty acid binding. The 4-HNE modification of 
cysteine side chains were later reported for adipocyte FABP and liver FABP (Grimsrud et 
al. 2007, Smathers et al. 2012). Besides cysteine residue, oxidative modification of 
methionine residues was also identified in liver FABP, but the antioxidant effect was 
reduced after fatty acid binding (Yan et al. 2009). The mechanism by which E-FABP 
diminishes ROS produced by PAM-LTx demonstrated in this study needs further 
investigation. However, it is reasonable to suggest that the protective role of E-FABP in 
PAM-LTx may have important clinical implications in neuronal injuries that involve 
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Hypoxia is at the core of neuronal death during traumatic brain injury, spinal cord 
injury and stroke.  We subjected nerve growth factor differentiated pheochromocytoma 
cell line 12 (NGFDPC12) to .5% [O2] for 24 to 48hrs.  The mRNA levels of the stress 
response protein HIF-1α went up 3.5, 5 and 6 fold of control at 18, 24 and 48hrs, 
respectively. Pro-apoptotic protein BNIP3 went up 2.5 and 3.5 fold of control at 18 and 
24hrs, respectively. Hypoxia treatment also induced a 2.5 fold increase in ROS after 
24hrs and that increase in ROS could be prevented with antioxidant MCI-186 at 50 and 
100 μM concentration. In addition, hypoxia increased Annexin V conjugation 2.5 fold of 
control at 24hrs. Treatment with docosahexaenoic acid (DHA) or the autophagy 
promoter, rapamycin, during hypoxia increased cell viability and brought back the levels 
of Annexin V to control level.  Interestingly, pre-treat cells with DHA for 24 hours before 
hypoxic insult also increased cell survival.  We found that DHA increased the levels of 
conjugated LC3 at 24 hrs under hypoxic condition, suggesting that autophagy is involved 
in DHA-induced neuroprotection.  Hypoxia also induced the up-regulation of EFABP and 
that expression was decreased when an antioxidant was added during hypoxia. The 
inhibition of EFABP expression during hypoxia decreased the cell viability and the 
hypoxia-stimulated EFABP mRNA expression was reduced when an antagonist of 
PPARγ was added.  We propose that addition of DHA or expression of EFABP inhibits 
apoptosis and protects NGFDPC12 cells from .5% [O2] hypoxia.   DHA also has the 






According to the CDC (https://www.cdc.gov/nchs/fastats/stroke.htm accessed 
May-2018) neuronal injury in stroke, traumatic brain injury and spinal cord injury is the 
first cause of disability and the fourth cause of death in USA.  With an incidence of 
750,000 a year stroke is the fifth cause of death in United States with more than 140,323 
deaths every year.  Apart for smoking and drinking alcohol, risk factors for stroke are 
mainly related to metabolic syndrome where high blood pressure, insulin resistance, 
overweight and dyslipidemia account for the majority of cases. The hallmark of this type 
of neuronal injury is hypoxia and ischemia. The classical description of CNS injury 
during hypoxia (Dirnagl et al. 1999) is a sharp decrease in pH, glutamate excitotoxicity, 
production of oxygen free radicals and oxidative stress, with acute necrosis with 
inflammation followed by prolonged periods of delayed cell death by apoptosis.  
Mitochondria respiratory dysfunction results in decreased ATP and the formation of 
reactive oxygen species (Nathaniel et al. 2015).  The main mediator of hypoxia induced 
endotoxicity is the activation of HIF-1α (hypoxia inducible factor-1α) that triggers the 
activation of stress response proteins or cell death pathways. 
DHA is a highly polyunsaturated fatty acid of the ω-3 series with 22 carbon atoms 
and six cis double bonds.  This chemical arrangement gives DHA the curved (kinked or 
bent) structure that is key to its capacity to increase the fluidity of membranes (Stillwell 
& Wassall 2003, Hashimoto et al. 1999).  In a diverse array of experiments increasing 
membrane fluidity resulted in increased drug permeability (Roach et al. 2004), carrier 
mediated transport (Wu & Robinson 1999), activities of membrane-bound enzymes 
(Keeffe et al. 1980), and enhanced neurotransmission (Clarke et al. 1999).  We reported 
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in a previous work (chapter 3 of this study) that DHA enhances the extension and 
thickness of neurites in the model of NGFDPC12 cells (Liu et al. 2015).  Almaguel et al 
reported that NGFDPC12 cells co-treated with PA and DHA (PA+DHA) from the start 
exhibited increased cell viability.  DHA decreased the morphological features of 
apoptosis, inhibited the PA-induced apoptotic cleavage of PARP and Lamin-B, and 
stabilized mitochondrial membrane potential (Almaguel et al. 2009).  DHA also keeps 
the integrity of lysosomal membranes during PA-LTx and prevents cathepsin-L over 
spilling from the lysosomes (Almaguel et al. 2010).    
Epidermal fatty acid binding protein (EFABP/ FABP5/DA11) is part of the 14-
15kDa cytosolic family of proteins that transport long-chain free fatty acid in the aqueous 
milieu of the cytoplasm (Gutierrez-Gonzalez et al. 2002).  After peripheral motor nerve 
injury of the dorsal root ganglia (De Leon et al. 1996) or hypoglossal motor neurons 
following nerve crush (Owada et al. 1997) EFABP is induced many folds of control.  
Further, EFABP is increased in the cerebellum and hippocampus after ischemia and it’s 
been identified in activated microglia (Boneva et al. 2010).  Ma et al. (Ma et al. 2010) 
showed that FABP5 expression is increased in neurons of the cornu ammonis 1 (CA1) of 
the hippocampus and remains stable within the dentate gyrus (DG) after ischemia.  In 
addition, hypoxia causes elevated expression of FABP5 in human aortic endothelial cells 
(Han et al. 2010). 
In this study, we examined the cellular events in NGFDPC12 cells undergoing 
hypoxia insult and identified cellular mechanisms associated with neuroprotective 




Materials and Methods 
Materials 
We purchased the following reagents from the appropriate suppliers: Ham’s F-12 
medium with Kaighn’s modification (F-12K) was purchased from Mediatech, Inc. 
(Manassas, VA); horse serum and fetal bovine serum were from Atlantic Biological 
(Lawrenceville, GA); Nerve growth factor (NGF, Cat# N-100) was from Alomone Labs 
(Jerusalem, Israel); fatty acid-free bovine serum albumin (Cat# 126575-10GM) was from 
EMD Milipore Corp (Billerica, MA); DHA (Cat# 90310) was from Cayman Chemicals 
(Ann Arbor, MI); PA (Cat# P0500-25G), EPA (Cat#E2011-10MG), and protease 
inhibitor cocktail tablets (Cat# 4693124001) were from Sigma-Aldrich (St. Louis, MO); 
and rapamycin (Cat# 9904S) was from Cell Signaling Technology (Danvers, MA). 
Peroxisome proliferator-activated receptor (PPAR) agonist WY14643 (Cat#1312) and 
antagonist GW9662 (Cat#1508) were bought from R&D Systems (Minneapolis, MN). 
 
Cell Culture and Treatments 
PC12 cells (rat pheochromocytoma cells RRID:CVCL_0481, ATTC Cat# CRL-
1721, Manassas, VA) were plated in F-12K medium with 15% horse serum, 2.5% fetal 
bovine serum (FBS), and penicillin/streptomycin. After attaching to the plates, cells were 
then differentiated with F-12K medium containing NGF (50 ng/mL) and 1% FBS and 
penicillin/streptomycin (1% FBS-NGF medium). Medium was changed every 2-3 days 
and cells were differentiated for 7-10 days before experimental treatments. Fully 
differentiated PC12 cells showing long neurites that form an extensive network were used 
in all experimental conditions. 
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 PA-LTx treatment was performed as previously described (Ulloth et al. 2003, 
Almaguel et al. 2009). Briefly, a PA stock solution (300 mM in 100% ethanol) was 
diluted 1,000 fold in warm 1% FBS-NGF medium containing 0.15 mM fatty acid-free 
BSA resulting in a complex of  PA:BSA at 2:1 (0.3 mM: 0.15 mM) molar ratio. Previous 
analysis showed that PA:BSA at 2:1 ratio leads to unbound free PA at low nM 
concentration throughout the course of the experiment (Almaguel et al. 2009). DHA 
stock (100 mM or 50 mM) was also prepared in 100% ethanol and diluted in 1% FBS-
NGF medium containing 0.15 mM fatty acid-free BSA with or without PA. For control, 
cells were treated with 1% FBS-NGF medium containing 0.15 mM fatty acid-free BSA 
and 0.1% ethanol. Cell morphology after treatment was documented using a phase 
contrast Olympus microscope equipped with a SPOT-Insight CMOS camera. 
For hypoxia experiments, a Galaxy 48R CO2 Incubator equipped with O2 
controller was purchased from Eppendorf (Hauppauge, NY). The incubator was 
maintained at 37 °C with an atmosphere of 5% CO2, 0.5% O2 and balanced with N2 gas 
for 12 hours before incubating with cells. NGFDPC12 cells were cultured in the hypoxic 
atmosphere for 12 to 48 hours before subsequent analysis and cells were cultured with 
5% CO2 and 95% air as the normoxic controls. For DHA and EPA pre-treatment study, 
NGFDPC12 cells were incubated with 1% FBS-NGF medium containing 150 μM  fatty 
acid-free BSA in the presence or absence of 30 μM DHA (or EPA) for 12 hours and 
changed back to 1% FBS-NGF medium before hypoxic treatment.  
 
Quantitative Real Time PCR Analysis 
The procedures for total RNA extraction, cDNA synthesis and quantitative RT-
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PCR were described previously (Almaguel et al. 2009, Padilla et al. 2011). The relative 
amount of mRNA was calculated by the 2
-ΔΔCT
 method, using β-actin as reference gene. 
The primer sets used in the current study are as following: 
HIF-1α, 5’-TCCATGTGACCATGAGGAAA-3’and 5’-CTTCCACGTTGCTGACTTGA-3’ 
BNIP3, 5’-CCAGAAAATGTTCCCCCCAAG-3’and 5’-TTGTCAGACGCCTTCCAATGTAG-3’ 
E-FABP, 5’-TTACCCTCGACGGCAACAA-3’and 5’- CCATCAGCTGTGGTTTCATCA-3’ 
β-actin, 5’-GGGAAATCGTGCGTGACATT-3’ and 5’-GCGGCAGTGGCCATCTC-3’ 
 
Reactive Oxygen Species Analysis 
Cellular ROS levels were measured by flow cytometry using the florescent 
indicator 2’,7’dichlorodihydrofluorescein diacetate (H2DCFDA, Life Technologies). 
After treatment, NGFDPC12 cells were incubated with 10 μM H2DCFDA in F-12K 
medium for 25 min at 37°C. Cells were then detached by HyClone HyQtase (GE 
Healthcare, Pittsburgh, PA), rinsed and analyzed with a Becton-Dickinson FACSCalibur 
as described earlier (Almaguel et al. 2009, Padilla et al. 2011). NGFDPC12 cells treated with 
10 μM of DL-Buthionine-[S,R]-sulfoximine for 24 hrs. served as positive control. 
 
Apoptosis Detection 
After treatment, NGFDPC12 cells were detached from plates by HyQtase and 
incubated with the apoptosis marker Annexin V-FITC for 20 min.  Annexin V positive 
cells were detected by flow cytometry as described previously (Padilla et al. 2011).  
 
Determination of Cell Viability 
Cell viability after hypoxic treatment was determined by crystal violet assay. 
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PC12 cells were seeded in 12- or 6-well plates at a density of 7,500 cells/cm
2 
and 
differentiated with NGF. After treatment, cells were gently rinsed, fixed, and stained with 
crystal violet solution as stated before (Padilla et al. 2011). Bound crystal violet was 
dissolved with 10% acetic acid and the optical density (OD) at 570 nm was determined 
using a Spectra Max i3X spectrophotometer (Molecular Devices, Sunnyvale, CA). Cell 
viability was calculated as percent of the OD reading relative to control group.  
 
Antibodies and Immunoblotting 
DNA topoisomerase I (Topo I) and its cell death-associated cleavage fragments 
were detected by immunoblotting using human scleroderma-associated autoantibodies as 
described previously (Pacheco et al. 2005, Pacheco et al. 2014). PARP (Cat# 9542S) and 
LC3 (Cat# 4108S) antibodies were purchase from Cell Signaling Technology. The 
polyclonal antibodies against E-FABP were generated in rabbits against recombinant E-
FABP produced in the laboratory.  We used Laemmli Sample Buffer (0.1 M Tris-HCl, 
pH 6.8 containing 4% SDS, 10 % glycerol and protease inhibitors) to extract total protein 
from cells. After quantification, 15-40 μg of cellular proteins were resolved on a 
NuPAGE Bis-Tris Gel (Thermo Scientific) and transferred to nitrocellulose membranes. 
Membranes were blocked and incubated with primary antibodies overnight at 4°C. After 
washes, the membranes were incubated with appropriate horseradish peroxidase-
conjugated secondary antibodies for subsequent chemiluminescent detection or with 






To knockdown E-FABP in NGFDPC12 cells, we selected Ambion In Vivo siRNA 
system. Rat FABP5 siRNA (s139047) and negative control siRNA with scrambled 
sequences were acquired (Life Technologies) and introduced into cells by X-tremeGENE 
siRNA transfection reagent (Roche Applied Science). The siRNA transfection, following 
the manufacturer’s instruction, was performed as below:  siE-FABP or siControl stock 
was prepared at 100 μM in water and 2 μl of stock was diluted with 250 μl of Opti-MEM. 
Transfection reagent (10 μl) was also diluted with 250 μl of Opti-MEM. Diluted siRNA 
and transfection reagent were combined and incubated for 20 min. Three day-
differentiated PC12 cells in 6-well plates were change to antibiotics-free medium 
(1.5ml/well) and then transfection solution (0.5 ml) was added to the well. After 24 hrs, 
the medium was changed to 1% FBS-NGF medium for continual differentiation for 




All measurements were done in triplicates in at least three independent 
experiments. Statistical comparison was analyzed by student’s t test. Significance was 






Hypoxia Induces Up-Regulation of HIF-1α and BNIP3, ROS Accumulation and 
Apoptotic Features in NGFDPC12 Cells 
Hypoxia triggers the gene expression of hypoxia-inducible factor-1α and 
increases its nuclear translocation in different tissues (Feng et al. 2016, Zhao et al. 2017). 
Therefore, we wanted to explore if NGFDPC12 cells at an oxygen tension of .5%, (.5% 
[O2]) would show a similar response. Indeed, Figure 1A shows that .5% [O2] increased 
the level of hypoxia inducible factor-1α significantly 2.47-fold of control at 12 hours, 
3.87-fold of control at 18 hours, 5.47-fold of control at 24 hours and 6-fold of control at 
48 hours.  One of the downstream effect of HIF-1α expression and activation under any 
stress condition is the expression of BNIP3 to activate either defense mechanisms like 
autophagy or to trigger the apoptotic cascade to decrease inflammation. BNIP3 
(BCL2/adenovirus E1B 19 kDa protein-interacting protein) activation under a strong 
insult activates pro-apoptotic protein like Bak and Bax with the subsequent formation of 
mitochondrial pores and release of cytochrome C from the mitochondria and execution of 
apoptosis.  We measured the gene expression of BNIP3 at different time points in 
NGFDPC12 cells under .5% [O2].  Figure 1B shows BNIP3 mRNA expression was 2.3-
fold of control at 12 hours, 2.6-fold of control at 18 hours, 3.37-fold of control at 24 
hours and 2.9-fold of control at 48 hours.  
At 48 hours after hypoxic treatment, we also observed a 2.6-fold increase in 
Annexin V labeling (Fig.1C), a measurement of early apoptosis. In summary, hypoxia-
induced injury and PA-LTx-induced injury (see Chapter 2) elicit similar cellular 
responses in NGFDPC12 cells. 
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We showed in chapter 2 and 3 that PA-LTx induces reactive oxygen species 
(ROS) accumulation in the cells.  The amount of ROS is directly related with the 
expression of HIF-1α and BNIP3 and apoptotic cell death.  We proposed that as in PA-
LTx, ROS could be the mechanism that triggers the fatal response in hypoxia.  We put 
NGFDPC12 cells in .5% [O2] incubator and measured ROS levels at 24 hours.  As shown 
in Figure 1D, the hypoxia-induced ROS levels is 2.2 fold of normoxia control.  Adding 
antioxidant MCI-186 at 50 μM concentration diminished ROS levels from 2.2 to 1.6 fold 
of control.  Increasing the concentration of MCI-186 to 100 μM decreased the ROS levels 
to 1.4 fold of control, an almost 40% reduction.  
 
 
Figure 1. Hypoxia induces up-regulation of HIF-1α and BNIP3, ROS accumulation and 
apoptotic features in NGFDPC12 cells. Cells were exposed to hypoxia condition (.5 % 
[O2]) for 12-48 hrs and the levels of (A) HIF-1α and (B) BNIP3 mRNA were analyzed by 






Figure 1. Continued. Hypoxia induces up-regulation of HIF-1α and BNIP3, ROS 
accumulation and apoptotic features in NGFDPC12 cells. Cells were exposed to hypoxia 
condition (.5 % [O2]) for 12-48 hrs and the levels of (A) HIF-1α and (B) BNIP3 mRNA 
were analyzed by real-time RT-PCR. (C) NGFDPC12 cells were exposed to hypoxia 
condition for 24 hrs and apoptotic cells were identified by Annexin V labeling. The 
percentage of Annexin V-tagged cells in a sample was determined by flow cytometry. 
(D) NGFDPC12 cells were exposed to normoxia or hypoxia conditions for 24 hrs with or 
without 50 or 100 μM antioxidant MCI-186 and intracellular ROS was determined by 
DCF flow cytometry. The results are expressed as fold-change relative to normoxia 






DHA and Rapamycin Protect NGFDPC12 Cells from .5% [O2] Hypoxia 
Our laboratory has shown that DHA is able to rescue cells from PA-LTx 
(Almaguel et al. 2009) and dietary omega-3 polyunsaturated fatty acids improve the 
outcomes of rats suffered from spinal cord injury (Figueroa et al. 2013). In addition, our 
data suggests that DHA’s protective effect involves autophagy stimulation (Chapter 2). 
Therefore, we set ourselves to test whether DHA or rapamycin, an mTOR inhibitor and 
autophagy promotor, is able to rescue cells from hypoxic injury.  Figure 2 panel A shows 
that normoxia-BSA treated NGFDPC12 cells are round, cell membrane well defined with 
neurites extensions forming a cellular network.  In panel B normoxia cells pre-treated 
with DHA show the same round body as the BSA treated cells but with longer and 
thicker neurites. This is consistent with our previous studies (Liu et al. 2008) where both 
EPA and DHA increased the size, extension and branching of the neurites in NGFDPC12 
cells.  Figure 2 panel C shows NGFPC12 cells in normoxia treated with rapamycin 
showing quite similar characteristics as DHA-treated cells.  Round big cell bodies could 
be observed with long thick branching neurites and higher confluency.  When cells were 
subjected to .5% [O2] hypoxia (panel D) the cells lost their round body shape, neurite 
connection, cell fragmentation can be seen and confluency is lost.  In cells treated with 
DHA (panel E) the cell viability, confluency and neurite extension were maintained 
compared to control, despite the fact that neurites were thinner.  When we compare 
hypoxia DHA pre-treated cells with hypoxia rapamycin treated cells we can observe 
similar results (panel F).  Cell bodies were big, round with quite long neurite with good 
branching. Quantitatively, cell viability assay (Fig. 3) demonstrates that both DHA and 
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rapamycin provide significant protective effect on NGFDPC12 cells under hypoxic 
insult.  
Next, we measured the percentage of apoptotic cells after treatments using 
Annexin V probe. In Figure 4, control cells were treated with BSA only.  The usual 
number of cells that constantly die irrespective of the treatment was used a reference 
point. DHA at 20 μM concentration did not increase the levels of Annexin V which is 
consistent with the microscopic observations.  Rapamycin at 20 nM concentration did not 
increase the levels of Annexin V either, consistent also with the microscopic 
observations.   When cells were subjected to .5% [O2] hypoxia annexin V levels went up 
3.5 fold of control at 48 hours. But co-treated the cells with DHA (20-40 μM) and 
rapamycin (20 and 30 nM) dramatically reduced the level of Annexin V-positive cells. 
We speculate that the induction of autophagy by rapamycin and DHA are the key 






        
Figure 2. DHA and rapamycin rescue NGFDPC12 cells from hypoxia injury-Cell 
morphology. Representative microscopic images show NGFDPC12 cells exposed to 
normoxia or hypoxia condition for 48 hrs with treatment of BSA control medium (A, D), 









Figure 3. DHA and rapamycin rescue NGFDPC12 cells from hypoxia injury-Cell 
Viability. NGFDPC12 cells were exposed to normoxia or hypoxia condition for 48 hrs 
with treatment of BSA control medium (CTL), 20 μM or 30 μM of DHA or 30 nM of 
rapamycin. Cell viability was determined by crystal violet assay. The results are 
expressed as percentage to normoxia control and the data is shown as Mean±SEM. 
Significance symbols: *=p<0.05. **=p<0.01.  *** =p<0.001. Significance symbols are 
shown above bars when comparing normoxia CTL and are shown above lines when 









Figure 4. DHA and rapamycin attenuate hypoxia-induced apoptosis. NGFDPC12 cells 
were exposed to normoxia or hypoxia condition for 24 hrs with treatment of BSA control 
medium (CTL), 20 μM or 30 μM of DHA (20-40 μM) or of rapamycin (20, 30 nM). The 
level of apoptotic cells was identified by Annexin V labeling followed by flow 




Pre-Treatment with DHA or EPA Recues NGFDPC12 Cells from Hypoxia-Induced 
Cell Death 
One concept of injury under hypoxia is the activation of phospholipases with 
release of saturated fatty acids inducing lipotoxicity and the release of ω-6 fatty acids like 
arachidonic acid to induce inflammation.  The key aspect of this metabolic process is the 
fact that those fatty acids were already part of the cell membrane.  We speculate that 
enriching the membranes during differentiation with ω-3 fatty acids like DHA or EPA 
(eicosapentanoic acid) will serve as substrate for phospholipases and will be released 
during hypoxia injury giving protection to the cell.  
We pre-treated the cells with DHA or EPA during the last 3 days of 
differentiation and then expose the cells to .5% [O2] hypoxia.  Figure 5 shows that when 
NGFDPC12 cells were subjected to hypoxia cell viability diminished to less than 40% of 
control.  Treat cells with DHA or EPA in normoxia condition did not significantly alter 
the cell viability but cells pre-treated with 30 μM DHA and then subjected to hypoxia cell 
viability remained at 80% when compared to control. Similarly, cells pre-treated with 30 
μM EPA and subjected to hypoxia showed a cell viability of 70% when compared to 
normoxia BSA-control.  Therefore, having a high concentration of ω-3 fatty acids in the 








Figure 5. Pre-treatment of DHA or EPA rescues NGFDPC12 cells from hypoxia-induced 
cell death. NGFDPC12 cells were exposed to normoxia or hypoxia condition for 48 hrs 
with or without pre-treatment with DHA or EPA and cell viability was determined by 
crystal violet assay. . The results are expressed as percentage to normoxia control and the 
data is shown as Mean±SEM. Significance symbols: *=p<0.05. **=p<0.01.  *** 
=p<0.001. Significance symbols are shown above bars when comparing normoxia CTL 




DHA Increases Autophagy to Rescue NGFDPC12 Cells from .5% [O2] Hypoxia 
In chapter 2 we used a highly specific human autoantibody to nuclear protein 
Topoisomerase I (Topo I) to distinguishes between apoptosis and necrosis (be it primary, 
secondary, and necroptosis) in NGFDPC12 cells during PA-LTx (see Figure 2A in 
chapter 2). We have also shown that DHA induces the same Topo I cleavage pattern as 
HgCl2 (a necrosis inducer) in the presence or absence of PA-LTx (refer to figure 8B in 
chapter 2).  We interpret that even though DHA and PA-LTx + DHA treatment showed 
the same Topo I cleavage pattern as HgCl2 it was not due to necrosis or necroptosis but 
due to cathepsin activation within the lysosomal compartment as a result of DHA-
induced enhancement of autophagy.  
A representative Topo I immunoblot is shown in Figure 6. HgCl2 induced the 70 
and 45 kDa band of Topo I at 24 hours.  Palmitic acid at 24 and 48 hours showed only the 
70 kDa band indicative of apoptosis.  But when we added the pan-caspase inhibitor 
ZVAD to PA treatment the third 45 kDa band appeared indicating that apoptosis was 
inhibited and necrosis or necroptosis was induced at 24 or 48 hours. These verified 
pattern of Topo I in lipotoxicity serves as a reference for the cellular responses in 
NGFDPC12 cells during .5% [O2] hypoxia.  Both normoxia and hypoxia conditions 
include three groups: NGFDPC12 cells without pretreatment (1% FBS), cells with BSA 
pretreatment or cells with DHA pretreatment (see Method section for details).  The 70 
kDa band can be seen in those three lanes even though the cell viability was high for 
those conditions.  Lane 12 shows that after 48 hours of .5% [O2] hypoxia, pre-treatment 
with DHA induced the 45 kDa band indicative of necrosis/ necroptosis or in the case of 
DHA cathepsins activation within the lysosome. This is of several experiments where the 
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difference between the bands when comparing 1% FBS, BSA and Pre-DHA treatments is 
obvious for the 45kDa band but the 70 kDa band is present in almost all the lanes. This 
70 kDa band seems to suggest that the cells were passing through apoptosis. The 
explanation could be that the cells were exogenous phenotypically healthy enough to 
keep attached to the flask but already endogenously going through apoptosis and 
eventually detachment from the flask.  
Another way to measure apoptosis by immunoblotting is by probing the cleavage 
pattern of poly-ADP-ribose polymerase (PARP) with antibodies formed in autoimmune 
diseases (Casiano et al. 1996) (Casiano et al. 1998).  The native protein has a molecular 
weight of 110 kDa that is indicative of the presence of the protein.  When cells are dying 
by apoptosis a second 85 kDa band appears indicating that the protein has been cleaved at 
specific sites by caspases.  If caspases are inhibited or the cells turn from apoptosis to 
secondary necrosis, a 50 kDa band appears indicating that cathepsins instead were 
activated. In Figure 7 we can see the difference of the cleavage pattern of PARP between 
1% FBA, BSA and Pre-DHA groups in .5% [O2] hypoxia.  The 85 kDa band is noticeable 
in the 1%FBS and BSA treatment groups. These two groups showed cell death 
morphology under microscope and the 85 kDa band is consistent with apoptotic cell 
death.  However, the pre-DHA treatment group, exhibited healthier cell morphology 
under microscope, showed a different PARP cleavage pattern.  The caspase-related 85 
kDa band is weaker and the cathepsin-related 50 kDa band is stronger in Pre-DHA cells 
compared to those of 1%FBS or BSA groups.  Again, we speculate that cathepsins are 
activated within the confine of the lysosomes during autophagy induced by DHA.  
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To confirm our speculation, the autophagy marker, LC3 II, was examined by 
immunoblotting. As shown in Figure 8, a stronger LC3 II band can be seen in both DHA 








Figure 6. Topo I cleavage pattern in NGFDPC12 cells under hypoxic condition. Lanes 1-
6: NGFDPC12 cells were treated with BSA control medium (BSA), a necrosis inducer 
HgCl2 (50 μM), PA-LTx (PA) in the presence or absence of ZVAD (40μM) for 24 and 
48 hrs.  Lanes 7-12: NGFDPC12 cells were exposed to normoxia or hypoxia condition 
with treatment of differentiating medium (1% FBS), BSA control medium (BSA) or 
pretreatment of DHA (50μM). Total cellular protein was extracted and Topo I 
immunoblot was performed using a human serum carrying Topo I autoantibodies (1:250 









Figure 7. PARP cleavage pattern in NGFDPC12 cells under hypoxic condition. 
NGFDPC12 cells were exposed to normoxia or hypoxia condition with treatment of 
differentiating medium (1% FBS), BSA control medium (BSA) or pretreatment of DHA 
(50μM). Total cellular protein was extracted and PARP immunoblot was performed. A 









Figure 8. DHA increases autophagy in NGFDPC12 cells in normoxia and in hypoxia. 
NGFDPC12 cells were exposed to normoxia or hypoxia condition with treatment of BSA 
control medium (BSA), pretreatment of DHA (50μM) or Rapamycin (30 nM). Total 





EFABP Gene Expression and Protein Synthesis Are Induced during Hypoxia 
Our data indicates that lipotoxicity and hypoxia stimulate similar stress responses 
in NGFDPC12 cells. In chapter 3 we showed how epidermal fatty acid binding protein 
(EFABP, FABP5) was more than just a fatty acid carrier protein.  EFABP has the 
capacity to buffer reactive oxygen species (ROS), serves as an antioxidant and increased 
cell viability under PA-LTx.  Knowing that hypoxia induces ROS we hypothesized that 
.5% [O2] hypoxia would increase the expression of EFABP as a protective mechanism. 
And indeed, as shown in Figure 9A, when cells were subjected to hypoxia for 24 and 48 
hrs the gene expression as measured by real time RT-PCR was twofold of control at 24 
hours and almost five fold of control at 48 hours. In Figure 9B, a representative EFABP 
immunoblot is shown in a time line of 12, 24 and 48 hours after .5% [O2] hypoxia, using 
β-Actin as a reference for protein loading. In accordance with mRNA results, EFABP 
protein level is also increased. EFABP may function as a protective agent to buffer the 
accumulated saturated fatty acid resulted from plasma and organelle membrane 
degradations and also as an antioxidant molecule to neutralize the ROS coming from 










            
Figure 9. Hypoxia induces up-regulation of EFABP.  (A) NGFDPC12 cells were exposed 
to normoxia or hypoxia condition for 24 and 48 hrs and the level of EFABP mRNA was 
determined by real time RT-PCR. The results are expressed as fold-change relative to 
normoxia control and the data is shown as Mean±SEM.  Significance symbols: *=p<0.05. 
(B)  NGFDPC12 cells were exposed to normoxia or hypoxia condition for 12, 24 and 48 
hrs and the level of EFABP protein was determined by immunoblots, using beta-acting as 




Antioxidant MCI-186 Reduces Hypoxia-Induced EFABP Gene Expression 
After showing that hypoxia induces ROS and that those ROS can be decreased 
with antioxidant treatment we set ourselves to test our hypothesis that hypoxia-stimulated 
ROS stimulates FABP5 in NGFDPC12 cells.  Again, we put the cells in .5 % [O2] 
hypoxia for 24 hours with and without antioxidant MCI-186 and then collected the 
mRNA to measure gene expression by RT-PCR.  Figure 10 shows hypoxia induced the 
gene expression of EFABP more than 3 fold of normoxia control and the EFABP up-
regulation was significantly reduced when antioxidant MCI-186 was added at 100 μM 
concentration. It is interesting to note that a trend of increasing EFABP expression can be 
seen in cells treated with MCI-186 under normoxia condition. We speculate that the 
reducing environment caused by MCI-186 might offset the normal balance of the redox 
status of the cell temporarily and the signal for protection is still triggered even in the 
reduced state. 
 
EFABP Protects NGFDPC12 Cells from Hypoxic Injury 
We have shown that EFABP protects NGFDPC12 cells from PA-LTx. Next, we 
examined the ability of EFABP to protect cells from hypoxic injury. For that, we 
transfected NGFDPC12 cells with siRNA of EFABP to reduce cellular EFABP levels and 
compared the cell viability of siControl cells and siEFABP cells after .5 % [O2] hypoxia. 
As predicted, Figure 11 indicates that siEFABP cells showed significantly worse 
outcome than siControl cells under hypoxia. We propose that EFABP’s protective 
function in hypoxia may rely on its antioxidant and fatty acids buffering capability, 









Figure 10. Antioxidant Reduces Hypoxia-stimulated E-FABP mRNA Expression. 
NGFDPC12 cells were exposed to normoxia or hypoxia conditions for 24 hrs with or 
without 50 or 100 μM antioxidant MCI-186 and the level of EFABP mRNA was 
determined. The results are expressed as fold-change relative to normoxia control and the 
data is shown as Mean±SEM.  Significance symbols: *=p<0.05. Significance symbols are 
shown above bars when comparing normoxia CTL and are shown above lines when 











Figure 11. Reduced cellular level of EFABP makes the cell survival worse in 
NGFDPC12 cells after hypoxic insult.  NGFDPC12 cells were transfected with siRNA of 
EFABP or negative control siRNA with scrambled sequences. The transfected cells were 
exposed to hypoxia condition for 48 hrs and cell viability was determined by crystal 
violet assay. The results are expressed percent to normoxia control and the data is shown 




FFABP Gene Expression Is Induced by Activation of PPAR 
The peroxisome proliferator-activated receptors are a group of nuclear receptor 
proteins that functions as transcription factors regulating the expression of genes involved 
in cellular differentiation, development, metabolism of carbohydrates, lipid and proteins 
and even in tumorigenesis (Feige et al. 2006, Berger & Moller 2002). The main ligands 
for PPAR are lipids and free fatty acids metabolites like eicosanoids. As their name imply 
one the effect of PPAR activation is the synthesis and assembly of peroxisomes. Very 
long chain fatty acids are metabolized within the peroxisomes by β-oxidation which 
increase in size and number when there is an increase load of fatty acids. Because FABPs 
in general have a PPAR response element on their gene (Juge-Aubry et al. 1997, 
Laprairie et al. 2017, Bando et al. 2017), we hypothesized that increase in FABP5 
expression during hypoxia may mediate through PPAR due to elevated levels of fatty 
acids, which is well established in the event of hypoxic injury (Dhillon et al. 1997).  First, 
we measured the effect of the PPAR family agonist WY-14643 on the gene expression of 
FABP5. For that, NGFDPC12 cells were treated with three different concentrations of 
WY-14643 for 24 hours under normoxia condition and EFABP mRNA as measured by 
real-time RT-PCR.  Figure 12 shows that EFABP mRNA expression increased to 3.7 
fold by 100 μM of WY-14643 and to 2.6 fold by 200 μM WY-14643. At concentration of 
400 μM, WY-14643 increased EFABP gene expression to 8.65 fold of control. 
Next, we proceeded to inhibit PPARγ with antagonist GW9662 during hypoxia. 
As seen in Figure 13, EFABP mRNA expression is increased to 2.75 fold of control 24 
hours after .5% [O2] hypoxia. The up-regulation of EFABP mRNA reduced to 1.45 fold 
in the presence of 5 μM GW9662 and to 1.65 fold in the presence of 10 μM GW9662.  
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Figure 12. PPAR activator increases EFABP mRNA expression.  NGFDPC12 cells were 
treated with PPAR activator WY-14643 for 24 hrs and level of EFABP mRNA was 
determined. The results are expressed as fold-change relative to control and the data is 










Figure 13. PPAR gamma antagonist reduces hypoxia-stimulated EFABP mRNA 
expression.   NGFDPC12 cells were exposed to normoxia or hypoxia conditions for 24 
hrs with or without treatment of PPAR gamma antagonist GW9662 and the level of 
EFABP mRNA was determined. The results are expressed as fold-change relative to 






The major pathway modulating the cellular response to hypoxia occurs at the 
transcription level and is controlled through a number of key transcription factors, with 
increased expression of genes involved in metabolism, stress response and survival, cell 
division and even angiogenesis.  
One of the most important oxygen tension sensor in the cell is the iron and 
ascorbate-dependent interaction between the hypoxia responsive transcription factor HIF-
1α and its complement VHL.  HIF-1α is part of the heterodimer Hypoxia Inducible 
Factor (HIF). Under normoxia conditions HIF-1α is hydroxylated by proline 
hydroxylases and targeted for proteasome degradation via von Hippel Lindau E3 
ubiquitine ligase complex.  Under hypoxia conditions, proline hydroxylase is not able to 
hydroxylate HIF-1α rendering it stable and able to interact with HIF-β becoming a 
heterodimer that stimulates the expression of hundreds of Hypoxia Response Elements-
containing genes (Bargiela et al. 2018). 
Mammalian target of Rapamycin (mTOR) is a serine-threonine kinase that 
regulates growth, differentiation, survival and energy by balancing anabolic and catabolic 
processes for cellular homeostasis (Perez-Alvarez et al. 2018).  mTOR controls many 
cellular functions such as protein synthesis, energy metabolism, cell size, lipid 
metabolism, autophagy, mitochondria, and lysosome biogenesis (Bockaert & Marin 
2015). mTOR exist in two different complexes mTORC1 and mTORC2.  They differ in 
their composition and in their sensitivity to Rapamycin.   
Autophagy is the catabolic mechanism by which dysfunctional or unnecessary 
cellular components are degraded through the action of lysosomes (Mizushima & 
Komatsu 2011). mTORC1 keeps autophagy in check by different routes. The first being 
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phosphorylation of ULK1/2 and ATG13 with disassembly of the pro-autophagy complex 
ULK1/2, ATG13, ATG101 and RB1-inducible coil-coil protein 1 (RB1CC1)/FIP200.  
Besides mTORC1 can phosphorylate ATG14 and UVRAG, which inactivates 
phosphatidylinositol 3-kinase class III (PI3KCIII) complex during initial (composed of 
PIK3C3/Vps34, Becline-1PIK3R4/Vps15, ATG14 and AMBRA1) and maturing stages 
(involving PIK3C3/Vps34, Beclin-1, PIK3R4/Vps15 and UVRAG) of autophagosomes 
(Nakamura & Yoshimori 2017). On the other hand, both ULK and PI3KCIII complexes 
are activated by AMPK-dependent phosphorylation (Kim et al. 2011, Kim et al. 2013). 
The last mechanism we will mention involves mTORC1 phosphorylation of transcription 
factor TFEB, which prevents its nuclear translocation and the transcription of several 
ATG (autophagy) and lysosomal proteins (Perez-Alvarez et al. 2018).  
During hypoxic or ischemic conditions, the CNS passes through a series of events 
called the “ischemic cascade”. The description is extensive but the cascade includes 
energy failure, glutamate excitotoxicity, inflammation and death by apoptosis in hours or 
even days after the event (Perez-Alvarez & Wandosell 2016). It’s been described a 
reduction of mTORC1 activity after brain ischemia due to decreased levels of oxygen, 
glucose and growth factors.  Increased inhibition of neuronal mTORC1 has been describe 
after ischemia, by diminished activity of PI3K/Akt pathway both in vitro and in vivo 
models (Mateos et al. 2016, Dutta et al. 2015).  
As we stated before HIF-1α main effect is to shift from oxygen-consuming 
oxidative phosphorylation to oxygen-independent glycolysis, to ensure a constant supply 
of ATP during hypoxia (Chen et al. 2016).  The connection between HIF-1α and the 
mTOR pathway is not completely elucidated and contradictory outcomes have been 
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reported in regard to neuronal cell viability.     It’s been reported that during glucose, 
oxygen or nutrient deprivation the activation of AMPK resulted in HIF-1α stabilization 
and expression via Akt/mTOR/p70S6K activation reducing neurological deficits, infarct 
volume, brain edema and apoptosis after ischemia induction with isoflurane 
preconditioning and inhibition of autophagy on a long run (Yan et al. 2016). On the other 
hand, others have demonstrated that rapamycin up-regulation of autophagy reduces 
infarct size and improves outcomes in both middle cerebral artery ligation (MCAL) and 
embolic middle cerebral artery occlusion (MCAO), murine models of stroke (Buckley et 
al. 2014, Chauhan et al. 2011).  
It’s been hypothesized for many years (Lee et al. 2000) the “ischemic tolerance” 
or “ischemic preconditioning” paradigm in the heart where sub lethal ischemic insults 
prior to real damage may be protective, allowing defensive endogenous mechanisms 
triggered after brain ischemia to make the tissue resistant to more severe ischemic injury.  
The tuberous sclerosis complex 1(Tsc1 also known as hamartin) as part of the mTORC1 
pathway has been proposed as a key player in mTOR induced up-regulation of autophagy 
as preconditioning factor. Overexpression of Tsc1 rendered the hippocampal neurons 
after OGD (oxygen glucose deprivation) resistant by maintaining effective autophagic 
flux.  Conversely, down regulation of Tsc1 resulted in autophagosome accumulation and 
inhibited autophagic flux (Papadakis et al. 2013).  This apparent contradiction of 
induction and activation of mTORC1 complex to be protective in some cases and 
inhibition of mTORC1 by rapamycin to be protective in others may be explained by time 
and context dependent mechanisms. Autophagy induction before or just after ischemic 
damage, results in beneficial effects measured as improvement of neurological score, 
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reduction of infarct area or diminution of brain edema (Yin et al. 2012, Chauhan et al. 
2015).  When autophagy has been induced hours after ischemic damage opposite results 
have been obtained (Guo et al. 2014, Jiang et al. 2017). It could be proposed that the 
availability of ATP and growth factors would keep the PI3K/Akt/mTORC1 increased and 
this will keep the cell in an anabolic state so that when autophagy is induced after the 
injury toxic metabolites have already accumulated to lethal levels causing the cell to 
default in hyperautophagy and cell death.  It is here when inhibition of autophagy may be 
more protective than induction of autophagy.   
We can conclude that autophagy is an endogenous protective mechanism that is 
activated during hypoxia damage mainly through inhibition of PI3K/Akt/mTORC1 
pathway.  When the insult is prolonged and autophagy is sustained longer than the 
capacity of the cell to maintain energy hyperautophagy ensues and cell death is the 
outcome.   More studies ascertaining the duration as well as the severity of 
nutrient/growth factors/oxygen deprivation are needed to elucidate the correct application 
of autophagy modulation in brain ischemia. 
Bcl-2 [B-cell leukemia\lymphoma 2]/adenovirus E1B19KD interacting protein3 
(BNIP3) is an atypical BH3 (Bcl-2 homology 3) domain only containing protein that 
interacts with BCL-2, BxL and adenovirus E1B-19K/EBV-BHRF protein (Yasuda et al. 
1998).  BNIP3 carboxy-terminal transmembrane (TM) domain (amino acids 164-184) 
directs BNIP3 to mitochondria and is well known to be involved in its pro-apoptotic 
activity (Chen et al. 1999). Overexpression of HIF-1α induces the expression of BNIP3 
through the HIF response element (HRE) on BNIP3 (Guo et al. 2001).  This 
characteristic makes BNIP3 a stress-hypoxia response protein.  We have reported 
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previously that BNIP3 gene expression is increased during lipotoxicity (Montero et al.).  
Increase BNIP3 and its interaction with Bax/Bak at the mitochondrial membrane 
stimulates the induction of the mitochondria permeability transition pore (mPTP) and 
release of cytochrome C (Vande Velde et al. 2000, Regula et al. 2002).  Cells lacking 
Bax/Bak are resistant towards BNIP3 mediated cell death and release of cytochrome C 
from mitochondria is induced by BNIP3 (Kubli et al. 2007, Quinsay et al. 2010). Further 
findings have shown that Z-VAD-fmk, a caspase inhibitor can suppress BNIP3 mediated 
cell death in neonatal cardiac myocytes (Regula et al. 2002).  Some have interpreted that 
BNIP3-induced cell death shows characteristics of both necrosis and apoptosis as shown 
by mPTP opening that is also considered a necrotic process and by activation of 
Bax/Bak that is apoptotic primarily (Vasagiri & Kutala 2014).   
Therefore, the effect of BNIP3 expression inducing apoptosis, necrosis or 
autophagy is cell line and context dependent.  It’s been reported that BNIP3 was 
constitutively expressed in some cell lines whereas in most of the normal cell lines its 
expression remains suppressed under regular conditions suggesting that it is maintained 
in an inactive state and is regulated by post translational modifications (Vasagiri & 
Kutala 2014).  In some cases not the amount of BNIP3 but its phosphorylation status 
determines the final outcome of the cell.  BNIP3 phosphorylation was induced after 
reoxygenation of hypoxia conditions and elevated levels of phosphorylated BNIP3 
correlates with increased cell death (Graham et al. 2007).  BNIP3 phosphorylation can 
induce caspase independent cell death in knock down caspase 3, caspase 9 and Apa-1 
mouse embryo fibroblast (Vande Velde et al. 2000).  In rat cardiac myocyte BNIP3 
overexpression resulted in autophagy and cell death after ischemia/reperfusion 
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(Hamacher-Brady et al. 2007). In models of rat spinal cord injury BNIP3 in the 
mitochondria interacted with microtubule-associated protein 1A/B-light chain 3 (LC3), 
thus forming a mitochondria-BNIP3-LC3-autophagy complex resulting in mitophagy 
(Yu et al. 2018).  Moreover in CCL39 cells hypoxia induction of BNIP3 through its 
HRE activation resulted in increased autophagy flux and increased in cell survival 
(Bellot et al. 2009).  Something that should call our attention is that the oxygen 
concentration was 1% and the treatment was 24hours.  This can explain that the 
autophagy seen during this time point is a normal attempt of the cell for survival and that 
BNIP3 at that amount and duration of stress is not enough to trigger cell death by the 
mPTP formation and cytochrome c release.  
EFABP (also known as skin type FABP, FABP5 cutaneous FABP or epidermal 
FABP) is widely expressed through the body.  It is the most distributed of all the fatty 
acid binding proteins.  Substantial levels are found in skin, macrophages, liver, neuronal 
tissue, lung, and elsewhere.  It is involved in systemic glucose and lipid homeostasis and 
its expression is drastically increased in adipose tissue when another FABP (adipose 
FABP) is knock down suggesting its importance in the body’s  basic metabolism (Storch 
& Corsico 2008).  EFABP has been shown to bind and drastically increase the half-life of 
the short-lived metabolite leukotriene A4 in rat basophilic leukemia cells and to increase 
the availability of eicosanoids by stabilizing intermediate metabolites for further 
conversion (Dickinson Zimmer et al. 2004).  During neurogenesis, particularly in the 
prenatal and postnatal period, EFABP is expressed at high concentration.  Treatment of 
PC12 cells by nerve Growth Factor increases its expression dramatically and knockdown 
of its gene decreases neurite outgrowth compared to mock-transfected cells (Allen et al. 
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2000).  If we take into consideration that lipids constitute 50% of brain dry weight 
(Edmond 2001, Rapoport et al. 2001) and that every metabolic reaction will take place 
inside or across a membrane we can understand how important fatty acid binding and 
transport proteins are in the nervous system.  The relevance of FABPs could be observed 
when deficiencies of the lipid cargo of FABPs, especially polyunsaturated fatty acids 
(PUFA), have been associated in diseases like schizophrenia, depression, Parkinson’s and 
Alzheimer dementia (Salvati et al. 2006, Watanabe et al. 2007, Iwayama et al. 2010). But 
for our discussion about the effect on PUFAs, particularly DHA, what is important is the 
increased in expression of FABPs as shuttles and conductors to the particular pathway 
that PUFAs would follow during injury and neural repairing in the brain (Duplus & 
Forest 2002). 
  From the perspective of hypoxia it has been shown that FABPs are expressed 
abundantly under low oxygen concentrations in different tissues.  In term human 
placental trophoblast (Biron-Shental et al. 2007) hypoxia increased the expression of 
FABPs and the accumulation of lipids droplets was observed in ex vivo placental human 
trophoblasts suggesting a role for these FABPs in uptake and accumulation of lipids 
during hypoxic stress (Biron-Shental et al. 2007).  The authors didn’t comment on 
whether the increase in fatty acids accumulation was for the purpose of fetal nervous 
system development or for energy availability during a stress situation. But they 
speculated that because FABPs went up at both protein and gene expression levels HIF-
1α surely played a role at transcription level (Kaelin 2002) because FABPs and EFABP 
in particular have a Hypoxia Response Elements (HRE) on the promoter sequence 
(Jadoon et al. 2015, Hu et al. 2015).  
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DHA is the most abundant n-3 polyunsaturated fatty acids in the mammalian brain, and 
it’s been shown that it plays important roles in neurogenesis, neurotransmission, and 
protection against oxidative stress (Innis 2007).  Studies have shown that DHA is 
incorporated in neuronal membranes in a short time period (Connor et al. 1990) and the 
effects of the incorporation can be measured at the microsomal, synaptosomal and 
mitochondrial membranes after just 6 days (Suzuki et al. 1997).  PUFA are known to 
effect ion channels, neurotransmitter receptor and second messengers in the neuronal 
membranes (Boneva et al. 2011), by increasing and preserving the fluidity that leads to 
the optimum functioning of membranes proteins such as receptors, enzymes, ion 
channels, and ion pumps. The conversion of ALA (α-linolenic acid) into DHA is very 
efficient in the infant brain but decreases to negligible levels in the adult rat brain 
(Rapoport et al. 2007, DeMar et al. 2006). It is important to mention that the conversion 
of ALA into DHA is carried out by astroglia and endothelial cells of the blood vessels 
and they supply this essential nutrient to neurons (Moore et al. 1991, Moore 1993).   
The significant majority of DHA in the brain is supplied by plasma and the main 
source is from the diet (Horrocks & Farooqui 2004).  Most of the PUFAs in the western 
diet is the n-6 arachidonic acid (ARA).  The balance between these two PUFA seems to 
very important (Simopoulos 2002).  Because ARA metabolites are mediators of 
inflammation (prostaglandin, leukotrienes, and other lipoxygenase or cyclooxygenase 
products) and DHA and EPA derivatives are competitive substrates for ARA metabolites 
it seems that a high ratio of n-3/n-6 PUFA is important for inflammation control in the 
cell and in the CNS (Schmitz & Ecker 2008).  Evidence for this observation has been 
reviewed by Simopoulos addressing the levels of n-3 relative to n-6 levels on patients 
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with cardiovascular disease, cancer, and inflammatory and autoimmune disease 
(Simopoulos 2008).  We can conclude that increased consumption of DHA-rich food and 
decreased intake of ARA-rich food protects against brain stroke, and also prevents 
chronic degenerative diseases.  In the realm of cognition in humans, dietary deficiencies 
of DHA are associated with increased risk for attention deficit disorder, dementia, 
depression, bipolar disorder and schizophrenia (Gomez-Pinilla 2008).  The importance of 
DHA in the CNS especially in the brain cannot be over emphasize. The organ with the 
highest lipid content in the human body is the brain, and 35% of the brain is composed 
PUFA (Yehuda et al. 1999) such as DHA, EPA and ARA (Sastry 1985). 
As we mentioned before, the brain has a limited capacity to synthesize its own 
DHA, and therefore, plasma-derived DHA has to be transported across the blood-brain 
barrier (BBB). FABP5 is also expressed by brain microvascular cells, and are responsible 
for DHA transport across the BBB (Pan et al. 2015). Reduced BBB expression of FABP5 
has been described in a mouse model of AD, and this was associated with decreased BBB 
trafficking and brain content of DHA (Pan et al. 2016). Different approaches have been 
tried to increased BBB expression of FABP5 and enhanced DHA trafficking.  The 
peroxisome proliferator-activated receptor (PPAR) signal transduction pathway has been 
characterized as one important mechanism for FABP5 expression in hepatocytes (Rogue 
et al. 2010).  Therefore there is a positive feedback loop of fatty acids as natural ligands 
of PPARs and upregulation of FABPs with increased transport to and inside the cells of 
fatty acids. The complex formed by the FA and FABP stabilizes the nuclear localization 
signal allowing it to translocate to the nucleus and activate the nuclear receptor PPAR. 
(Armstrong et al. 2014). The FABP interaction with PPAR is somewhat specific.  For 
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example, FABP4 directs ligands to PPARγ, whereas FABP5 canalizes ligands to 
PPARβ/δ (Tan et al. 2002). Moreover, FABP1 and FABP2 can differentially modulate 
the activation of PPARα in a ligand-selective manner (Hughes et al. 2015). Our group 
published that in a model of rats fed a DHA-enriched diet for 8 weeks spinal cord FABP5 
gene expression was elevated compared to control (Figueroa et al. 2016).  We can 
conclude that DHA has the capacity to upregulate BBB expression of FABP5 and help 
facilitate its own transport across the BBB (Pan et al. 2018).  
Tacking together we propose that EFABP is neuroprotective in the context of 
hypoxia because neuronal tissue has a large amount of membrane lipids compared to the 
rest of the body and given its high concentration of polyunsaturated fatty acids in its 
membrane is susceptible to lipid peroxidation.  EFABP will hinder the increased 
concentration of saturated fatty acids release from the membrane by phospholipase A2 
during hypoxia (Dhillon et al. 1997) and will buffer the amount of ROS that are produced 
under low oxygen tension and excessive oxidation of fatty acids.  Besides EFABP might 
direct the protective polyunsaturated fatty acids like DHA to where they are needed and 
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Summary of Dissertation Findings 
Our general findings of this study are that PA induces the expression of stress 
response genes, increases the accumulation of reactive oxygen species, and decreases cell 
viability by apoptosis in NGFDPC12 cells.  We found that even though PA induces 
apoptosis, PA-induced cell death cannot be prevented by inhibition of apoptosis.  The 
PA-induced lipotoxicity can be prevented by inhibiting the apoptosome and 
necroptosome with treatment of RIP1 inhibitor necrostatin-1 and enhanced even more by 
the combination treatment of necrostatin-1 and the autophagy promoter rapamycin.     
DHA rescues PA-induced cell death by inhibiting apoptosis and necroptosis and 
promoting autophagy. DHA decreases the expression of PA-induced stress response 
proteins but interestingly doesn’t decrease PA-induced ROS production.  Besides DHA 
stimulates the mRNA expression, phosphorylation and conjugation of autophagy 
controlling proteins. Inhibiting the capacity of DHA to induce autophagy decreases DHA 
capacity to rescue NGFDPC12 cells form PA-LTx.    
We also observed that PA induces the mRNA expression and protein amount of EFABP 
in a dose response manner.  The PA-induced ROS accumulation is time and dose 
dependent.  ROS in turn stimulated the expression of EFABP and this expression could 
be prevented when co-treating the cells with the antioxidant N-acetyl-cysteine during PA-
LTx.  Conversely lowering EFABP expression by siRNA increased the accumulation of 
ROS and decreased cell viability. Lastly stimulating PPARβ and PPARγ with direct 
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agonist increased the expression of EFABP and that expression correlated with increased 





Figure 1. Schematic diagram of protective pathways stimulated by DHA and EFABP in 




As a parallel study .5% [O2] hypoxia induced the expression of stress response 
genes and triggered apoptosis in NGFDPC12 cells just like PA-LTx. Hypoxia disrupts 
the architecture of differentiated PC12 cells microscopically by diminishing the body 
size, reducing the confluency, thinning the neurites and producing apoptotic bodies. The 
decrease in cell viability can be prevented with an array of different concentration of 
DHA and the autophagy promoter Rapamycin just like in PA-LTx.  Pre-treatment of 
NGFDPC12 cells with DHA and EPA (another PUFA) increased cell viability under 
hypoxia. As in PA-LTx hypoxia also induces ROS and it can be prevented with 
antioxidant MCI-186. The mRNA and protein level of FABP5 are also increased under 
hypoxia in a time dependent manner and this increase in FABP5 can be prevented by 
antioxidant treatment during hypoxia. Lastly the hypoxia-induced expression of FABP5 
can be inhibited by treating the cells under hypoxia with PPARγ antagonist GW9966.  
 
Discussion 
The precise mechanisms of neuronal injury by lipotoxicity and the cellular events 
that take place as a consequence of increased levels of saturated fatty acids are still a 
work in progress.  Saturated fatty acids affect the membrane fluidity, membrane capacity 
for signal transduction, protein-protein interaction, activation of cell death and cell 
survival machinery and a myriad of basal metabolic pathways that takes the cell out of 
homeostasis.  Saturated free fatty acid stimulates oxidative pathways that lead to the 
production of ROS, destabilization of mitochondria with activation of the intrinsic 
apoptotic pathway and cell death.  The rational for this study is that FFA accumulate in 
the brain after hypoxia-ischemia CNS injury (Bazan 1970, Homayoun et al. 1997) 
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showing a 10 fold elevation in concentration (Dhillon et al. 1997) and a correlation 
between PA levels and CNS injury. 
 
Lipotoxicity 
To start we treated NGFDPC12 cells with the pathological concentration of PA 
after CNS injury.  PA treatment showed to be toxic to NGFDPC12 cells.  We first probed 
the effect of PA on the gene expression of two key proteins involved in the response of a 
tissue under stress, HIF-1α (hypoxia inducible factor- 1α) and BNIP3 (Bcl2/adenovirus 
E1B 19kDa protein-interacting protein 3).  As we mentioned in previous chapters these 
two proteins complex with other proteins and depending on the severity of the injury and 
energy availability induce increase protein and organelles turn over by activating 
autophagy or trigger the activation of caspases resulting in apoptosis.  That PA is enough 
of an insult to trigger cell death was demonstrated by measuring the increased amount of 
phosphatidylserine in the outer leaflet of the cytoplasmic membrane that occurs in 
apoptosis using Annexin V levels by flowcytometry. PA treatment caused the normal 
array of the neurite meshwork to be lost, diminished cell confluency, increased cell 
shrinking, cell blebbing and chromatin and nucleus condensation.   
As a way of confirmation we used the Topoisomerase I cleavage pattern during 
cell death to differentiate between apoptosis and necrosis (Casiano et al. 1996, Casiano et 
al. 1998) during PA lipotoxicity. Using staurosporine as our positive control we found 
that PA at 24 and 48hrs will induce the 70kDa band characteristic of apoptosis.  Trying to 
understand how to rescue the cells from PA-induced apoptosis we blocked the caspases 
with the pan-caspase inhibitor zVAD.fmk and the results were intriguing.  Not only 
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zVAD.fmk was not capable of rescuing the cell from PA-LTx but it also induced the cell 
to die by the necrosis/necroptotic type of cell death.  We observed that PA+zVAD 
treatment induced the Topoisomerase I 45kDa band characteristic of necrosis.      
Assuming that the cell has defaulted to another kind of regulated cell death when 
zVAD.fmk was present we hypothesized that the event taking place was necroptosis and 
proceeded to use inhibitors to inhibit necroptosis and apoptosis and to measure cell 
viability by Crystal Violet assay.  Treating NGFDPC12 cells with zVAD.fmk caused a 
decreased in cell viability by itself.  Needless to repeat in didn’t increased cell viability in 
the presence of PA.  We then proceeded to treat the cells using the RIP1 inhibitor 
necrostatin-1 and it increased cell viability compared to control.  Interesting necrostatin-1 
increased the cell viability of PA-treated NGFDPC12 cells significantly. We also 
measured the effect of the autophagy promoter rapamycin on cell viability during PA-
LTx.  It didn’t change the cell viability when applied by itself and didn’t increased the 
cell viability when under PA-LTx.  We moved on to combine these inhibitors and 
promoters to see if there was an additive effect.  We tried to inhibit apoptosis and 
necroptosis at the same time.  Inhibiting necroptosis and inducing autophagy with 
necrostatin-1 and rapamycin respectively rendered the best outcome. This combination 
increased cell viability dramatically over control cells and restored cell viability of cells 
undergoing PA-LTx. Others have recently published that necrostain-1 inhibits cell death 
from oxidative stress and mitochondrial damage induced-apoptosis (Chen et al. 2018a).  
The addition of zVAD.fmk to necrostatin-1 and rapamycin took the benefit that inhibition 
of necroptosis and induction autophagy had provided to the cells and brought it back to 
the PA+zVAD.fmk+necrostain-1 level for cell viability.  These findings allowed us to 
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clarify previous observation done by Uloth et al. (Ulloth et al. 2003) when they tried to 
inhibit PA-LTx induced cell death with zVAD.fmk but were not able to rescue the cells 
and called the process caspase independent cell death. 
 
DHA Neuroprotection in PA-LTx 
We have found in previous works (Almaguel et al. 2009, Almaguel et al. 2010) 
that DHA is protective to PA-LTX in NGFDPC12 cells.  We proceeded to test the effect 
of DHA regarding apoptosis, necroptosis and autophagy. Microscopically DHA-treated 
cells promoted long and thick neurites extensions, healthy body shape and size and keep 
the cells attached and confluent during PA-LTx.  Different concentrations of DHA 
ranging from 20 to 50uM protected NGFDPC12 cells from PA-LTx. Interesting pre-
treatment of DHA significantly also protected the cells and increased the cell viability 
during PA lipotoxicity. 
DHA not only increased cell viability but also decreased the gene expression as 
measure by mRNA levels of HIF-1α and BNIP3 during PA-LTx indicating that the effect 
of DHA in the cell is positive enough to bring the cell down to non-stress level.  We were 
expecting to see a decrease in PA-induced ROS when DHA was added to the media but 
we didn’t see it. When DHA is added to PA ROS levels remain the same but DHA didn’t 
increase the accumulation of ROS when applied by itself. 
The most interesting part of the findings of this study was the fact that DHA 
neuroprotection in part was due to the induction of autophagy.  For the last ten to fifteen 
years most of the literature in the field proposed autophagy as a cell death mechanism, 
even calling it autophagic cell death (Azad et al. 2008) or going as far as calling it 
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autophagic programmed cell death (Tsujimoto & Shimizu 2005).  More recently a new 
wave of articles has been published establishing a role for autophagy in cell survival and 
neuroprotection (Li et al. 2018, Marino et al. 2014, Lee 2012). We treated PA-injured 
cells with DHA and observed an increased in different molecular events characteristics of 
autophagy.  The first one was phosphorylation of beclin-1 at serine residue 93 as 
demonstrated by Western Blot.  Becline-1 (also known as ATG6) is the key protein in the 
activation of autophagy (Marino et al. 2014).  When beclin-1 is phosphorylated it 
acquires the capacity to dissociate from Bcl-2 and starts its interaction with the Atg5-Atg-
7-Atg12 axis and conjugation of LC3.  The autophagy promoter rapamycin was used as 
positive control and it induced phosphorylation of beclin-1 in control cells.  DHA also 
induced the phosphorylation of becline-1 in control cells.  PA treatment eradicated the 
becline-1 phosphorylated band completely suggesting that PA-LTx by inducing apoptosis 
even eliminates the basal autophagic flux necessary for normal metabolism.  The 
treatment of NGFDPC12 cells under PA-LTx restored and even increased above basal 
level the phosphorylation of becline-1 at serine 93. This is key because when becline-1 is 
phosphorylated Bcl-2 is not able to interact with beclin-1 and left to inhibit Bak and Bax 
and prevent the formation of the mitochondrial permeability transition pore with 
cytochrome c release with activation of caspases and apoptosis (Marino et al. 2014). The 
two processes apoptosis and autophagy can’t occur together.  This is a change in 
paradigm because we can focus on what the cell needs to survive and relegate to a second 
level what the cell is doing to die. 
As additional evidence for DHA-induced autophagy taking place as a defense 
versus PA-LTx we measured the gene expression of two proteins involved in the 
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regulation of autophagy Atg7 and Atg12 (Glick et al. 2010). Atg7 is important for the 
conjugation of LC3 and formation of the initial stages of the autophagosome called the 
phagophore.  Again DHA didn’t elevate the amount of mRNA as measured by PCR on 
control cells.  PA decreased to almost half the level of Atg7 mRNA at 24hrs of 
lipotoxicity.  When DHA was added to PA treated cells Atg7 mRNA levels were brought 
back to normal levels.  Something different but still interesting occurred with Atg12 
mRNA levels as measured by PCR.  PA again decreased the levels of Atg12 expression 
but DHA this time not only brought back the levels to normal but increased the 
expression of the gene 50% compared to control cells.   
The last piece of evidence is the direct measured of the activity of Atg7 (a 
conjugation and elongation protein) by showing the conjugation of LC3 with 
phosphatidyl ethanolamine that is key for membrane assembly of the phagophore, the 
formation of the protein conjugate that migrate at 14kDa during electrophoresis LC3-PE 
or LC3II.  DHA when applied by itself stimulated the formation of LC3II on control 
cells.  It’s worth noting that we have published that PUFA be it DHA or EPA increases 
the cell viability, cell size, neurites length and neurites thickness compared to control 
(Liu et al. 2008).  We speculate that DHA ramps up autophagy in the cell and that 
contribute to the degradation of oxidized molecules and more availability of growing 
substrates. PA nullified completely any conjugation of LC3 but DHA when in the 
presence of PA induced a strong conversion of LC3 to LC3-PE.  The lysosomotropic 
agent chloroquine which alters the autophagic flux by preventing acidification of 
lysosomes nullified the DHA-induced neuroprotection during PA-LTx. Taken together 
we think this is the highlight of the study because the applications can be myriads from 
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stroke to diabetic neuropathy and every pathology where neuroregeneration is necessary 
(Wang et al. 2018, He et al. 2017, Kesidou et al. 2013).   
In order to answer the question whether DHA was able to recue NGFDPC12 from 
caspase independent cell death we treated NGFDPC12 cells with DHA during PA-LTx + 
zVAD.fmk and DHA was able to keep the cell viability to control levels. We understand 
now that when cells are treated with zVAD.fmk in the presence of PA what we called 
before caspase independent cell death is actually necroptosis.  We showed in the present 
study that HgCl2 (necroptosis inducer) induces the conjugation of LC3I but staurosporine 
(apoptosis inducer) don’t. It means to us that autophagy or at least its machinery is used 
during HgCl2-induced cell death or that autophagy is a failed attempt of survival that 
eventually will succumb to necroptosis. Very interesting to us was the fact that DHA 
induced the same Topoisomerase cleavage pattern as HgCl2, zVAD.fmk, PA+zVAD.fmk 
in the presence or absence of PA suggesting that activation of cathepsins within the 
confine of a stable lysosomal membrane as we would expect in autophagy is the major 
contribution of DHA to rescue cells. 
 
EFABP Neuroprotection in PA-LTx 
Since a complete picture of DHA neuroprotection is still lacking and the 
mechanisms involved remain to be elucidated, we decided to investigate possible 
physiological interacting partners in lipotoxicity.  Our lab is being at the forefront in the 
understanding of fatty acids binding proteins. We showed that EFABP was important in 
the protection of NGFDPC12 cells under PA-LTx.  EFABP protein levels increased 
significantly during PA-LTx at 24 and 48hrs and that increase in protein level was 
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associated with an increase in mRNA levels that was responsive in a dose and time 
manner.  The pick for EFABP expression was at 12hrs under 300uM palmitic acid 
concentration but still the increased expression could be seen at 18hrs during 150uM PA 
concentration.  The increase in EFABP was correlated with PA-induced ROS that could 
be suppressed with two different antioxidants MCI-186 and N-acetyl-cysteine. The direct 
induction of ROS with TBHP (tert-butyl- hydroperoxide) induced an almost four fold 
expression of FABP5 mRNA levels as measured by RT-PCR.  This results were 
confirmed by modifying the promoter region of the FABP5 gene.  Considering that 
FABP5 gene has two putative NF-κB binding sites in the promoter region that mediate 
the up-regulation of EFABP in MCF-7 cells (Kannan-Thulasiraman et al. 2010) we 
explored the interactions of ROS and FABP5 regulation in cultures treated with SN50, 
which blocks nucleus translocation of NF-κB. We observed that in PA+SN50 treated 
cells EFABP mRNA expression was lower compared to control cells.  Even more 
inhibition of EFABP expression by preventing NF-κB translocation was correlated to a 
dramatic increase in ROS levels.   
To determine the necessity of palmitic acid metabolism as the causative agent of 
ROS-induced EFABP expression in PA-LTx we used a non-metabolized methyl ester of 
palmitic acid, methyl-palmitic acid (mPA).  We observed that mPA at three different 
concentrations does not alter either the EFABP mRNA expression or ROS levels and 
NGFDPC12 cells did not lose their morphological integrity as it occurred with PA 
treatment.  Therefore PA activation and metabolism are required in the lipotoxic process. 
We proposed in chapter 3 that the fundamental aspect of PA-LTx is an augmented state 
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of oxidative stress and that minimizing or buffering that oxidative stress is the key to 
protect from lipotoxicity.   
In order to confirm that EFABP is key to the homeostasis of the cell during 
saturated fatty acid injury we silenced the gene using siRNA technology.  siRNA is a 
specific, potent, and highly successful approach for loss-of-function studies. We used this 
approach to evaluate the hypothesis that FABP5 is unequivocally necessary for 
neuroprotection during PA-induced ROS injury.  PA treatment in NGFDPC12 cells 
resulted in elevated EFABP mRNA levels in siControl cells but a significant decrease in 
EFABP mRNA expression in siFABP5+PA treated cells.  Inhibiting EFABP by siEFABP 
results in higher levels of ROS when compared to siControl cells.  This suggests to us 
that fatty acid binding protein in general do more than just trafficking fats around the 
cytoplasm of the cell and are involved in keeping the oxidative environment of the cell in 
check.  When PA is added to siEFABP treated cells the amount of ROS is almost three 
times that of siControl cells treated with PA that already was the double the amount of 
ROS of the siControl. The most impacting result is the fact that silencing of EFABP 
during PA-LTx decreased cell viability as measured by WST-1 assay when compared to 
siControl.  Doing the opposite, transfecting cells with recombinant EFABP and exposing 
them to PA-LTx prevented the cells from increasing ROS when compared to PA + 
vehicle.  We emphasize that cells treated with recombinant EFABP and PA had higher 
cell viability when compared with cells treated with the transfection vehicle and PA.  It 
tells us that by limiting the supply of saturated fatty acids to be metabolized by the 
mitochondria or by buffering the ROS that will result from saturated fatty acid 
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metabolism EFABP is necessary to avoid an augmented state of oxidative stress and cell 
death. 
As we mention in the introduction lipids are at the core of metabolic syndrome 
and their effect can be seen in insulin resistance, diabetes, arthrosclerosis, ischemic 
disease and stroke. In non-neuronal tissue like pancreatic islet cells, the chronic elevation 
of plasma free fatty acids leads to lipotoxicity, which has been reported to be responsible 
for the loss of β-cell function and plays a major role in the pathogenesis of diabetes (Lee 
et al. 1994).  EFABP has been shown to be regulated by PPARs (peroxisomes-
proliferator activated receptor) (Hyder et al. 2010) and the balance between PPARα and 
PPARγ activities for example play a crucial role in determining the cell fat storage 
(Auwerx 1999).  Taken together the modulation of EFABP expression through PPAR’s 
control seems to be another important factor in lipotoxicity.  Using GW0742 (PPARβ 
agonist) and GW1929 (PPARγ agonist) we measured the effect on EFABP mRNA 
expression and observed a dramatic stimulation by GW0742 treatment and modest 
stimulation by GW1929 treatment at 24hours.  When PA was added in the presence of 
these two agonists cell viability assays showed better resistance compared to PA 
treatment alone. Furthermore, the protective effect provided by PPARβ and PPARγ was 
abolished in siEFABP-transfected cells, confirming the important role of EFABP in the 
PPAR agonist-initiated resistance during PA-LTx.   Therefore by understanding the role 
EFABP and its relation to PPARs we can modulate the metabolisms of fats that is so 






Lipotoxicity seems to be involved in ischemic-hypoxic pathological processes in 
different kinds of tissues from pancreatic, cardiac, nervous, hepatic and pulmonary (Petry 
et al. 2018, Chen et al. 2018b, Gu et al. 2017, Rius et al. 2017, Yilmaz et al. 2015).  With 
this paradigm in mind we envisioned to seek cellular events that we observed take place 
during PA-LTx in NGFDPC12 when these cells are subjected to hypoxia.  Hypoxia in 
our study was defined at .5% oxygen concentration.  Not to our surprise hypoxia 
increased the levels of mRNA expression of HIF-1α indicating the stress it imposes on 
the cells. HIF-1α stimulates and complexes with BNIP3 to stimulates the cell for copying 
with the challenge by ramping up cell survival mechanism or if the attempt fails to trigger 
cellular demise through the cleaner and less inflammatory route.  We remind the reader 
that PA-LTx also induced the expression of HIF-1α and BNIP3.   
Hypoxia also increased the levels of AnnexinV, a characteristic feature of cells 
going into the early stages of apoptosis.  Contrary to the tumor hypoxic environment 
where cells “learn” how to survive in low oxygen tension (Chouaib et al. 2018, Joseph et 
al. 2018, Lee et al. 2018), neurons are extremely sensitive to hypoxia (Beaudin et al. 
2017) because they are already in a “below than average” oxygen environment 
(Ndubuizu & LaManna 2007) and decreases in blood flow rapidly reach pathological 
levels.  We also observed an increased in ROS during hypoxia.  This is another parallel 
event common both to hypoxia and PA-LTx. We will repeat here that this “augmented 
state of oxidative stress” is the essence of the cause for cell demise.  All cell events 
described in this study are activated in response to oxidation and are attempts at getting 
rid of oxygen species and peroxidation.  This increase in ROS during hypoxia can be 
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buffered with MCI-186 antioxidant.  This preliminary finding we hypothesize will serve 
to answer the question whether decreasing ROS increases cell viability.  As we showed in 
chapter three an increase in ROS induced the expression of E-FABP and protected the 
cell from lipotoxicity. 
 
DHA Neuroprotection in Hypoxia 
Another parallel finding between PA-LTx and hypoxia is that both can be 
reversed with DHA treatment.  This is the highlight finding of chapter four.  DHA kept 
the integrity of cell membranes, the extension of neurites, and the appropriate shape and 
size of the NGFDPC12 cell bodies during hypoxia.  As in chapter two induction of 
autophagy seems to be protective for NGFDPC12 during hypoxia.  We treated the cells 
with autophagy promoter rapamycin and observed the same effect of protection as DHA.  
The cell viability of DHA or rapamycin treated cells under hypoxia as measured by 
crystal violet was a high as control cells in normoxia.  Even more both DHA and 
rapamycin at different concentrations decreased the levels of AnnexinV induced by 
hypoxia.  Both rapamycin and DHA stimulated autophagy as seen by the second 14kDa 
band indicative of the conjugation of LC3 on WB.  We speculate that the same events 
that took place in DHA protection against lipotoxicity like beclin-1 phosphorylation and 
Atg7 and Atg12 mRNA expression will be seen in DHA-protection during hypoxia.  
These will be subject for future studies. 
In a previous publication (Liu et al. 2008) we have reported that the 
polyunsaturated fatty acid EPA give the same morphological characteristics of 
neurogenesis to NGFDPC12 cells and neuroprotection.  We pre-treated the cells with 
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either DHA or EPA and exposed them to hypoxia.  Both polyunsaturated fatty acids gave 
protection to the cells almost as high as DHA co-treatment during hypoxia.  As we 
proposed in chapter 2, once a polyunsaturated fatty acid is incorporated in the cell 
membrane phospholipases activated during hypoxia cleave the fatty acid free and use it in 
the molecular process be it phagophore formation, membrane signaling or even LC3 
conjugation  (Stillwell et al. 2005, Stillwell & Wassall 2003). 
Topoisomerase I cleavage pattern by western blot showed that pre-DHA induces 
the 45kDa band characteristic of cathepsins activation and necrosis (Casiano et al. 1996, 
Casiano et al. 1998).  We proposed that DHA helps to keep the integrity of lysosomes 
and allow for the autophagic flux to continue.  Contrary to what be expected with this 
necrosis pattern cell viability of DHA treated cells during hypoxia was high.  A similar 
finding was observed with the cleavage pattern of PARP protein (Casiano et al. 1996, 
Casiano et al. 1998).  Albeit the normoxia side of the blot presented in the result section 
of chapter 4 shows the 50 kDa in all three conditions, it could be observed that the only 
treatment showing this 50kD band in hypoxia was the pre-treatment with DHA.   The two 
hypoxia control groups didn’t show the band and the cell viability of this condition was 
low. 
 
EFABP Neuroprotection in Hypoxia 
Another parallel of PA-LTx and hypoxia was the fact that EFABP expression 
increases during hypoxia, even 5 fold increase at 48hrs.  EFABP protein level also 
increased during hypoxia and showed a constant increase from 12 to 48 hours.  The 
hypoxia-induced ROS accumulation lead the cell to increase the levels of EFABP 
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mRNA.  This hypoxia-induced ROS-mediated increase in EFABP mRNA level could be 
blunted by buffering ROS using antioxidant MCI-186.  We propose that EFABP is a 
ROS scavenger and we hypothesize EFABP can be actually buffering saturated free fatty 
acids from producing more ROS.  Silencing of EFABP with siRNA resulted in a similar 
outcome as silencing EFABP during lipotopxicity.  It decreased the cell viability to half 
the percent of normoxia cells.   The PPARγ agonist WY14643 increased the EFABP 
mRNA during normoxia condition.  The PPARγ antagonist GW9966 decreased the 
expression of EFABP during hypoxia.  Futures studies will be done to test the correlation 
of EFABP inhibition and cell viability during lipotoxicity.  This is another fascinating 
parallel between PA-LTx and hypoxia because it implies a role for lipotoxicity during 
hypoxia.  We expect that this work will be continued and the correlation established. 
In summary, DHA mechanism of protection from lipotoxicity is due to inhibition 
of apoptosis and necroptosis and activation of autophagy.  The effect can be seen by co-
treatment or pre-treatment suggesting the incorporation of DHA in cell membranes.  The 
present study cast light over the change of PA-LTx-induced cell death from apoptosis to 
necroptosis in the presence of caspase inhibitors.  Also DHA protection from hypoxia by 
inhibiting apoptosis and stimulating autophagy and the role EFABP play in both PA-LTx 
and hypoxia.  We expect that lipids will continue emerging as important players in many 
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